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ABSTRACT 
 
 
Natural products have provided considerable value for drug discovery over the past half-
century. Nearly four fifth of drugs were natural products or inspired by natural compounds. 
Bioactive secondary metabolites isolated from natural source, either fungal or terrestrial, are 
relatively safer for human health and the environment and can serve as drug or as drug leads for 
the development of synthetic or semi-synthetic analogs. Natural products have also been 
successfully used in agriculture as plant growth regulators, signal transductions, fungicides, 
herbicides and tranquilizers. In our continued efforts to identify bioactive compounds, seventy-
seven plant and fungal extracts were evaluated using a direct-bioautography assay coupled with 
three Colletotrichum species to detect antifungal metabolites. Three crude extracts that showed 
significant antifungal activity were selected for further bioassay-guided isolation. Various 
chromatographic techniques including preparative thin layer chromatography, vacuum liquid 
chromatography, flash chromatography, high pressure liquid chromatography and over pressure 
layer chromatography were utilized to isolate biologically active secondary metabolites from 
natural products of fungal and plant origin. Among all the techniques, over pressure layer 
chromatography were first adopt here for preparative isolation of natural products. It turned out 
to be a rapid and efficient method of exploiting co-migrating bioactive metabolites, and eleven 
compounds including two new molecules were isolated by using this technique. The structure of 
the isolated compounds was elucidated through various spectroscopic methods, including high-
resolution mass spectrometry, one and two-dimensional nuclear magnetic resonance 
	   iii 
spectroscopy. Finally, the isolated compound was submitted for several in vitro assays, including 
antifungal, herbicidal, antibacterial, and cannabinoid and opioid receptor agonist assays. Some 
compounds showed potent antifungal activity against strawberry pathogens and one compound 
also showed good herbicidal and antibacterial activity. These compounds could be exploited as 
drug leads to potential agrochemicals or pharmaceuticals. All the promising drug leads have been 
submitted for antifungal testing using 24-well strawberry leaf disc assay. 
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CHAPTER 1 BACKGROUND 
1.1 NATURAL PRODUCT-BASED DRUGS OR DRUG LEADS 
Natural products refer to small organic chemical molecules produced by plants, fungi, 
bacteria and lower eukaryotes. They also include peptides, proteins, other larger-molecular-
weight toxin from marine sources, and hormones from animals (e.g. natural estrogens from 
pregnant mare urine) 1. In terms of the availability of starting materials, plants and fungi provide 
a rich source of numerous pharmaceutical and agrochemical agents. There are around 250, 000 
types of plants in the world and it is reported that only 10% of them have been investigated. 
Fungi are also good source of bioactive compounds and about 95% of fungal species have not 
been studied 2, 3, 4. Plants and fungi therefore continue to be a great reservoir for identifying novel 
bioactive secondary metabolites. Historically, the majority of new drugs were natural products or 
were inspired by natural compounds 5, 6 and over 120 of the most important medicines, including 
penicillin (1) and cyclosporine (2), are obtained from fungal extracts 4 (Figure 1.1). 
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Figure 1.1 Some famous compounds derived from natural source. 
 
Natural products can also serve as lead structures for the development of new synthetic or 
semi-synthetic analogs. Many of the isolated lead natural compounds are available only in 
extremely small quantities, especially those from marine organisms such as sponges. The 
preparation of natural product analogs, which are not naturally occurring, may provide a good 
yield of desired compounds. And it allows scientists to design and enhance the druglike 
properties of the medicines that nature has provided, such as bioactivity, solubility and 
pharmacokinetics. Of importance is that the analogs are easier to synthesize than the parent 
compounds. Designing unnatural compounds that preserve or even improve biological activity, 
while removing unnecessary molecular complexity, is the main aim of analog synthesis 7. Figure 
1.2 shows two successful examples of natural product-inspired drug design by structural deletion 
and unnecessary functionality removal from the parent natural products 8, 9. 
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Figure 1.2 Two famous structural modification examples of natural product templates7. 
 
E7389 (3), currently in phase I clinical trials, was generated from the total synthesis of 
halichondrin B (4, HB), a highly cytotoxic marine natural product 8, 10, 11. Zheng, et al. 
discovered that the deletion of a large region of the molecule did not affect its antimitotic 
properties 12. Furthermore, replacing the easily cleaved lactone with a ketone maintained an in 
vitro profile very similar to the parent compound but increased the stability in vivo13. Another 
powerful illustration of structure simplification is the development of bryostain analog A. 
Bryostatin 1 (5) is a very promising marine natural product and displays potent biological 
activity against a variety of human diseases 14. It is currently in phase II clinical trials as an 
anticancer agent. Simplification of the scaffold region of Bryostatin 1 resulted in analog A (6), 
which was more potent than the parent compound 15.   
 
Despite these statistics natural products research has experienced a slow decline during the 
past two decades 15. The main reason lies in the rapid development of combinational chemistry 
and high-throughput screening (HTS) in pharmaceutical company 7. However, untapped 
biological resources, “smart screening” methods 16, robotic separation with structural analysis, 
(3) (4) 
(5) (6) 
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metabolic engineering, and synthetic biology have prompted a renewed interest in natural 
products as a source of chemical diversity and lead compound generation. Advance technologies 
may provide a vast resource for the future discovery of pharmaceutical and agrochemical agents.  
 
1.2 NATURAL PRODUCT-BASED FUNGICIDES 
Natural products have also been successfully used in agriculture as fungicides, herbicides, 
insecticids, algeacides, plant growth regulators, signal transductions, herbicides and tranquilizers 
17. Griseofulvin (7) (Figure 1.1) was the first reported agrochemical fungicide, which is still used 
today in the treatment of fungal infections 18. After that, several other plant or bacterial natural 
products were available on the market as plant protectants through the induction of systemic 
acquired resistance (SAR) process including Messenger® (EDEN Biosciences, Inc., Bothell, WA) 
and Serenade® (AgraQuest, Davis, CA), Sonata® (AgraQuest, Davis, CA), and Milsana® (KHH 
BioSci, Inc., Raleigh, NC). Messenger is derived from a natural protein (harpin), which 
stimulates a plant’s defense and growth mechanism to protect itself from adverse bacterial and 
fungal diseases. Serenade and Sonata are both microbial-protectants with ability against Botrytis, 
mildews, ruts, blight, and bacterial spot. Milsana is a plant extract widely used for preventive 
control of powdery mildew. Of special importance, these naturally occurring plant protectants 
are relatively safer and do not adversely affect the environment and invertebrates due to target 
specific and biodegradability. 
 
Why do natural products possess such particular specificity and potency compared to 
artificially synthesized molecules? The answer lies in over millions of years’ evolutionary 
selection by nature. Nature has its own high-through screening process for the optimization of 
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biologically active compounds. Natural products are endowed with well-defined three-
dimensional structures carrying a number of functional groups (hydrogen bond acceptor/donors, 
etc.) that synthetic molecules may lack 19. Additionally, the structures of the biological receptors 
of such natural products (e.g. protein binding sites) normally have high conservations among 
proteins of markedly different genetic sequences, such as secondary metabolites that have 
evolved for a certain purpose by a producing organism may provide different but equally potent 
effects in other organisms 15.  
 
The common property in both agrochemical and pharmaceutical pursuits is chemistry. 
Whether the bioactivity of a natural product is for an agrochemical or pharmaceutical application 
depends on dose. Scientists found that there may be indistinguishable between therapeutic and 
toxic properties of a compound except by dose. Because of numbers of natural products that have 
been identified, it was unavoidable that agrochemical and pharmaceutical areas would eventually 
meld.  
1.3 OPIOID AND CANNABINOID RECEPTORS IN DRUG DISCOVERY 
Opioid receptors belong to a large family of G protein-coupled receptors. Opioid-binding 
sites were first discovered in 1973 20. Since then, extensive pharmacological studies have been 
done on a variety of opioid receptor types. To date, three opioid receptors have been identified 
including µ, κ, and δ. Their activation can be induced by both endogenous opioid peptides and 
exogenous opioid drugs, such as morphine21, which is capable of causing analgesia, respiratory 
depression, euphoria, feeding, the release of hormones, inhibition of gastrointestinal transit, and 
decreased bowel motility22, 23. Currently, the most clinically available opioid analgesics are µ-
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agonists that refer to morphine and its analogs. However, their use was restricted because of the 
side effects including tolerance and physical dependency.  
 
Cannabinoid receptors are also members of a large superfamily of G protein-coupled 
receptors (GPCRs). There are two subunits of cannabinoid receptors including CB1 and CB2. 
Previous studies showed that activation of cannabinoid receptors resulted in the stimulation of 
appetite 24. Particularly, CB1 agonists were reported to regulate energy input and output through 
shared central and peripheral mechanisms and CB1 antagonists was expected to contribute long-
period efficacy for weight loss 22. 
 
Over the past thirty years, scientists have recognized that development of opioid and 
cannabinoid receptors targeting drugs is efficient to cure or alleviate CNS symptoms. Although 
many works have been done in the discovery and development of opioid and cannabinoid-based 
therapeutics, there are few drugs acting on these two types of receptors. Dronabinol (8) is the 
only drug acting on cannabinoid receptors in the clinic. However, this drug causes many side 
effects such as confusion, headache, nausea, vomiting and among others 22. It is apparent that 
new molecules are needed to continue the fight. Natural products provide a major source of new 
chemical scaffolds which act on opioid or cannabinoid receptors because small molecules with 
novel structures and potency can be the biological probes to uncover what is behind these two 
receptors and the mystery of many related CNS diseases, and also can be the leads for new 
therapeutics.  
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1.4 CURRENT SITUATIONS OF COMMERCIAL FUNGICIDES 
Strawberry anthracnose is a serious disease in many areas of the world and particularly 
severe in the southeastern United States where diseases are often enhanced by warm temperature 
and frequent rains during the harvest season. Anthracnose is a disease that appears as black, 
sunken lesions on leaves, stems, or fruits and is caused by fungi capable to produce their asexual 
spores 25. Strawberry anthracnose disease is mainly caused by filamentous fungi in the genus 
Colletotrichum that often cause typical symptoms of anthracnose diseases on a variety of plants 
including cereals, grasses, cucurbits, tomatoes, and are serious problems for strawberry (Fragaria 
× ananassa Duch.) fruits and plant production worldwide 26. Colletotrichum species are defined 
as destructive pathogens that cause significant economic damage to crops worldwide. The three 
most common Colletotrichum species including Colletotrichum fragariae A. N. Brooks, 
Colletotrichum acutatum J. H. Simmonds, and Colletotrichum gloeosporoides (Penz.) 
Penz.&Sacc. can occur singly or in combination 27, 28.C. acutatum has a very wide host range and 
can infect almond, apple, blueberry, and strawberry 29, 30, 31. Strawberry anthracnose can be 
devastating since other plant parts may be infected in addition to the fruit. This causes millions 
of dollars in crop loss each year 32.  
 
Phomopsis viticola Sacc. is another common plant pathogen that causes severe diseases of 
grapes all over the world, known as Phomopsis cane and leaf spot disease. P. viticola (Ellis and 
Everh.) B. sutton can infect canes, leaves, rachis and berries. It was reported that cane infections 
acted as the primary source of inoculum, while rachis and berry infections caused the highest rate 
reductions and economic loss 33. Another important species of Phomopsis, P. obscurans, causes 
a disease known as leaf blight of the cultivated strawberry that became a serious problem in 1985. 
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P. obscurans can infect foliage, runners, petioles, and fruits with a dark brown center surrounded 
by light-brown rings with purplish halos 34, 35. 
 
Botrytis cinerea Pers.: Fr. is a ubiquitous fungus that infects a wide range of important plants 
and vegetables, including ornamentals, bulbs, and fruit crops in temperate regions. The pathogen 
produced profuse conidia and mycelia on the surface of dead and infected stems and calyxes, and 
cause Botrytis bunch rot of grapes and strawberries 36, 37, 38. Fusarium oxysporum Schlechtend: 
Fr causes a disease known as Fusarium wilt, which is a major problem in most cotton growing 
regions of the world. In 1995, it causes huge economic loss in the cotton belt of the United States 
39. 
 
Increasing incidence of fungal strain resistance and potential environmental and mammalian 
toxicities, caused by application of conventional fungicides, are two factors that drive a need to 
search for new plant protectants 40. Particularly desirable is exploiting active natural products 
with new chemical classes that might function by different modes of action than existing 
fungicides, thus avoiding problems of cross-resistance to current chemicals. Bioactive natural 
products isolated from plants or terrestrial fungi are safer for human health and the environment 
and can be used in modern crop protection or serve as lead structures for the development of 
synthetic or semi-synthetic analogs. 
1.5 PRIMARY GOAL OF THIS STUDY 
The primary goal of this study was to identify the secondary metabolites responsible for 
the antifungal activity against plant pathogens from terrestrial and fungal organisms. Some 
fractions or pure compounds also were tested for their opioid and/or cannabinoid receptor 
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binding affinity, antibacterial and herbicidal activity. Plant and fungal crude extracts were 
selected based on the antifungal bioautographic results. 59 plant and fungal extracts were 
screened using a direct-bioautography assay to detect antifungal metabolites against three 
Colletotrichum species and three of them, Diospyros virginiana, Cladosporium cladosporioides, 
and Milogrante (Highlighted in yellow) showed promising antifungal activity and were selected 
for further isolation study (Table 1.1).  
 
Table 1.1 59 Extracts Screened For Antifungal Activity Using Direct-Bioautography. 
Material Number Part Code Weight (mg) 
Anadenanthera spp. 2762:6-10-2005 Seeds (yopo) A-1 5.9 
Berchemia scandens BUR240394-8 Stem B-1 5.2 
 BUR280394-2 Root B-2 5.2 
 IBEET7618 Shoot B-3 5.4 
 CON021100-4-A Leaf B-4 5.9 
Croton capitatus MOBOT145 PX C-1 5.4 
 CON240700-3-A Stem &Root C-2 5.4 
Diospyros virginiana CON310700-2-A Root D-1 5.4 
 CON310700-2-B Bark D-2 5.4 
 CON310700-2-C Xylem D-3 4.9 
 CON310700-2-D Leaf D-4 5.6 
 CON310700-2-E Fruit D-5 5.7 
 MOBOT165 LF D-6 5.7 
 MOBOT166 ST D-7 5.5 
 MOBOT26 ST D-8 4.9 
 MOBOT328 Fruit D-9 6.6 
 MOBOT329 LF-ST D-10 5.5 
Eupenicillium parvum MH/But  E-1 4.8 
 MH/HAH/EtOAc  E-2 5.2 
Hypericum hypericoides MOBOT1014 PL H-1 5.3 
H. hypericoides -- PL H-2 5.4 
Hypericum punctatum -- PL H-3 5.3 
Hypericum stans MOBOT1016 PL H-4 4.6 
HGC-1  Fungus H-5 6.1 
Ipomoea purpurea CON200900-3-A Whole Plant I-1 6.3 
Ipomoea violaceae 2744:4-16-2005  I-2 5.1 
Lactuca/Launae 
taraxacifolia 2761-6-7-05 Stem L-1 5.2 
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Lagochilus inebrians 2739:4-12-2005  L-2 4.7 
Leonotis leonurus 2727  L-3 5.0 
Leonurus cardiaca 2766  L-4 4.4 
Nelumbo nucifera 2451 Flower N-1 5.3 
N. nucifera 2453  N-2 4.8 
N-2574US  Fungus N-3 5.2 
Solanum carolinense CON200900-2-A Whole Plant S-1 4.9 
S. carolinense 3808:7-15-2008 Whole Plant S-2 5.9 
Virola surianmensis 2752:4-19-2005  V-1 5.2 
Virola theiodora 2738:4-12-2005  V-2 5.2 
NZ-658  Fungus   
NZ-617  Fungus   
ATCC-5907  Fungus   
NZ-647  Fungus   
NZ-656  Fungus   
ATCC-38849  Fungus   
NZ-654  Fungus   
UK-168  Fungus   
NRRL-5507  Fungus   
NZ-574  Fungus   
NZ-648  Fungus   
C. echinulata  Fungus   
ATCC-48726  Fungus   
NRRL-13489  Fungus   
UK-115  Fungus   
Milogrante  Fungus   
NZ-652  Fungus   
NZ-610  Fungus   
ATCC-34655  Fungus   
ATCC-60782  Fungus   
NRLA-17159  Fungus   
ATCC-42761  Fungus   
 
 
Crude extracts, fractions, sub-fractions and pure compounds of Cladosporium 
cladosporioides and Milogrante were also tested for opioid and cannabinoid receptor binding 
affinity. Radio-ligand binding assays for opioid (subtype δ, κ and µ) and cannabinoid receptors 
(CB1 and CB2) have been a useful tool in the discovery of novel agents. Active compounds were 
isolated by bioassay-guided fractionation methods. The structures of purified compounds were 
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elucidated using various NMR spectroscopy and mass spectrometry techniques. Absolute 
configuration of chiral centers in compounds was assigned and confirmed by X-ray 
crystallography, and/or chemical derivation. Pure compounds were further tested by 96-
microtiter diluted broth assay and 24-well plate strawberry leaf disc assay to determine their in 
vitro potency against plant pathogens. 
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CHAPTER 2 ANTIFUNGAL METABOLITES FROM THE ROOTS OF DIOSPYROS 
VIRGINIANA BY OVERPRESSURE LAYER CHROMATOGRAPHY 
2.1 INTRODUCTION 
2.1.1 Pharmacology and Chemistry of Diospyros Species (American Persimmon) 
Discovery of new crop protectants from natural products has received considerable interest as 
alternatives to synthetic agrochemicals for use as pest and disease-control agents. This interest 
stems from the fact that these are generally safer for human health and the environment. 
Biologically active natural products can be used in modern crop protection or can serve as lead 
structures for the development of new semi-synthetic analogs. Our current research efforts are 
directed to the identification of natural product-based fungicides. Secondary metabolites may be 
ideal candidates as plant protectants, since their mode of action is selected by nature’s evolution 
that is likely to be different from existing agents, thus avoiding the problem of resistance of the 
fungi to current fungicides.  
 
Diospyros belongs to the family Ebenaceae which consists of three genera and ca. 500 
species of trees and shrubs 41, of which more than 350 species are distributed in tropical and 
subtropical regions worldwide 42, 43. Diospyros is the largest and the most economically 
important genus of Ebenaceae. Most of them have a good yield of edible fruits, ebony and
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valuable timbers. D. kaki is the most well known species, which was originated in East China 
and has been cultivated in Japan for centuries 44. The mixture of the leaf extract of D. kaki and 
jasmine has been the major constituent of anti-tobacco smoking candies in Japan. Many other 
Diospyros species have been reported to have important biological and pharmacological 
activities. For example, D. peregrina and D. melanoxylon, have been used in folk medicine for 
the treatment of inflammation and urinary discharges, and for enrichment of blood since olden 
times 45. Plumbagin, the major component of D. kaki 46 is the first bioactive compounds isolated 
from Diospyros species 47. It was reported to show mosquito antifeedant and insecticidal 
activities 48. Various extracts of Diospyros species have also been used as medicines in ancient 
Thailand, Japan, India and China 45. Famous examples include the uses of alcohol extracts of D. 
usambarensis 49 and D. zombensis 50  as fungicidal and molluscicidal agents, and the uses the 
leaves of D. diepenhorstii as piscicidal and molluscicidal agents 45. The fruits of D. lotus have 
been used as a sedative, antitussive, antiseptic, antidiabetic, antitumor, astringent, laxative, 
nutritive and as a febrifuge 51. 
 
In the past century, more than 130 Diospyros species have been phytochemically screened 
and interestingly almost all parts (leaves, bark, roots, fruits) of the Diospyros species have been 
detected for chemical constituents and biological evaluation. The most widely distributed 
component is triterpenes, which was found in above 90% of Diospyros plants 45. All the 
triterpenes have a pentacyclic core in common and belong to lupane, ursane and oleananes 
skeletons. The major compounds of lupane class, which have been reported from more than 25 
plants, include lupeol, betulin and betulinic acid, with betulinic acid being the first lupane 
derivative isolated from one Diospyros species52. 
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Lupeol (lup-20 (29)-en-3β-ol) is a triterpenoid purified from many popular medical plants 
such as Diplotropis ferruginea Benth 53, Syzygium formosanum Hay 54, Pimenta racemosa var. 
ozua 55, Tamarindus indica, American ginseng, and Crataeva nurvala, as well as a variety of 
fruits and vegetables including olive, fig, mango, strawberry, white cabbage, green pepper 56. 
Previous studies found that lupeol is a multi-target agent with a broad range of biological 
activities against inflammation, cancer, arthritis, protozoal, diabetes, heart diseases, renal toxicity 
and hepatic activity 57. The major significance of lupeol is that it causes no toxicity to normal 
cells when administered in even higher doses58, which illustrates the fact that secondary 
metabolites extensively present in edible fruits and vegetables, are potentially more safe than 
synthetic molecules for human use.  
 
The inhibitory effects on inflammation of lupeol have been widely studied under in vitro and 
animal models. Nguemfo et al. stated that lupeol showed higher maximum inhibition in an 
animal model than a well-known phytochemical α-Mangosteen at similar dose (57.14% vs. 
38.70%) 59. Geetha et al. reported the use of lupeol in a mice model of arthritis to suppress the 
phagocytic activity of macrophages, and T-lymphoeytes and CD4+ cell medicated cytokine 
generation 60. Furthermore, a recent study conducted by Vasconcelos and coworkers (2008) 
showed that application of lupeol caused a significant reduction in eosinophils infiltration and in 
Th2-associated cytokines (IL-4, IL-5, IL-13) levels responsible for the immune response in 
asthma 53. Ding and coworkers concluded that lupeol reduced the LPS-induced IL-6 secretion at 
concentration of l µM 60. The mechanism of anti-inflammatory activity of lupeol has been 
studied by several groups. Lupeol has the ability to decrease the generation of pro-inflammatory 
cytokines such as tumor necrosis factor α (TNFα) and Interleukin β (ILβ) 61. Further studies 
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showed that lupeol treatment can decrease the levels of type II cytokines IL-4, IL-5, and IL-13 in 
a bronchial asthma mouse model 59.  
 
Lupeol and its derivatives have also been studied for their great potential as anticancer agents 
in several cancer cell lines including prostate, skin, pancreatic and breast cancer 56, 62, 63, 64, 65. It is 
noteworthy that lupeol has been shown to exhibit strong antineoplastic and anti-proliferative 
activity under in vitro and in vivo situations by directly inhibiting tumor growth, cell cycle 
progression and inducing the apoptosis of tumor cells 66, 67, 68. Lupeol was also reported to have 
anti-mutagenic activity and can inhibit chemically induced DNA damage 69, 70, 71. Recent studies 
by Prasad and Nigam et al. showed that topical treatment of lupeol could prevent 7,12-
dimethylbenz [α] anthracene [DMBA]-induced DNA strand break in murine skin70 and  
Benzo[α]pyrene[B(α)P]-induced genotoxicity in a mouse model 72. Lupeol also has great 
potential to modulate signaling pathways such as nuclear factor kappa B (NFκB) and the 
phosphatidylinositol 3-kinase [PI3K]/Akt 73. Taken together, these compelling evidences warrant 
that lupeol is a really attractive molecule that can be a lead scaffold for synthetic chemistry and 
we need to pay great attention to it in further drug investigation. 
 
Betulinic acid (3β-hydroxy-lup-20(29)-en-28-oic acid) is a common compound widely 
distributed in many plant species with a number of pharmacological activities including anti-
inflammatory, anticancer, antimalarial, antibacterial, anthelmintic, antioxidant properties and 
inhibition of human immunodeficiency virus (HIV)74. The sources of betulinic acid include 
Betula alba (Betulaceae), Ziziphusspp. (Rhamnaceae), Syzygiumspp. (Myrtaceae), and 
Paeoniaspp. (Paeoniaceae)74, 75. Hundreds of publications have described the application of 
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betulinic acid for treatment of cancer 76, 77, 78, viral infections 79, hair loss 80, and other conditions. 
However, the most regarded activities of betulinic acid are anti-HIV-1 activity and specific 
cytotoxicity against a variety of tumor cell lines 77. 
 
In 1994, Fujioka et al. reported that betulinic acid was capable of inhibiting HIV-1 
replication with an IC50 value of 1.4 µM 81. In light of its promising anti-HIV activity, a variety 
of betulinic acid analogs were subsequently synthesized to enhance the anti-HIV activity. 
RPR103611 was concluded to be the only low-molecular-weight analog to date that effectively 
inhibits HIV infection at an envelope-dependent post-binding step with an IC50 value ranging 
between 40 and 100 nM in various in vitro cell-based assays 82. SAR studies showed that the A-
ring of betulinic acid was not an ideal site for structure modifications 83. The mechanism of anti-
HIV of betulinic acid and betulin analogs appeared to be associated with viral entry and 
maturation 75.  
 
A report in 1995 showed that betulinic acid selectively inhibited human melanoma cells 
grown in vitro 84. The mechanism of anti-tumor activity of betulinic acid was thought to be 
through induction of apoptosis independent of the cell’s p53 regulation 85. Betulinic acid and its 
derivatives were found to have a high protein tyrosine phosphatase 1B (PTP1B) and 
diacylglycerol acyltransferase (DGAT) inhibitory activity 86, 87. Betulinic acid was reported to 
show activity against TPA-induced tumors, ovarian, melanoma xenographs in mice models 88. 
Because of its selective cytotoxicity against tumor cells and lacking of side effects to normal 
cells, betulinic acid became a very promising novel chemotherapeutic agent for the treatment of 
HIV infection and cancer. 
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Ursane is another class of pentacyclic triterpene that are widespread in the Diospyros species. 
One representative metabolite in this class is ursolic acid (3-β-hydroxy-urs-12-en-28-oic acid), 
which was isolated in good quantities from many Diospyros plants and other tea trees, spice 
plants such as paulownia 89. Ursolic acid has been reported to decrease incidence of gastric 
ulceration induced by pyloric ligation 90, and also inhibit proliferation of multiple myeloma cells 
91.  
 
Besides triterpenoids, the uniqueness of Diospyros genus is the presence of a large number of 
napththoquinone metabolites, which all have a juglone framework. 7-methyljuglone (5-hydroxy-
7-methyl-1, 4-naphthoquinone) is a chief component in this class, and was previously isolated 
and identified as an active component from the root extracts of Euclea natalensis with 
titubercular and termiticidal activity 92. One recent report showed that 7-methyljuglone exhibited 
intracellular and extracellular inhibition of M. tuberculosis comparable to streptomycin and 
ethambutol 93. Because of its fairly simple chemical structure and pharmacological effects, many 
scientists have paid attention to the total synthesis of this compound. It was first synthesized by 
Cooke et al. in 1952 and improved by Musgrave et al. in 2001 94. 
 
Shinanolone (6-methyl-4, 8-dihydroxy-3, 4-dihydronaphthalene) is also a 1,4-
naphthoquinone metabolite, which is common in Diospyros species. One report showed that 
shinanolone exhibited anti-mycobacterial activity against M. tuberculosis at a concentration of 
0.1 mg/mL and antibacterial activity against a variety of test organisms95,96.  
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As mentioned before, the most common Diospyros naphthoquinone is 7-methyljuglone. 
Isodiospyrin (5-hydroxy-6-(1-hydroxy-6-methyl-5,8-dioxo-naphthalen-2-yl)-2-methyl-
naphthalene-1,4-dione) is a dimer of 7-methyljuglone linked between C-6 and C-8’. It was the 
first compound isolated from the wood of Diospyros virginiana by Fallas and Thomson in 1968 
97 and was reported to show significant cytotoxicity against the HCT-8 colon tumor, P-388 
lymphocytic leukemiaK, HEPA-3B hepatoma, KB nasopharynx carcinoma, CLOL-205 colon 
carcinoma and HeLa cervical carcinomaL. Isodiospyrin acts as a novel human DNA 
topoisomerase I (htopo I) inhibitor through the ability to antagonize camptothecin-induced, htopo 
I-mediated DNA cleavage and inhibits htopo I by direct binding to htopo I without access to the 
DNA substrate 98. Furthermore, isodiospyrin exhibits strong inhibitory effect on the kinase 
activity of htopo I toward splicing factor 2/alternate splicing factor in the absence of DNA. Thus, 
these findings have important implications on naphthoquinone and its derivatives’ cellular mode 
of actions, i.e. these novel DNA topoisomerase I inhibitors can prevent both DNA relaxation and 
kinase activities of htopo I. 
 
Diospyrin is a plant-derived bisnaphthoquinonoid compound with less active properties than 
its racemic isomer, isodiospyrin. It is a dimer of 7-methyljuglone linked between C-2 and C-3’. 
Diospyrin has been used as a potential lead molecule to new drug against cancer as well as 
several other diseases like leishmaniasis, trypanosomiasis, malaria and tuberculosis99, 100, 101, 102. 
Diospyrin derivatives were found to be cytotoxic with the ability to generate reactive oxygen and 
to induce apoptosis in human cancer cell lines 103. 
 
Diospyros virginiana L. (named by Carl Linnaeus), also called American persimmon, is 
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native to North America, and the fruits were reported to show cholesterol-lowering activity, and 
usefulness to treat bloody stools, thrush, and sore throats 104. The tree is common in the South 
Atlantic and Gulf States, especially in the Mississippi River Vally. Traditional uses of the plant 
include treatment of diarrhea and hemorrhoids, but today it is mainly used for culinary purposes. 
Excessive consumption of the fruits can cause gastrointestinal disorder 105. Many Diospyros 
species are a rich source of triterpenes, naphthoquinones, and other naphthalene derivatives 92. A 
literature research contains reports of eight compounds, including isodiospyrin, shinanolone 92, 
diospyrin, 7-methyljuglone 97 and scopoletin 106 isolated from the wood of D. virginiana, and 
lupeol, betulin and betulinic acid isolated from the leaves of D. virginiana 107. However, little 
attention has been given to chemical fractions from the roots of D. virginiana. 
 
The aim of this research was to identify naturally occurring active compounds with 
antifungal activity against seven common plant pathogens. These include isolates of 
Colletotrichum fragariae A. N. Brooks, Colletotrichum acutatum J. H. Simmonds, and 
Colletotrichum gloeosporoides (Penz.) Penz. & Sacc., Botrytis cinerea Pers.: Fr, Fusarium 
oxysporum Schlechtend: Fr, Phomopsis obscurans (Ellis and Everh.) B. sutton, and P. viticola 
Sacc., which cause severe diseases to many crops each year, especially strawberry plants. In this 
research program, we evaluated 37 plant extracts using a direct- bioautography bioassay to detect 
antifungal activity against three Colletotrichum species. Of these, D. virginiana root extracts 
showed the most promising activity. Based on preliminary screening results, a bioassay-guided 
fractionation of D. virginiana root extract was conducted to isolate and identify the pure 
metabolites possessing antifungal activity. A preparative overpressure layer chromatography 
(OPLC) method was successfully used for the separation of two new natural compounds, 4-
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hydroxy-5, 6-dimethoxynaphthalene-2-carbaldehyde (9) and 12, 13-didehydro-20, 29-
dihydrobetulin (10) together with nine known compounds, including 7-methyljuglone (11), 
diospyrin (12), isodiospyrin (13), shinanolone (14), lupeol (15), betulin (16), betulinic acid (17), 
betulinaldehyde (18), and ursolic acid (19) from the acetone extract of the roots of D. virginiana. 
Their identification was accomplished by 1D- and 2D-NMR (One Dimensional-and two 
Dimensional- Nuclear Magnetic Resonance) spectroscopy and HR-ESI-MS (High resolution 
electrospray ionization mass spectroscopy) methods. All the isolated compounds were evaluated 
for their antifungal activities against Colletotrichum fragariae, C. gloeosporioides, C. acutatum, 
Botrytis cinerea, Fusarium oxysporum, Phomopsis obscurans, and P. viticola using an in vitro 
micro-dilution broth assay. The results indicated that compounds 3 and 5 showed high antifungal 
activity against P. obscurans at 30 µM with 97.0 and 81.4% growth inhibition, and moderate 
activity against P. viticola (54.3 and 36.6%). It appears that an optimized OPLC system offers a 
rapid and efficient method of exploiting bioactive natural products. 
2.1.2. Over Pressure Layer Chromatography (OPLC) 
We should keep in mind that a single plant can contain up to several thousand secondary 
metabolites, so high-performance and rapid separation methods are absolutely needed to be 
emphasized 95. Several conventional methods including silica gel, polyamide and reversed-phase 
liquid chromatography are often used to isolate pure compounds from natural plants, but they are 
tedious, time-consuming, and require multiple chromatographic steps 108. Overpressure layer 
chromatography (OPLC) with a programmable pump equipped to deliver the mobile phase 
overcomes the problems stated above. OPLC was developed by Tyihák and Mincsovics in the 
late seventies 109. A TLC plate is covered by a sheet of flexible material in OPLC and subjected 
to a high external pressure (Figure 2.1). The high external pressure generated by the 
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programmable pump pushes the mobile phase through the analytical or preparative adsorbent 
layer. This allows a faster separation and more compact spots than conventional TLC. Generally, 
the separation distance of the compounds migrated over the adsorbent is two to five times greater 
than in conventional TLC. Another advantage of OPLC is that it is a sealed system with less 
solvent loss as a result of evaporation 110, 111. Therefore, the resolution is better than the obtained 
by conventional TLC, especially in the lower and closer Rf range. Compared to conventional 
methods, OPLC offers a more rapid and reliable method for the isolation of naturally occurring 
compounds.  
 
 
Figure 2.1 OPLC systerm (BIONISIS SA., Le Plessis-Robinson, France).  
 
OPLC was widely used in analytical and preparative applications reported in previous 
literature112, 113, 114, 115, 116. In the present paper, a preparative off-line OPLC technique was used 
to isolate co-migrating compounds from the roots of D. virginiana using transfusion operation 
(the chamber outlet is open during development). The difference between off-line and on-line 
OPLC separations lies in the existence of a flow-cell detector. On-line OPLC usually couples to 
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other chromatographic, electrophoretic, and spectroscopic techniques (e.g. OPLC-FTIR, OPLC-
UV, OPLC-MS, and OPLC-MALDI-MS). In off-line OPLC separation, there is no flow-cell 
detector connected to the outlet and the eluent is detected by TLC analysis. 
 
2.2 EXPERIMENTAL SECTION 
2.2.1 Apparatus 
OPLC: Personal OPLC 50 instrument (OPLC-NIT, Budapest, Hungary), at 50 bars 
external pressure; OPLC silica gel (SiO2) layer, 60 F254 20×20 cm on glass plate (LG 011, 
OPLC-NIT Ltd., Budapest, Hungary) with 200 µM sorbent thickness, 11 µM particle size, 6 nM 
pore size, and 20×20 cm on aluminum sheet (BSLA 001, OPLC-NIT Ltd., H-Budapest) with 
200µM sorbent thickness, 5 µM particle size, 6 nM pore size; an AS-30 sample applicator 
(DESAGA, Wiesloch, Germany) was used for the sample application. TLC: Classical TLC 
analysis was performed on silica gel 60 F254 20×20 cm on aluminum sheet (Gibbstown, New 
Jersey, USA). Detection was carried out under UV light (254 and 366 nM), and visualization 
with vanillin-H2SO4 (1 g of vanillin in 100 mL of 20% H2SO4 in EtOH) reagent, followed by 
heating at 105 °C for 5 min. UV Spectra: Varian Cary 50 spectrophotometer; in MeOH; λmax (log 
ε) in nm. IR Spectra: Bruker Tensor 27 spectrophotometer; ν in cm-1. 1H- and 13C-NMR spectra: 
Bruker model AMX-500 and 400 NMR spectrometers with standard pulse sequences, operating 
at 500 and 400 MHz for 1H, and 125 and 100 MHz for 13C; δ in ppm rel. to Me4Si as internal 
standard, J in Hz. High resolution electrospray ionization mass spectroscopy (HR-ESI-MS): 
Micromass Q-Tof Micro mass spectrometer with a lock spray source; in m/z. 
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2.2.2 Chemicals and Solvents 
Silica gel column chromatography was performed with silica gel 60 (70-230 mesh, Merk). 
Pre-coated aluminum silica gel 60 F234 20×20 cm plates (Merck) were used for classical TLC 
analysis. ACS-grade solvents, acetonitrile (MeCN), acetone, dichloromethane (DCM), 
chloroform (CHCl3), diethyl ether (Et2O), ethyl acetate (AcOEt), ethanol (EtOH), n-hexane, 
isopropanol (iPrOH), methanol (MeOH), benzeneand toluene from Fisher Scientific (New Jersey, 
USA) were used for SiO2 column chromatography (CC) and TLC separations. HPLC-Grade 
solvents, acetonitrile (MeCN), chloroform (CHCl3), dichloromethane (DCM), and H2Ofrom 
Sigma Aldrich (St. Louis, USA) were used for HPLC and OPLC chromatograms.  
2.2.3 Plant Material 
The roots of D. virginiana were collected from the Missouri Botanical Garden, USA, in 
June 2009. The plant material was identified by Dr. Vaishali C. Joshi, and a voucher specimen 
CON310700-2-A was deposited with the National Center for Natural Products Research, School 
of Pharmacy, The University of Mississippi. 
2.2.4 Extraction of the Plant Material 
Dried powdered roots (66 g) were extracted in a Soxhlet extractor with acetone (600 mL) 
for 8 h, and the extract was subsequently evaporated under vacuum to yield a dry residue (2 g). 
The crude extract was fractionated on a SiO2 column (100 g, 50×5 cm, ChemGlass) using hexane 
(500 mL), 5% AcOEt in hexane (600 mL), CHCl3 (600 mL), 5% iPrOH in CHCl3 (600 mL), and 
MeOH (600 mL), resp. Four fractions were obtained in total, Fractions 1-4. Bioautography-
guided assay showed that the activity was found to reside in fraction 1 (120 mg) and fraction 2 
(240 mg), with some activity in fraction 3 (710 mg), while fraction 4 (800 mg) did not show any 
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activity against three notorious plant pathogenic fungi of the Colletotrichum species. The active 
fractions were subjected to bioassay directed isolation of the pure isolates (Figure 2.2). 
 
 
 
Figure 2.1 Bioassay-guided fractionations of the acetone extract of Diospyros virginiana roots. 
 
2.2.5 Isolation of Compound 11 (7-methyljuglone)  
Fraction 1(120 g), which is the combination of n-hexane and 5% EtOAc in n-hexane 
fractions contains two compounds with different Rf values. This fraction was applied to 
preparative TLC plates and developed with chloroform-acetone (9:1, v/v) to yield one major 
compound 11, 7-methyljuglone 114.  
2.2.6 Selection of OPLC Conditions for Fractions 2 and 3 
Fraction 2 (240 mg) and Fraction 3 (800 mg) were applied and purified by off-line 
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OPLC-transfusion technique. In order to get good separation, many mobile phases (n-hexane-
ethyl ether, toluene-EtOAc, n-hexane-EtOH,n-hexane-EtOAc, DCM, DCM-MeOH, CHCl3-
acetone, CHCl3-EtOAc, n-hexane-EtOAc, DCM-EtOAc, EtOAc-n-hexane, DCM-ethyl ether, 
CHCl3-MeOH, CHCl3-acetonitrile, CHCl3-isopropyl, toluene-EtOAc-n-hexane-formic acid) with 
different ratios were tested and compared. Chromatographic results showed that two mobile 
phases, DCM (100%) and n-hexane-ether (6/4, v/v) were preferred by Fraction 2 separation. 
Four mobile phases, CHCl3-EtOAc (95/5, 98/2, v/v), n-hexane-ether (6/4, v/v), CHCl3-
acetonitrile (98/2, v/v) and toluene-EtOAc-n-hexane-formic acid (60:10:10:1, v/v/v/v) were 
suitable for Fraction 3 purification. 
2.2.7. Isolation of Compounds 9, 12, 13, 15, 18, 19 From Fraction 2 Using OPLC 
A portion of Fraction 2 (20 mg) was purified by OPLC with DCM as the eluent. Elution 
conditions were as follows: flash volume, 300 µL; eluent volume, 30,000 µL; flow-rate, 500 µL 
min-1; development time, 3606 s; external pressure, 50 bars. 88 Subfractions (1 mL/fraction) 
were obtained in total, of which sub-fractions 49–54 were detected as the same compound and 
combined together to give betulinaldehyde (18) (0.8 mg), amorphous yellow solid. The structure 
was identified by NMR spectroscopy and by comparison with reported data 117. Sub-fractions 
72–88 afforded ursolic acid (19; 1.3 mg), amorphous white solid. The structure was identified by 
the comparison with previous data118. Sub-fractions 28–37 were combined to give a mixture of 
three compounds (7.9 mg) and further purification was performed with n-hexane-ether (6/4, v/v, 
20,000 µL; flash volume, 300 µL; flow-rate, 500 µL min-1; development time, 2406 s) as eluent 
and 66 Sub-fractions were obtained, among which Sub-fractions 10’–18’ furnished lupeol (7; 
2mg) by the spectroscopic data and previously study 119. Sub-fractions 19’–66’ (marked as 
Fraction A) were combined to give a mixture of 3.6 mg containing four compounds with close Rf 
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values in several TLC systems (SiO2; hexane/EtOAct 3:2, CH2Cl2/iPrOH 9:1, CHCl3/MeOH 
19:1). To obtain enough material (Fraction A) for further purification, OPLC procedures were 
repeated six times under the same conditions, then Fraction A multiplied to 19.6 mg and then 
was purified by OPLC with DCM (100%, 20,000 µL; flash volume, 300 µL; flow-rate, 400 µL 
min-1 time, 3007 s). Sub-fractions 27”-33” were combined and identified as lupeol. Sub-fractions 
12’’ was detected as pure on the TLC plate and showed yellow fluorescence under UV366. This 
pure compound was identified as 4-hydroxy-5, 6-dimethoxynaphthalene-2-carbaldehyde (9; 
1mg), which was reported here for the first time. Sub-fractions 9’’–11’’were combined and 
submitted for NMR analysis. It was elucidated as diospyrin (12; 2 mg) and it was in agreement 
with the previous data115. Sub-fractions 14”-21” were combined to give amorphous yellow solid 
that was elucidated as isodiospyrin (13; 2 mg) by the NMR analysis and comparison to reported 
data 114, 116. 
2.2.8 Chromatograms of Pure Compounds 9, 12, 13, 15, 18 and 19  
Off-line OPLC separation of Fraction 2 led to isolation of compounds 9, 12, 13, 15, 18 
and 19 which correspond to 4-hydroxy-5, 6-dimethoxy-2-naphthaldehyde (9), diospyrin (12), 
isodiospyrin (13), lupeol (15), betulinaldehyde (18), and ursolic acid (19). Four µL of 20 mg/mL 
with 6 mm band size of compounds 9, 12, 13, 15, 18, 19 and Fraction 2 were applied at 30 mm 
measured from the bottom edge of the adsorbent layer (200 × 200 × 0.2 mm). The distance 
between two bands was 10 mm. OPLC infusion development (the outlet is closed) was 
developed twice with DCM (100%, HPLC-grade) as eluent. The elution was conducted as 
follows: volume of rapid eluent admission, 300 µL; development volume, 4887 µL; eluent flow-
rate, 400 µL min-1; development time, 740 s; external pressure, 39 bar. They were developed 
twice with DCM (100%, HPLC-grade) using off-line OPLC infusion development and the 
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chromatogram can be seen in Figure 2.3. Compound 1 showed yellow florescent under UV366. 
Figure 2.3c showed that the compounds had very similar Rf values (19, 0.42; 18, 0.53; 13, 0.55; 
15, 0.64; 9, 0.68; 12, 0.75) on the chromatogram, however, they were all nicely isolated from 
each other by the application OPLC. 
 
Figure 2.3 Chromatograms of off-line OPLC separation of six pure compounds from faction 2 
under UV with developed by DCM (a & b), and visualized by vanillin-sulfuric acid plus heating 
(c). The bold numbers represent the compounds in Figure 2.8. 
2.2.9.  Isolation of Compounds 10, 13, 14, 16, 17 From Fraction 3 Using OPLC 
Fraction 3 (24 mg) was subjected to OPLC with CHCl3-AcOEt (95: 5, v/v, 40,000 µL) 
with flash volume, 300 µL, flow rate, 500 µL min-1 and elution time 4806 s. One hundred and 
twenty-three sub-fractions (1 mL/fraction) were collected in total. Sub-fractions 54–66 yielded 
botulin 120 (16; 3.4 mg). Sub-fractions 10-22 were combined to give 2.3 mg of mixture of two 
compounds and labeled as fraction B, which was further purified by n-hexane-ether (6/4, v/v) 
using OPLC to yield isodiospyrin that was previously isolated in Fraction 2. Sub-fractions 67–90 
were combined to give 7.4 mg of mixture containing two or three compounds and one of them 
(a) UV 366 nm
(b) UV 254 nm
(c) Vanillin-sulfuric acid reagent
f-2 5 11 10 1 4
f-2 5 11 10 1 7 4
f-2 5 11 10 1 4
7
7
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showed yellowish-green fluorescence under UV366 and were marked as fraction C. Fraction C 
was performed with 20,000 µL of toluene-EtOAc-n-hexane-formic acid (60/10/10/1, v/v/v/v) 
solvent system with flash volume 300 µL, flow rate 250 µL min-1 and total elution time 4812 s. 
Ninety-three sub-fractions were totally obtained and detected by TLC. Sub-fractions 18’-26’ 
were tested as the same compound that was elucidated as amorphous white solid, betulinic acid 
121 (17). Fraction C (39 mg, multiplied by repeating the above OPLC procedures five times) was 
purified using OPLC with CHCl3-acetonitrile (98/2, v/v) with flash volume 300 µL, flow rate 
300 µL min-1 and total elution time 4806 s. Sub-fractions 79’-87’ were combined to give a 
yellowish-green compound, which was identified as shinanolone 122 (14, 1.5 mg). The other 
minor compounds were in such small quantities that they were impossible to isolate. To obtain 
enough material for further purification, flash chromatography of fraction 3 (400 mg; BIOTAGE 
(Isolera One); CHCl3/AcOEt (0–5%; 200 mL) and CHCl3 (100%, 201 mL–640 mL); flow rate, 5 
mL min-1; Si, SNAP 25 g column) was conducted. A total of 81 sub-fractions (1 mL/fraction) 
were collected. Sub-fractions 38 –51 were combined to yield a mixture (30 mg). This mixture 
was subjected to the OPLC (CHCl3/MeCN 49: 1 (40,000 µL); flash volume, 300 mL flow rate, 
250 mL/min total elution time, 9624 s). 183 Sub-fractions (1 mL/fraction) were obtained. 
Subfractions 100–112 were combined and identified as botulin (16; 2mg). Sub-fractions 136–144 
yielded betulinic acid (17; 1mg). Sub-fractions 114–126 gave the new triterpene, 12, 13-
didehydro-20, 29-dihydrobetulin (10; 1 mg) as a natural product 123. 
2.2.10 Chromatograms of Pure Compounds 10, 13, 14, 16 and 17 
Compounds 10, 13, 14, 16 and 17 represent 12, 13-didehydro-20, 29-dihydrobetulin (10), 
isodiospyrin (13), shinanolone (14), betulin (16), and betulinic acid (17). They were developed 
with CHCl3-acetonitrile (97:3, v/v) using off-line OPLC infusion development and the 
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chromatogram is showed in Figure 2.4. Two µL of 20 mg/mL with 4 mm band size of 
compounds 10, 13, 14, 16, 17 and fractions 3 were applied and the distance between two bands 
was 8 mm. Off-line OPLC infusion development was developed with CHCl3-acetonitrile (97/3, 
v/v, HPLC-grade) as eluent. The elution was conducted as follows: volume of rapid eluent 
admission, 150 µL; development volume, 2787 µL; eluent flow-rate, 200 µL min-1; development 
time, 843 s; external pressure, 39 bar. Compound 6 showed yellow-greenish color under UV366. 
These co-migrating compounds had similar Rf values (17, 0.19; 14, 0.21; 10, 0.33; 16, 0.35; 13, 
0.7). Particularly, compounds 10 and 16 had very similar Rf values on the OPLC plate. Forced 
flow and longer development distances in the OPLC applications clearly revealed 10 and 16 
separations with Rf values 0.33 and 0.35, respectively.  
 
Figure 2.4 Chromatograms of off-line OPLC separation of five pure compounds from fraction 3 
under UV with developed by CHCl3-acetonitrile (97:3, v/v) (a & b), and (c) visualized by 
vanillin-sulfuric acid reagent plus heating. 
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2.3 BIOLOGICAL EVALUATION 
2.3.1 Direct-Bioautography 
2.3.1.1 Pathogen production 
Three Colletotrichum species including C. fragariae (isolate CF63), C. acutatum (isolate 
CaGoff), and C. gloeosporioides (isolate CG162) obtained from Dr. B. J. Smith (USDA, ARS, 
Small Fruit Research Station, Poplarville, MS) were used for direct-bioautography study. Isolate 
CF63 is one of the most infective isolates infecting strawberry plants and causing both crown 
and fruit rot 124. CaGoff, CF63 and CG162 were used as standard test isolates because of our 
comprehensive knowledge of these isolates and their fungicide sensitivity profiles in both 
bioautography and microtiter formats. 
2.3.1.2 Inoculum preparation 
Fungal cultures were initiated on ½ strength potato dextrose agar (PDA, Difco, Detroit 
MI) from spores stored in sterile 10% glycerol RPMI (Roswell Park Memorial Institute, Gibco) 
buffer with MOPS (3-(N-morpholino) propane sulfonic acid) at -80°C. Fifty µL suspended spore 
solution was inoculated on PDA plate using crossed inoculation method. Inoculated plates were 
incubated at 24 ±  2°C under cool-white fluorescent lights (55±5 µmols/m2/s1) with a 12 h 
photoperiod. Colletotrichum cultures were subcultured or harvested from PDA every 7-10 days. 
Conidia were harvested by flooding plates with 3-5 mL of sterile distilled water and dislodging 
conidia by softly brushing the colonies with an L-shaped glass rod. Conidial suspensions were 
filtered through sterile Miracloth (Calbiochem-Novabiochem Corp., La Jolla, CA) spread on a 
sterile funnel to remove mycelia. Conidia suspensions were adjusted with sterile distilled de-
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ionized distilled (DDI) water to a concentration of 1.0 × 106 CFU (colony forming units)/ mL (19, 
20). Conidia concentrations were determined photometrically from a standard curve based on the 
percent of transmittance (%T) at 625 nm. Conidial suspensions of each Colletotrichum species 
(CF63, CaGoff and CG162) were then adjusted to a concentration of 3.0×105 conidia/mL with 
liquid potato-dextrose broth (PDB, Difco). Using a chromatographic sprayer, each 250 µM silica 
Gel GF Uniplate (Analtech, Inc. Newark, DE) thin-layer chromatography (TLC) plate was 
sprayed lightly (to a damp appearance) three times with the conidial suspension 125. 
 
2.3.1.3. Bioautography 
Antifungal compounds were indicated by inhibition of fungal growth on chromatographic 
plates using modifications of TLC bioautographic assays 126, 127, 128. The acetone extract of D. 
virginiana roots was dissolved in chloroform at 20 mg/mL concentrations. Using a disposable 
glass micropipette for each sample, 4 µL and 8µL of each test compound were placed on the TLC 
plate in a grid format to achieve a final amount of 80 and 160 µg/spot.  
 
To detect biological activity directly on the TLC plate, silica gel plates were sprayed with 
either of the three spore suspensions. Inoculated plates were placed in a 30 cm×13 cm×7.5 cm 
398-C moisture chamber (Pioneer Plastics, Inc. Dixon, KY) and incubated in a growth chamber 
at 24±1°C and 12 h photoperiod under 60±5 µmols/m2/s1light. Inhibition of fungal growth was 
observed 4 days after treatment. Sensitivity of each fungal species to each test compound was 
determined by comparing the size of inhibitory zones.  
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Technical fungicide grade standards benomyl, cyprodinil, azoxystrobin, and captan 
(Chem Service Inc., West Chester, PA) were used as positive controls at 2 mM in 2 µL of 95% 
ethanol. Benomyl (a benzimidazole inhibitor of microtubule formation) and captan (a phthalimid 
with multisite inhibition) are the commercial fungicides labeled for control on strawberry 
anthracnose. Azoxystrobin (a methoxyacrylate preventing the generation of ATP) is 
commercially used to control Colletotrichum and Botrytis diseases. Cyprodinil (a methionine 
biosynthesis inhibitor) is mainly used for control of cereal diseases and of Botrytis spp. on grapes 
and vegetables 129. For the antifungal assay 20 mg/mL of crude extracts or semi-purified 
fractions were applied to precoated Si gel TLC plates, developed with CHCl3, and dried for 
complete removal of solvents. The chromatograms were sprayed with a spore suspension of C. 
fragariae, C. acutatum, and C. gloeosporioides in potato dextrose broth (PDB) and incubated for 
4 days in a moistened chamber at 25 °C, following the previously reported procedure (Figure 
2.5). The result showed that mild polar compounds appear to be responsible for antifungal 
activity. 
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Figure 2.5 Bioautogrphic results of root crude extracts and fractions of Diospyros virginiana. 
Diospyros virginiana (D-1) root extracts showed promising antifungal activity against three 
Colletotrichum species. Fraction 1-3 exhibited antifungal activity against plant pathogens, and 
Fraction 4 did not exhibit any activity. 
2.3.2 Microtiter Assay 
A standardized 96-well micro-dilution broth assay developed by Wedge and Kuhajek 130 
was used to evaluate the antifungal activity of pure compounds from D. virginiana that were 
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identified as active by bioautography (Figure 2.6) 
 
 
Figure 2.6 Experimental design of a standardized 96-well micro-dilution broth assay. 
 
Isolates of C.acutatum, C. fragariae, C. gloeosporioides, B. cinerea, F.oxysporum, P. 
obscurans, and P. viticola were used to evaluate the antifungal activity of the test compounds 
using in vitro micro-dilution broth assay. Each fungus was challenged in a dose-response format 
using test compounds where the final treatment concentrations were 0.3, 3.0 and 30.0 µM. 
Technical grade commercial fungicides captan, azoxystrobin, and benomyl, which represent 
three different modes of actions, were used as positive fungicide standards.  Each compound was 
evaluated in duplicate and the experiment was performed three times in time.  Mean absorbance 
and standard errors were used to evaluate fungal growth after 48 and 72 h, except for P. 
obscurans and P. viticola (120 and 144 h). 
MICROTITER  ASSAY
Experimental  Design
A
B
C
D
E
F
G
H
0.3 µM 30 µM3.0 µM Control
Blank Blank Blank Blank
Incubate  plate  0 – 72  h
Read  absorbency  at  620  nm 
in  microplate photometer
20 µl  fungicide  sln
+
80 µl  RPMI  buffer
+
100 µl conidial  susp
Botrytis  cinerea
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2.4 RESULTS AND DISCUSSION 
The roots of D. virginiana were extracted with acetone in a Soxhlet extractor. The 
constituents of this extract were mainly separated by OPLC. An OPLC system is considered as 
the bridge between TLC and HPLC, which uses a programmable pump to push the mobile phase 
through the “flat column” and the forced flow leads to a faster separation and improved 
efficiency than capillary flow. Furthermore, the use of longer separation distances increases zone 
capacity compared to conventional TLC. OPLC offers a sealed system where compounds can be 
developed with less solvent in less time. OPLC stands out from a number of isolation techniques 
due to its flexibility to stop the elution process and visualize the separation of compounds under 
UV during the process of development. According to observation result, we can decide to 
continue the elution and/or change the elution solvent or convert a double-development method. 
Rapid speed of elution through OPLC columns limits the diffusion effects of the compounds, 
making the separation of closely related compounds more purified than the one from classical 
TLC, thereby concentrating bioactive compounds into a smaller more concentrated zone or band 
and thereby enhancing direct bioautography detection sensitivity. Another advantage of OPLC is 
that the eluent flow rate is adjustable through the adjustment of three different solvent systems 
(A, B, and C) for isocratic or step-wise gradient runs131, 132, 133. However, the OPLC column has 
to be used in right direction. Figure 2.7 showed the conditions of OPLC chromatogram for 
Fraction 2 and its compounds in two directions (A & B). Apparently, B showed a longer and 
cleaner separation among compounds, which indicates that the right developing direction of 
OPLC plate needs to be emphasized. OPLC coupled with direct-bioautography offers a powerful 
tool to separate co-migrating bioactive compounds for the discovery of natural product for pest 
management.  
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Figure 2.7 Fraction 2 and its pure compounds. 
 
A new naphthalene derivative, 4-hydroxy-5, 6-dimethoxynaphthalene-2-carbaldehyde (9), 
and a triterpene, 12,13-didehydro-20, 29-dihydrobetulin (10) were isolated from a natural source 
for the first time, along with nine known compounds, 7-methyljuglone (11), diospyrin (12), 
isodiospyrin (13), shinanolone (14), lupeol (15), betulin (16), betulinic acid (17), betulinaldehyde 
(18), and ursolic acid (19). Although they are common in most of the Ebenaceae family 45, 
compounds 18 and 19 were isolated for the first time from D. virginiana. The structures of the 
known compounds were confirmed by comparison of their spectroscopic data (1H- and 13C-NMR, 
and MS) with literature values (Figure 2.8).134 
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Figure 2.8 Isolated compounds from the roots of Diospyros virginiana. 
The HR-ESI-MS of compound 1 indicated a molecular formula C13H12O4, and its IR 
spectrum exhibited characteristic absorption bands for OH and conjugated C=O groups. The 1H-
NMR spectrum showed signals for an CHO group at δ (H) 10.03 ppm, and an aromatic AB 
system at δ (H) 7.37 (d, J=9.0) and 7.78 (d, J=9.0). These data suggested a naphthalene-2-
carbaldehyde structure with two MeO groups (δ (H) 4.06 and 4.13 ppm), and an OH substituent 
(δ (H) 9.75 ppm). The 13C-NMR spectrum showed 13 signals of which ten were typical aromatic 
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C-atoms. Assignment of structure was accomplished by HMBC experiment. The NOESY 
experiment showed a correlation between the MeO group signal at δ (H) 4.06 and H-C (7) signal 
(δ (H) 7.37 (d, J=9.0 Hz)), and MeO signal at δ (H) 4.13 and the OH signal at δ (H) 9.75 ppm, 
corroborating the location of the MeO groups at C (5) and C (6). Thus, 9 was characterized as 4-
hydroxy-5, 6-dimethoxynaphthalene-2-carbaldehyde. 
 
Compound 10 was obtained as a white solid. The molecular formula was determined as 
C30H51O2 by HR-ESI-MS (m/z443.3874 ([M+H]+)). The 13C-NMR data of 10 indicated the 
presence of 30 C-atoms comprising seven CH3 groups, ten CH2 groups, seven CH groups, and 
six quaternary C-atoms. TheCH3 groups resonated at δ (H) 0.79 (s, 6 H), 0.93 (d, J=6.8, 6 H), 
0.98 (s, 3 H), 0.99 (s, 3 H), and 1.10 (s, 3 H) in the 1H-NMR spectrum, indicating the lupane 
triterpene skeleton for 10 135. The 13C-NMR spectrum also revealed the presence of one olefenic 
CH group (δ(C) 125.0), which correlated in the HMQC spectrum with the H-atom at δ (H) 5.20 
(H-C (12)). The latter H-atom showed HMBC correlation with C (9), C (14), and C (18), 
evidencing the C (12)=C (13) bond. This was confirmed by the COSY correlation between H-C 
(12) (δ (H) 5.20) and CH2 (11) (δ (H) 1.90), and further supported by the HMBC correlation of 
Me (27) (δ (H) 1.10) and C (13) (δ(C) 136.7) (Figure 2.9). From these data, the compound 10 
was deduced to be 12,13-didehydro-20, 29-dihydrobetulin. This is the first report of 10 from a 
natural source together with its full spectral data, although it has been prepared synthetically, and 
only the 1H-NMR data were reported 123.  
4-hydroxy-5, 6-dimethoxynaphthalene-2-carbaldehyde (9): Yellow amorphous solid; UV 
(MeOH): λmax nm (log ε): 375 (4.1), 320 (4.2), 270 (3.8); IR (neat): νmax 3332, 2923, 2851, 2360, 
2341, 1687, 1372, 1274, 1055 cm-1; 1H- NMR (500 MHz, CDCl3): δ 4.06 (3H, s, OMe), 4.13 
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(3H, s, OMe), 7.29 (1H, s br, H-C (3)), 7.37 (1H, d, J= 9.0 Hz, H-C (7)), 7.78 (1H, d, J=9.0 Hz, 
H-C (8)), 7.81 (1H, s br, H-C (1)), 9.75 (1H, OH-C (4)), 10.03 (1H, s, H-C (11)); 13C-NMR (125 
MHz, CDCl3): δ 56.67 (OMe), 62.20 (OMe), 106.14 (C(3)), 115.46 (C(7)), 121.49 (C(10)), 
126.02 (C(1)), 127.19 (C(8)), 130.120 (C(9)), 134.09 (C(2)), 143.46 (C(5)), 149.95 (C(6)), 
154.28 (C(4)), 191.79 (C(11)); HR-ESI-MS: m/z =233.0812 ([M + H]+,  C13H13O4; calc.  
233.0814). 
 
12,13-didehydro-20, 29-dihydrobetulin (=(3β)-Lup-12-ene-3, 28-diol; 10): White 
amorphous solid; [α]20D = +79.2 (c 0.05, MeOH ); IR (KBr): νmax 3340, 2940, 2867, 1446, 1372, 
1027 cm-1; 1H-NMR (400 MHz, CDCl3): δ 0.73 (1H, d, J=7.2 H-C(5)), 0.79 (6H, s, Me-24, Me-
26), 0.89 (1H, m, , H-C(20)), 0.93 (6H, d, J= 6.8 Hz, Me-29, Me-30), 0.98 (3H, s, J=9.0 Hz, Me-
25), 0.99 (3H, s, Me-23), 1.10 (3H, s, Me-27), 1.20-1.81 (8CH2), 1.90 (2H, m, H2-C(11)), 3.19 
(1H, d, J=10.4, H-C(28ª)), 3.22 (1H, m, H-C(3)), 3.53 (1H, d, J=10.4, H-C(28b)), 5.13 (1H, br. s, 
H-C(12)); 13C NMR (100 MHz, CDCl3): δ 15.6 (C(29)), 15.7 (C(24)), 16.7 (C(25)), 17.3 (C(26)), 
18.3 (C(6)), 21.3 (C(30)), 23.2 (C(21)), 23.3 (C(27)), 23.4 (C(11)), 25.9 (C(2)), 27.2 (C(15)), 
28.1 (C(23)), 30.6 (C(16)), 32.8 (C(7)), 35.2 (C(1)), 36.9 (C(14)), 38.7 (C(22)), 38.0 (C(4)), 39.3 
(C(20)), 39.4 (C(19)), 40.0 (C(10)), 42.0 (C(8)), 42.3 (C(17)), 47.6 (C(18)), 54.0 (C(9)), 55.1 
(C(5)), 69.9 (C(28)), 79.0 (C(3)), 125.0 (C(12)), 136.7 (C(13)). HR-ESI-MS m/z = 443.3874 ([M 
+ H]+,  C30H51O2; calc. 443.3889). 
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Figure 2.9 Relevant 1H-13C HMBC (→) and 1H-1H COSY (↔) correlations of 10. 
 
The antifungal activities of compounds 9-19 were evaluated using a 96-well micro-
dilution broth assay against the plant pathogens B. cinerea, F. oxysporum, P. obscurans, P. 
viticola, and three Colletotrichum species. Phomopsis species were the most sensitive fungi to 
these compounds. 7-Methyljuglone (3) and isodiospyrin (5) showed the highest antifungal 
activities against P. obscurans. Compound 3 showed 97.0% growth inhibition of P. obscurans at 
30 µM at 120 h, whereas compound 5 showed 81.4% growth inhibition. The antifungal activities 
of 11 and 13 at 30 µM against P. viticola were 53.4 and 57.7%, respectively. 
 
The new compounds 4-hydroxy-5, 6-dimethoxynaphthalene-2-carbaldehyde (9) and 12, 
13-didehydro-20, 29-dihydrobetulin (10) at 30 µM showed weak antifungal activities with 26.9 
and 22.1%, respectively (Figure 2.10). Compounds 11 and 13 at 30 µM caused 54.3 and 36.6% 
growth inhibition of P. viticola at 120 h. Any test compound possessing < 50% growth inhibition 
at 30 µM is considered to have a weak antifungal activity in this bioassay. Compound 9 was 
more active against P. viticola at 120 h than at 144 h. This response is often observed when an 
inducible enzyme system is turned on, and a compound is detoxified by the fungus. However, the 
upward slope of the graph for compound 9 in Figure 2.11 from the low to high concentration 
may be indicative of precipitation in the aqueous micro-dilution broth assay (there is not enough 
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amount of compound 9 for another microtiter assay). Because the microtiter plate reader 
measures changes in optical density, it does not discriminate between fungal growth and 
precipitation. Compound 9 appears to have come out of solution at the higher concentration (30 
µM) in the P. viticola testing (Figure 2.11). Lipophilic compounds are problematic in in vitro 
aqueous bioassays, and follow-up antifungal testing will take place using a detached leaf 
bioassay 136. The graphical results indicated that compounds 10, 11, and 13 appear to remain 
soluble at 120 and 144 h. Commercial fungicides captan and benomyl are significantly more 
active than any of the compounds tested. Azoxystrobin, which is commercially used to control 
Colletotrichum and Botrytis diseases, shows poor activity against P. viticola. Both captan and 
azoxystrobin show 100% growth inhibition at 3 µM against P. obscurans. Although once an 
excellent agent for controlling anthracnose and other diseases of strawberries and ornamentals, 
resistance developed by pathogens has resulted in benomyl being less useful 137. While the test 
compounds appear inherently antifungal, we hypothesize that these compounds are probably 
present in the plant as constitutive defense compounds that act to deter infection or fungal 
growth. Since these compounds were found without elicitation, they are probably constitutive in 
nature 138,139 and may have a potential role in preventing fungal infection in D. virginiana. 
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Figure 2.10 Mean fungal growth inhibition (%) of Phomopsis obscurans after exposure to 1, 2, 3 
and 5 using a dose-response format at 120 and 144 h was noted.  Abreviations used are: Cap: 
Captan; Azo: Azoxystrobin; Ben: Benomyl. The bold numbers represent the compounds in 
Figure 2.6. (1: Compound 9; 2: Compound 10; 3: Compound 11; 5: Compound 13. 
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Figure 2.11 Mean fungal growth inhibition (%) of Phomopsis viticola after exposure to 1, 2, 3 
and 5 using a dose-response format at 120 and 144 h was noted.   
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2.5 CONCLUSION 
Using a bioassay-guided fractionation of the acetone extract D. virginiana, we isolated 
the antifungal constituents of the roots of this plant. This research demonstrates that OPLC is a 
powerful technique that can be used to separate and isolate co-migrating natural products 
produced by plants. These constituents were tested for the first time against Colletotrichum spp., 
B. cinerea, F. oxysporum, P. obscurans, and P. viticola. The most promising agricultural lead 
compounds against the pathogen P. obscurans are compounds 11 and 13. Phomopsis leaf blight 
and fruit rot is a serious disease with strawberries and causes serious economic loss of this fruit 
each year. Our results suggest that compounds 11 and 13 warrant further in vivo testing as plant 
protectants or leads to control Phomopsis species 136.  
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CHAPTER 3 ISOLATION OF ANTIFUNGAL METABOLITES FROM TWO 
ISOLATES OF CLADOSPORIUM CLADOSPORIOIDES 
3.1 INTRODUCTION 
3.1.1 Cladosporium spp. 
 Cladosporium spp., one of the largest genera of dematiaceous hyphomycetes, is widely 
distributed throughout the world especially in the tropics and subtropics 140. It contains more than 
30 species and 772 names 141, and the most common species include C. elatum, C. harbarum, C. 
spherospermum and C. cladosporioides 142. Species belong to Cladosporium are not 
characterized by common taxonomic classification due to their lack of sexual reproduction, and, 
hence are grouped into Fungi imperfecti 143, in which fungi produce their spores asexually. 
Identification and differentiation of the species of this genus are based on morphological and 
molecular methods. This genus is characterized by having a unique coronate scar structure 144, 
and by being linked to Davidiella teleomorphs 145, 146. Colonies of Cladosporium were reported 
to have a unique color ranging from olive-green to greenish brown on PDA. They grow 
relatively slowly, but sporulate abundantly, giving the colonies a dusty, velvety appearance 147. 
 
 Cladosporium spp. is considered as the most isolated fungi in nature and can be found on 
dead plants, contaminated food, straw, soil, colors, and textile 143. Cladosporium rot in wine 
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grapes was the common disease induced by two species, C. cladosporioides and C. herbarum 148. 
Besides plants, Cladosporium spp. can also be pathogenic and toxigenic to humans. So far, 
research literatures have recorded cases of cerebral phaeohyphomycosis, cutaneous infections, 
onychomycosis, sinusitis and pulmonary infections caused by Cladosporiumspp 143. In addition, 
spores of this genus are easily spread in air and cause serious allergic diseases to respiratory tract 
mucosa or asthma as well as intrabronchial lesions 149, 150. 
3.1.2  Cladosporium cladosporioides 
Cladosporium cladosporioides (Fresen.) de Vries is a very common saprophytic fungus 
in this genus which can contaminate many types of seeds. It is the pathogen of many different 
host plants and can be isolated from many sources including air, soil, textiles and several other 
substrates 151. In a direct-bioautography assay, C. cladosporioides are usually one of the adopted 
indicator organisms used for the detection of antifungal fractions and compounds in the 
bioassay-guided isolation 152, 153, 154, 155. C. cladosporioides has also been involved in several 
human diseases causing pulmonary constrictions (asthma and pulmonary emphysema) and 
cutaneous infections (phaeohyphoomycosis) 149, 156, 157, 158. In 2002, C. cladosporioides was 
reported to exist in three cerebrospinal fluid specimens and a brain biopsy specimen of a human 
patient 159. Currently, 34 strains of C. cladosporioides have been isolated and identified from 
different sources 140. A strain refers to a genetic variant of the same species. So one fungus could 
have a variety of strains under the same species name. Plant extracts have been considered to be 
ideal candidates for treating fungal infections. However, besides plant extracts natural occurring 
microorganisms can also be useful in the control of plant pathogens, such as Penicillium and 
Trichoderma. Recently, one invention reported that an isolate of C. cladosporioides was very 
effective in both prevention and treatment of pathogen caused diseases on plant issues, such as 
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apple scab (Venturia inaequalis)  160. A particular isolate of C. cladosporioides combined with 
benzoic acid was effective against Plasmopara viticola by 81.27% growth inhibition 161. An 
isolate has been used for fungus infections caused by Botrytis and Fusarium species 162. More 
interestingly, C. cladosporioides has been widely used for biosorption of gold or silver from 
solutions163. A fungal isolate C. cladosporioides 1 was found to possess preferential metal 
binding properties and could efficiently adsorb gold and silver metals from a mixture which 
contain other metals including zinc, cadmium, chromium, nickel and copper 163. Another isolate 
C. cladosporioides 2 could remove zinc, cadmium, chromium, nickel and copper in addition to 
gold and silver 164. One report showed that C. cladosporioides was employed as reductant in the 
extracellular biosynthesis of silver nanoparticles (AgNP) 165 (Figure 3.1). 
 
Figure 3.1 Conidiophores of Cladosporium cladosporioides sprouting from agar with all types of 
dispersion structures140. 
 
The pathogenicity and toxicity that C. cladosporioides produces to plants or human are 
normally attributed to the toxic secondary metabolites they produce. C. cladosporioides produces 
very active compounds, such as cladosporin and emodin, as well as some other less toxic 
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metabolites. Fungal secondary metabolites are bioactive compounds that are produced as 
families of related compounds during the stationary phase of growth and are usually of low 
molecular weight. Some famous fungal secondary metabolites are known as penicillin, 
cephalosporin, ergotrate and statins 166, 167. Secondary metabolites do not appear to participate 
directly in fungal growth and development, but are involved in the interactions between fungi 
and their environment. In contrast, primary metabolites, such as vitamins, phytosterols, acyl 
lipids, nucleotides, amino acids, and alcohols are directly involved in normal fungal growth, 
development, and reproduction. In addition, primary and secondary metabolites have similar 
precursor molecules, chemical structures and biosynthetic origins 168. Bioactive secondary 
metabolites that have been isolated from C. cladosporioides include cladosporin (20) 169, 
isocladosporin (21) 170, cladospolides A (22) and B (23) 171, cladosporol (24) 172 and the 
calphostins (25) 173 (Figure 3.2).  
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Figure 3.2 Structures of compounds isolated from C. cladosporioides by previous studies. 
3.1.3 Biological and Chemical Study of Cladosporin 
3.1.3.1 Biological activities of cladosporin 
Cladosporin (20) (also known as asperentin), 3,4-dihydro-6, 8-dihydroxy-3-(6-methyl 
tetrahydropyran-2-ylmethyl) isocoumarin, is an important secondary metabolite derived from C. 
cladosporioides in 1971. It is a major compound of C. cladosporioides but a minor metabolite of 
other fungal sources including Aspergillus flavus 174, Aspergillus repens 175, 176, Oidiodendron 
truncata 177, Chaetomium globosum 178, and several Eurotium species 176. It showed specific 
antifungal and antibacterial properties, as well as insecticidal activity 170, 179. It was reported to 
inhibit the spore generation of Penicillum and Aspergillus species at ≤ 40 µg/mL, and uracil and 
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leucine uptake into Bacillus brevis cells 171. Also, it completely inhibited the growth of several 
dermatophytes in vitro at 75 µg/mL169. Xie, et al., found that cladosporin exhibited antifungal 
activity against Escherichia coli, Rhizoctonia solani, Trichoderma viride and Colletotrichum 
cameliaeet al. at a concentration of 100-200 µg/mL 180. Cladosporin was shown to be a plant 
growth inhibitor by Springer and Cutler in 1981, which inhibited the growth of etiolated wheat 
coleoptiles at 10-3, 10-4, and 10-5 M 175. Later in 1994, cladosporin was tested for antitumor 
induction in an Agrobacterium tumefaciens potato disc assay and it showed -79% antitumor 
induction 181. Due to these statistics, cladosporin has been considered as a promising novel 
fungicide.  
3.1.3.2 Stereochemistry of cladosporin 
Cladosporin was crystallized from methanol as pale yellow crystals and soluble in 
ethanol, and ethyl acetate, moderately soluble in chloroform, slightly soluble in benzene, and 
insoluble in hexane and water 169, 182. Its stereochemistry was completely assigned through X-ray 
diffraction by Vederas, Cutler and other researchers at Merck (Figure 3.3) 175, 183.  
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Figure 3.3 The crystalline structure of cladosporin. 
 
As Figure 3.3 showed, the absolute configuration of three chiral carbons, C8, C4 and C5, 
need to be established. The stereochemistry of C8 was determined as R by circular dichroism 
(CD) analysis, which showed an opposite curve to that given by a known compound 174. 
Subsequently, the X-ray structure assigned the stereochemistry of the tetrahydropyran ring at C4 
(S) and C5 (R) 175. The X-ray data was described in page 72. 
3.1.3.3 Biosynthesis of cladosporin 
Biosynthesis of cladosporin involves assembly of basic two carbon units from acetate and 
malonate through acetate-malonate (AA-MA) pathway, which is an important pathway in the 
biosynthesis of polyketides and fatty acids 184. The formation of polyketides closely resembles 
the biosynthesis of long chain fatty acids 185. This pathway involves a series of Claisen reactions 
in which two molecules of acetyl-CoA react in a Claisen condensation to give acetoacetyl-CoA, 
and then repeated to generate a poly-β-keto ester of required chain length (Figure 3.4). 
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Figure 3.4 The formation of the poly-β-keto chain by claisen condensation. 
 
In 1973, Grove and the co-workers reported the biosynthesis of cladosporin (II, Figure 
3.5) in an entomogenous strain of Aspergillus flavus by incorporation of [1-13C] acetate and [2-
14C] malonte 186. This labeling experiment confirmed the biosynthetic pattern of cladosporin 
from a precursor (I, Figure 3.5) consisting of one acetate-derived initiating unit and seven 
malonate-derived two-carbon building units (Figure 3.5). 
 
 
Figure 3.5 Biosynthesis of cladosporin ring system from acetate and malonate units. 
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Recently, the asymmetric total synthesis of cladosporin was just reported by Chinese 
scientists in Lanzou University 187. They started the synthesis in 8 steps from tetrahydropyran 
(THP), which was found in numerous biologically active natural products. Cladosporin (20) 
bears a 2, 6-disubstituted tetrahydropyran (THP) ring and a δ-valero lactone with a fused 1, 3-
dihydroxybenzene ring. The synthesis started with 28, which was generated from ring-open of 
oxide 27. Treatment of allytrime-thylsilane in the presence of a catalytic amount of TMSOTf led 
to 29, which had 2,6-trans-THP selectivity. Enantioenriched epoxide 30 was obtained by m-
CPBA epoxidation of alkene 29. After treatment with the Grignard reagent and CuI at -30 °C, 
epoxide 30 was reduced to alcohol trans-4. The lactone 32 was furnished from trans-4 through 
two reactions including oxa-Pictet-Spengler cyclization and Jones oxidation. After removal of 
both aromatic methyl ether groups under Maier’s conditions, lactone 32 was converted to 
cladosporin (Figure 3.6). 
 
Figure 3.6 Total synthesis of cladosporin 187. 
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3.1.4  Biological and Chemical Study of Isocladosporin 
Isocladosporin (21) is a diastereoisomer of cladosporin at C-14 (or C-6’), and was 
isolated from C. cladosporioides in 1993 188. The absolute configuration of natural 
isocladosporin has not been deduced. There exist two solution-state conformations (see Figure 
3.7) that were proposed by Jacyno in 1993 188. In 2012, She, et al., synthesized the 
isocladosporin and proved that the relative configuration of isocladosporin was supposed to be 
the structure of (21. a) (Figure 3.7), because the physical properties of (21. b) was different from 
that of natural isocladosporin isolated by Jacyno 187. Isocladosporin was tested to be slightly 
more potent than cladosporin in the etiolated wheat coleoptile bioassay, producing 100% growth 
inhibition, compared to 81% for cladosporin at 10-3 M 188. 
 
Figure 3.7 Two solution-state conformations (a & b) of isocladosporin. In structure b, H-11 
protons have been omitted for clarity. 
3.1.5 Other Compounds Isolated From C. cladosporioides 
Other compounds isolated from C. cladosporioides include cladospolides A (22) and B 
(23), cladosporol (24), and the calphostins (25). Cladospolides A (22) and B (23) are two 
geometrical isomers that were isolated by Hirota and co-workers in 1981 and 1985 respectively. 
It is interesting to know that both isomers showed different biological activities--cladospolides A 
acted as a root growth inhibitor of lettuce seedlings, while cladospolides B acted as a root growth 
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promoter of lettuce seedlings 189, 190. In 1995, one more bioactive metabolite was isolated from C. 
cladosporioides elucidated as cladosporol (24), which was a β-l, 3-glucan-biosynthesis inhibitor 
due to its epoxy-alcohol structure 172. A complex of Calphostins (25) (A, B, C, D, I) was isolated 
from C. cladosporioides by Japanese scientists in 1989. These calphostins showed potent and 
specific inhibitory activity against protein kinase C (PKC), with emphasis of calphostin C that 
specifically inhibited PKC at 0.05 µM 173. 
 
3.2 THE AIM OF THIS RESEARCH 
In summary, fungi provide an abundant source of natural products that may have 
potential agricultural, environmental, and pharmaceutical use. In the course of discovery of 
bioactive metabolites from fungus extracts, 40 fungi crude extracts were screened using a direct-
bioautography coupled Colletotrichum bioassay. Eight extracts were identified as active. Two of 
the extracts, the acetone extracts of Cladosporium cladosporioides NRRL 5507 and another 
isolate of C. cladosporioides (labeled as Miligrante) showed the most promising activities 
against three Colletotrichum species (Figure 3.8). To our best knowledge, there are no reports on 
the antifungal activity of C. cladosporioides against the three Colletotrichum species. The crude 
extracts, fractions, and pure compounds of C. cladosporioides were also tested for cannabinoid 
and opioid receptor activity. Based on the encouraging biological effects, the isolation and 
purification of the crude extracts of this species was initiated. 
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Figure 3.8 Bioautographic results of two isolates of C. cladosporioides against three 
Colletotrichum species. The first row showed the result of isolate 1 (C. cladosporioides NRRL 
5507) and the second row showed the result of isolate 2 (Milogrante). 
3.3 BIOLOGICALLY ACTIVE COMPOUNDS FROM CLADOSPORIUM 
CLADOSPORIOIDES NRRL 5507 
3.3.1 Results and Discussion 
 Bioassay-guided fractionation of C. cladosporioides crude extracts led to the isolation of 
six compounds, including the major constituent cladosporin (20) (5.038 g), isocladosporin (21) 
(8.3 mg), 5’-hydroxyasperentin (33) (117 mg), asperentin-8-methyl ether (34) (3 mg), palmitic 
acid (36) (10 mg) and linoleic acid (8 mg) (37). And the compound, 6, 5’-diacetyl cladosporin 
(35) (4.5 mg) was synthesized based on pyridine-catalyzed acetylation of compound 33 (Figure 
3.9). The chemical structures of these compounds were established on the basis of extensive 1D 
and 2D NMR and HRESIMS data. Cladosporin, as a major component, was crystallized from 
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three fractions, Hex/EtOAc (25:75), Hex/EtOAc (50:50), and EtOAc(100%) fractions as pale 
yellow crystals. The absolute stereochemistry of cladosporin was validated by single-crystal X-
ray. Compounds 33 and 34 were isolated from Aspergillus flavus 174, Chaetomium globosum 178 
and Eurotium repens before 179 but they were isolated for the first time from C. cladosporioides. 
The stereochemistry of 5’-hydroxyasperentin (33) at C-5’ was confirmed for the first time on the 
basis of NOE data. Pure compounds were submitted for antifungal activities against seven plant 
pathogens. Phomopsis viticola was the most sensitive fungus to the test compounds. Phomopsis 
viticola is a plant pathogen that causes severe disease of grape often known as Phomopsis cane 
and leaf spot disease of grape. At 30 µM, Cladosporin (20) exhibited 92.7%, 90.1%, 95.4% and 
83.0% growth inhibition against C. acutatum, C. fragariae, C. gloeosporoides and P. viticola, 
respectively. Isocladosporin (21) showed 50.4%, 60.2% and 83.3% growth inhibition at 30 µM 
against C. fragariae, C. gloeosporoides and P. viticola, respectively. Cladosporin exhibited 
antifungal activity against Cryptococcus neoformans with IC50 value of 17.72 µg/mL. 
Furthermore, in herbicidal bioassays, cladosporin has moderate to high monocot herbicide 
activity against Agrostis but no dicots herbicide effect against Lettuce.  
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Figure 3.9 Compounds isolated from Cladosporium cladosporioides NRRL 5507. 
3.3.2 Biological Evaluation 
3.3.2.1 Antifungal activity against plant pathogens (Microtiter Assay) 
Pure compounds were further evaluated for their antifungal activity using an in vitro micro-
dilution broth assay. Compound 20 showed significant antifungal activities and at 30 µM caused 
92.7 % growth inhibition of C. acutatum, 90.1 % of C. fragariae, 95.4% of C. gloeosporoides at 
48 h, and showed promising antifungal selectivity against P. viticola (79.9 %) and P. obscurans 
(-21.7%) at 120 h. (Figure 3.9-3.13). In Figure 3.9 and 10, compound 20 exhibited moderate 
antifungal activities against C. acutatum and C. fragariae compared to the standard fungicide 
azoxystrobin, which only caused 40.5% and 58.9% respectively. These data suggested that 
compound 20 could be considered as a novel natural product lead for the development of 
fungicidal agent against strawberry pathogens. Compound 21 showed low antifungal activity and 
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at 30 µM caused 50.4% growth inhibition of C. fragariae, 60.2% of C. gloeosporoides at 48 h 
(Figure 3.10 and 3.11). Compound 21 showed promising antifungal selectivity between P. 
viticola (80.3 %) and P. obscurans (22.5%) at 120 h (Figure 3.12 and 3.13). Compound 26 and 
28 showed no antifungal activities against three Colletotrichum species, but showed good 
selectivity over P. viticola (53.9% and 79.4%) and P. obscurans (25.6% and 10.3%) (Figure 3.12 
and 3.13). Due to these properties, compounds 20, 21, 33 and 35 could be further evaluated as 
fungicidal leads for pest and disease control. 
 
 
Figure 3.10 Mean fungal growth inhibition (%) of Colletotrichum acutatum after exposure to 12, 
13, 14 and 16 using a dose-response format at 48 h. Abreviations: Cap: Captan; Azo: 
Azoxystrobin; Ben: Benomyl. (12: compound 20; 13: compound 21; 14: compound 33; 16: 
compound 35).  
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Figure 3.11 Mean fungal growth inhibition (%) of Colletotrichum fragariae after exposure to 12, 
13, 14 and 16 using a dose-response format at 48 h. 
 
 
Figure 3.12 Mean fungal growth inhibition (%) of Colletotrichum gloeosporoides after exposure 
to 12, 13, 14 and 16 using a dose-response format at 48 h. 
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Figure 3.13 Mean fungal growth inhibition (%) of Phomopsis viticola after exposure to 12, 13, 
14 and 16 using a dose-response format at 120 h. 
 
 
Figure 3.14 Mean fungal growth inhibition (%) of Phomopsis obscurans after exposure to 12, 13, 
14 and 16 using a dose-response format at 120 h. 
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After overall study of the relationship between the structures and antifungal activities of the 
pure isolates at 30 µM, we found several essential positions that might be responsible for their 
antifungal activities (Table 3.1). Comparing the structures between compound 20 and 21, the 
absolute configuration of C-6’ affects antifungal activity. R configuration of C-6’ in 21 greatly 
decreased antifungal activity against Colletotrichum species, but slightly increased the antifungal 
activities against Phomopsis species. Comparing the structures between 21 and 33, introduction 
of one hydroxyl group at C-5’ position caused complete loss of antifungal activity against 
Colletotrichum species and decreased the selectivity against Phomopsis species, which indicated 
the importance of openness of 5’ position to keep it active. By comparing the structures between 
21 and 34, the replacement of hydroxyl group with methoxy group at C-8 caused broad loss of 
antifungal activities against all the test fungi, which indicated this position might be the active 
site where hydrogen bonds were formed to enhance the interaction between the enzyme and 
agent. Comparing compound 33 and 35, the replacement of hydrogen at C-6 and C-5’with acetyl 
groups greatly increased the selectivity against Phomopsis species. 
Therefore, S configuration of C-6’, openness of C-5’, hydroxyl group at C-8, and 
introduction of functional groups at C-6 are several remarkable observations we obtained from 
the antifungal SAR study. This might provide us some useful information for further SAR study. 
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Table 3.1 Overall Fungal Growth Inhibition of Compounds 20, 21 and 26-30 Against Plant 
Pathogens at 30 µM. 
 
Chemical Structures C. fraga. C. gleos. C. acut. P. obscu  P. vitico. 
 20 
90.1% 95.4% 92.7 % NA 79.9% 
21 
50.4 % 60.2 % 38.3 % 22.5% 83.0% 
  33 
NA NA NA 25.6% 53.9% 
         34 
NA NA NA NA 35.1% 
     
35 
NA NA NA 10.3% 79.4% 
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3.3.2.2 Opioid &cannabinoid receptor binding affinity 
The crude extracts, fractions and pure compounds isolated from this species have been 
submitted for testing to determine their affinity for opioid receptors (subtype δ, κ and µ) and 
cannabinoid receptors (subtype CB1 and CB2). The result showed that only the crude extracts 
possessed modest opioid effect (δ, 70.11; κ, 65.67; µ, 56.58). The binding affinity was lost in the 
sub-factions and pure compounds of C. cladosporioides (Table 3.2). This indicated that the 
combination of the active compounds in the crude extracts contributed to the affinity of opioid 
receptors other than single compound. Synergism refers that two or more agents, when used 
together, produce an effect greater than one single agent. It is very common phenomenon in 
fungal extracts in which the active compounds interact within themselves to synergize the 
therapeutic effects 191.  
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Table 3.2 Binding Affinity Assay of the Cladosporium cladosporioides for Human Opioid 
Receptors and Cannabinoid Receptors. 
Note: For crude extracts and their fractions, the concentration is 10 µg / mL; for pure isolates, 10 
µM was used. 
3.3.2.3 In vitro antimicrobial activities of cladosporin and 5’-hydroxyasperentin 
Since we have a good quantity of cladosporin (5.038 g) and 5’-hydroxyasperentin (117 
mg) (Figure 3.9) (the quality of other pure compounds is less than 1 mg and not enough for 
 
Species  
 
Fractions  
(10 µg/mL) 
Opioid Receptors (%) 
Cannabinoid 
Receptors (%) 
  
δ κ µ CB1 CB2 
Cladosporium 
cladosporioides 
 
Crude extracts 70.11 65.67 56.58 21.6 20.5 
25% Hexane in 
EtOAc 
53.7 -10.95 -27.96 36.3 8.3 
50% Hexane in 
EtOAc 
36.5 -43.54 -12.89 0.9 10.0 
EtOAc 27.2 -24.44 -37.72 -16.1 4.8 
25%MeOH in 
EtOAc 
27.4 -14.57 -41.96 26.4 5.5 
MeOH 37.2 -20.49 -62.40 17.1 3.9 
 Cladosporin 
(10 µM) 
-39.7 -24.1 42.3   
 5’-
Hydroxyaspere
ntin 
(10 µM) 
-0.2 -18.9 -6.2   
Naloxone (10 µM) 101.3 103.8 99.7 - - 
CP 55,940 (10 µM) - - - 99.4 101.0 
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further studies), these two compounds were submitted for their antibacterial and antifungal 
(against human pathogens) activities. The antibacterial activities were tested against 
Staphylococcus aureus, methicillin-resistant S. aureus (MRS), Escherichia coli, Pseudomonas 
aeruginosa, and Mycobacterium intracellulare. Ciprofloxacin was used as positive control for 
antibacterial activity. 
 
The antifungal activities were evaluated against a panel of pathogenic fungi including 
Candida albicans, C. glabrata, C. krusei, Aspergillus fumigatus and Cryptococcus neoformans 
associated with opportunistic infections. Amphotericin B was included as a standard antifungal 
drug for comparison. Cladosporin exhibited antifungal activity against Cryptococcus neoformans 
with IC50 value of 17.72 µg/mL but no antibacterial activity against test organisms (if compounds 
are not active at the highest test concentration of 20 µg/mL, we considered it to be inactive). 5’-
hydroxyasperentin did not show any antibacterial activity or antifungal activity against the ten 
species. This indicated that substituents at 5’-position might lead to the loss of antifungal activity. 
Furthermore, the number of double bonds in the side chain of the structure is normally crucial for 
maintaining both antibacterial and antifungal activity. Both compounds lack of long side chain 
with double bonds, which might be the reason for their weak or inactive properties. 
3.3.2.4 Herbicidal activity of cladosporin 
Cladosporin was also tested for its potential herbicidal activity. Three different 
concentrations (10, 100 and 1000 µM) were used. Ranking of plant growth was subjective. A 
ranking of 0 indicated no apparent inhibition (sample well plants looked identical to the Control 
+ Solvent well plants).  A ranking of 5 indicated no growth or complete inhibition.  A ranking of 
five was given only if no seeds germinated. From Table 3.3, Cladosporin showed moderate to 
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high monocot herbicide activity against Agrostis, but no effect against dicots herbicidal activity 
against Lettuce. Monocots (or monocotyledons) normally have a single embryonic seed leaf, 
leaves with parallel veins, and flowers with parts in threes, while dicots (or dicotyledon) have 
two embryonic seed leaves and leaves with netlike veins.  
 
Table 3.3 Herbicidal Activity of Cladosporin 
Compound Concentration Solvent Day Ranking 
    Lettuce Agrostis 
Cladosporin 10 µM 10% acetone 7 0 0 
Cladosporin 100 µM 10% acetone 7 0 1 
Cladosporin 1000 µM 10% acetone 7 0 4 
 
(Ranking based on scale of 0 to 5.     0=no effect; 5=no growth) 
 
3.3.3 Experimental Sections 
3.3.3.1 General experimental procedures 
All melting points were obtained on a Thomas Hoover Uni-melt Capillary Melting Point 
Apparatus and are uncorrected. All IR spectra were generated neat on an ATI Mattson FT-IR 
using NaCl plates. Optical rotations were recorded using a Rudolph Research Analytical Autopol 
V polarimeter. UV was respectively obtained using a Perkin-Elmer Lambda 3B UV/vis 
spectrophotomer. 1H and 13C NMR spectra were obtained on Bruker model AMX 500 NMR 
spectrometers with standard pulse sequences, operating at 500 MHz in 1H and 125 MHz in 13C. 
The chemical shift values were reported in parts per million units (ppm) from trimethylsilane 
(TMS) using known solvent chemical shifts. Coupling constants were recorded in Hertz (Hz). 
Standard pulse sequences were used for COSY, HMQC, HMBC, TOCSY, NOESY and DEPT. 
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High-resolution mass spectra (HRMS) were measured on a Micromass Q-Tof Micro mass 
spectrometer with a lock spray source. Column chromatography was carried out on silicagel (70-
230 mesh, Merck) and Sephadex LH-20 (Mitsubishi Kagaku, Tokyo, Japan). TLC (silica gel 60 
F254) was used to monitor fractions from column chromatography. Preparative TLC was carried 
out on silica gel 60 PF 254+366 plates (20 × 20 cm, 1 mm thick). Visualization of the TLC plates 
was achieved with a UV lamp (λ=254 and 365 nm) and anisaldehyde/acid spray reagent (MeOH: 
acetic acid: anisaldehyde: sulfuric acid, 85:9:1:5). HPLC analyses were performed on a Waters 
LC Module I equipped with a UV detector 486 utilizaing the Millenium 32 Chromatography 
Manager software (Waters). An ODS column (Phenomenex Luna C18, 10 × 250 mm, 5 µm) was 
used. All HPLC solvents were HPLC grade, filtered through appropriate membranes (water 
through 0.45 µm and organic solvents through 0.22 µm filters) and sparged prior to and during 
analysis with nitrogen at a flow rate of 50 mL/min. 
3.3.3.2 Fungal material 
The fungus was collected in Tifton, Georgia, in 1978, lyophilized, and stored at -20 °C. 
The fungus was plated out on potato-dextrose agar, which was maintained at 24°C until discrete 
fungal colonies appeared. Then 50 mL of potato-dextrose broth was inoculated with the fungus 
and incubated for two weeks in stationary phase at 24 °C. The fungus was subsequently seeded 
onto a shredded wheat medium consisting of100 g of shredded wheat and 200 mL of Difco 
mycological broth (pH 4.8) (40 g of yeast extract, 400 g of sucrose and 100 g of mycological 
broth in 2 L DDI H2O) in a 2.0 L Fernbach flask (15 flasks were used) followed by incubation 
for 22 days at 24 °C 188.  
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Figure 3.15 Bioassay-guided isolation of bioactive compounds from C. cladosporioides using 
bioautography. 
3.3.3.3 Extraction and isolation 
Following incubation, 300 mL of acetone was added to each flask, and the fungus and the 
substrate were homogenized. The suspension was filtered and the filtrate was concentrated under 
vacuum at 40 °C to yield water fraction. The water extraction was then extracted with EtOAc 
(500 mL × 3). The combined EtOAc extracts were dried over anhydrous Na2SO4 and 
concentrated under a vacuum. The EtOAc extract (21 g) was chromatographed on silica gel 60, 
70-230 mesh (400 g), with fractions stepwise eluted with hexanes, ethyl acetate and methanol, 
yielding Fractions A-G. Bioautography-guided bioassay showed fraction C, D and E exhibited 
antifungal activities and were selected for further bioassay-guided isolation (Figure 3.16). 
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Figure 3.16 Antifungal activities with very clear inhibitory zones of fractions C, D and E from C. 
cladosporioides crude extracts. 
 
Fraction C was purified by HPLC on RP-18 using a MeOH-H2O gradient to afford four 
compounds, cladosporin (20) (5.038 g), isocladosporin (21) (8.3 mg), palmitic acid (29) (10 mg) 
and linoleic acid (30) (8 mg). Fraction D was separated on Sephadex LH-20 CC eluting with 
DCM-MeOH (1:1) to afford 128 fractions. Sub-fractions 72-128 were combined to afford 5’-
hydroxyasperentin (26) (117 mg). Sub-fractions 31-71 were combined and were separated by 
Biotage Isolera 1-EV system using a CHCl3/MeOH gradient to afford cladosporin-8-methyl ether 
(27) (3 mg) (Figure 3.15). 5’-hydroxyasperentin (50 mg) reacted with 2 mL acetic anhydride and 
2 mL pyridine (catalyst) for 24 hours to generate three less polar compounds. These three 
compounds were purified by preparative TLC (developed with petroleum: EtOAc 1:1) and dried 
under nitrogen to give one pure compound, 6, 5’-diacetyl cladosporin (28, 4.5 mg). The electrons 
transfer in this reaction was shown as below: 
C D E 
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*Pyrindine has a lone pair of electrons on nitrogen which cannot be delocalized around the 
ring, making nitrogen a common nucleophile and often used in acetylation reactions. 
 
Cladosporin (20): white solid; [α]20D = -14.0(c = 1.0, EtOH); mp 175−177 °C; 1H NMR (400 
MHz, CDCl3) δ 10.99 (d, J= 1.6 Hz, 1H), 8.46 (m, 1H), 6.29 (d, J= 2.0 Hz, 1H), 6.16 (d, J= 
1.6Hz, 1H), 4.71−4.66 (m, 1H), 4.13−4.10 (m, 1H), 3.97 (br s, 1H),2.88−2.75 (m, 2H), 
2.02−1.95 (m, 1H), 1.84−1.78 (m, 1H), 1.68− 1.53 (m, 4H), 1.37−1.32 (m, 2H), 1.20 (d, J = 6.4 
Hz, 3H); 13C NMR(100 MHz, CDCl3) δ 170.1, 164.1, 163.7, 141.6, 106.9, 101.8, 101.0,76.3, 
67.8, 66.6, 38.8, 33.4, 30.9, 30.6, 19.0, 18.0; HRESIMS calcdfor C16H21O5 [M + H]+ 293.1384, 
found 293.1389. 
 
Isocladosporin (21): a white solid; [α]20D = −5.0 (c = 1.0, CHCl3); mp 158−159°C; 1H NMR (400 
MHz, CDCl3): δ 11.07 (d, J = 2.0 Hz, 1H), 7.83(m, 1H), 6.34 (d, J = 2.0 Hz, 1H), 6.17 (s, 1H), 
4.83−4.78 (m, 1H),3.72−3.66 (m, 1H), 3.49−3.45 (m, 1H), 2.84−2.71 (m, 2H), 1.92−1.71 (m, 
3H), 1.60−1.50 (m, 3H), 1.27−1.20 (m, 2H), 1.15 (d, J = 6.4Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 170.3, 164.2, 163.3, 141.9, 106.8, 101.9, 101.3, 76.0, 74.1, 73.2, 41.7, 33.6, 33.1, 31.6, 
23.4, 22.0;HRESIMS calcd for C16H21O5 [M + H]+ 293.1384, found 293.1394. 
3.3.3.4 X-ray crystallographic study of cladosporin 
A single-crystal X-ray diffraction study was conducted on compound 20. C16H20O5, 
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MW=292.3, pale yellow needles were obtained with the slow evaporation of a solution in ethyl 
acetate. A single crystal, approximate dimensions 0.45 × 0.36 × 0.20 mm, was used for data 
collection on a Bruker Smart Apex II system, using Cu KR radiation with a graphite 
monochromator, fine-focus sealed tube. The crystal was kept at 100 K under a stream of cooled 
nitrogen gas from a KRYO-FLEX low-temperature device. Cell dimensions are α = 862.1 (2) Å, 
b = 6.8656 (3), c = 1427.8 (3), ß = 1168.6 (3) pm, V = 1438.4 (6) 106 pm3. Data collection, 
indexing, and initial cell refinements were all carried out using APEX II software. All non-
hydrogen atoms were visible in the difference electron density maps and refined with riding 
model at idealized positions. Anisotropic displacement parameters were included in the 
refinement for all non-hydrogen atoms. Frame integration and final cell refinements were done 
using SAINT software; 2064 reflexions 4.5 < 2θ < 52°, -2 < h <10, 0 < k < 14, 0 < l < 17, 2002 
independent intensities (Rint = 0.015), no absorption correction. Refinement converged at R1 (I 
> 2σ (I))=0.038, wR2 (all data) = 0.087, S = 1.049, max. (δ/σ) = 0.001, min/max height in final 
ΔF map -0.16/0.15 e Å-3. Structure solution, refinement, graphics, and generation of publication 
materials were performed using SHELXTL, V6.12 software. Hydrogen atoms were placed in 
their expected chemical positions using the HFIX command and were included in the final cycles 
of least-squares refinement, with isotropic Uij’s related to the atoms ridden upon (Figure 3.17). 
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Figure 3.17 Crystal structure of cladosporin (20) from C. cladosporioides. 
3.3.3.5 HPLC spectrum of cladosporin and isocladosporin 
A partial of ethyl acetate fraction was purified by HPLC on RP-18 using gradient elution 
from H2O/MeOH (starting with 80:20 for 10 min, and then MeOH increased to 100% within 30 
min; 100% MeOH for 10 min) with the flow of 8 mL/min. The big two peaks refer to 
cladosporin and isocladosporin with retention time of 43 min and 44 min, respectively (Figure 
3.18). 
 
Figure 3.18 HPLC spectrum of cladosporin (20, left peak) and isocladosporin (21, right peak). 
	   74 
3.3.3.6  Opioid and cannabinoid binding assay 
Cell Culture. CHO-K1 cells (ATCC) were stably transfected via electroporation with full 
length human recombinant cDNA for cannabinoid receptor subtypes 1 and 2 (obtained from 
Origene). These cells were maintained at 37oC and 5% CO2 in a Dulbecco’s Modified Eagles’s 
medium (DMEM) nutrient mixture F-12 HAM supplemented with 2 mM L-glutamine, 10% fetal 
bovine serum, 0.5% penicillin–streptomycin, and G418 (600 mg/mL). CHO-K1 cells stably 
transfected with opioid receptor subtype δ, κ and µ were a generous gift from Roth labs 
(University of North Carolina at Chapel Hill, Chapel Hill, N.C., U.S.A.). These cells were 
maintained at 37oC and 5% CO2 in a DMEM nutrient mixture supplemented with 2mM L-
glutamine, 10% fetal bovine serum, 0.5% penicillin–streptomycin, and either G418 (600 mg/mL) 
or hygromycin B (300 mg/mL). Membranes were prepared by scraping the cells in a 50 mM 
Tris-HCl buffer, homogenized via sonication and centrifuged for 40 minutes at 13650 rpm at 4oC. 
These were kept at -80oC until used for binding assays. Protein concentration was found via Bio-
Rad Protein Assay 192.  
 
Radio-ligand Binding for Cannabinoid and Opioid Receptor Subtypes. Cannabinoid binding 
took place under the following conditions: 10 µM of each compound was incubated with 0.6 nM 
[3H] CP 55,940 and 10 µg CB1 or CB2 membrane for 90 minutes in a salinized 96-well plate. 
The reaction was terminated via rapid vacuum filtration through GF/C filters presoaked with 
0.3% BSA using a Perkin Elmer 96-well Unifilter (Perkin Elmer Life Sciences Inc., Boston, 
Mass. U.S.A.) followed by 10 washes of 50 mM Tris-HCl. Plates were read using a Perkin Elmer 
Topcount (Perkin Elmer Life Sciences Inc., Boston, Mass. U.S.A.). Total binding was defined as 
binding in the presence of 0.1% DMSO.  Nonspecific binding was defined as binding observed 
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in the presence of 10 µM CP55, 940. Specific binding was the difference between total and 
nonspecific binding. Percent binding was found with the following formula: 100-(Binding of 
compound- nonspecific binding)*100/Specific Binding. Opioid binding took place under the 
following conditions: 10 µM of each compound was incubated with [3H]-DAMGO (µ), [3H]-U-
69, 593 (κ), or [3H]-Enkephlin (δ) for 60 minutes in a 96-well plate. Tritium and membrane 
concentration for each cell line was determined by saturation experiments performed after each 
batch of membrane was scraped. The reaction was terminated via rapid vacuum filtration through 
GF/B filters presoaked with 0.3% BSA using a Perkin Elmer 96-well Unifilter followed by 10 
washes of 50 mM Tris-HCl. Total binding was defined as binding in the presence of 0.1% 
DMSO. Nonspecific binding was defined as binding observed in the presence of 10 µM 
DAMGO (µ), nor-Binaltorphimine (κ), or DPDPE (δ). Specific binding was the difference 
between total and nonspecific binding. Percent binding was found with the following formula: 
100-(Binding of compound- nonspecific binding)*100/Specific Binding. Ki and IC50 values were 
calculated using Graph-Pad Prism 5. 
3.3.3.7 In vitro antimicrobial assay 
All organisms used for the biological evaluation of the metabolites from Eurotium repens 
were obtained from the American Type Culture Collection (Manassas, VA) and include the fungi 
Candida albicans ATCC 90028, Candida glabrata ATCC 90030, Candida krusei ATCC 6258, 
Cryptococcus neoformans ATCC 90113, and Aspergillus fumigatus ATCC 204305 and the 
bacteria Staphylococcus aureus ATCC 29213, methicillin-resistant S. aureus ATCC 33591 
(MRS), Escherichia coli ATCC 35218, Pseudomonas aeruginosa ATCC 27853, and 
Mycobacterium intracellulare ATCC 23068. Susceptibility testing was performed using a 
modified version of the CLSI (formerly NCCLS) methods 193. M. intracellulare was tested using 
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a modified method194. Samples were serially diluted in 20% DMSO/saline and transferred in 
duplicate to 96-well flat bottom microplates. Microbial inocula were prepared by correcting the 
OD630 of microbe suspensions in incubation broth to afford final target inocula. Ciprofloxacin 
(ICN Biomedicals, Ohio) for bacteria and amphotericin B (ICN Biomedicals, Ohio) for fungi are 
included as positive controls in each assay. All organisms were read at either 630 nm using the 
Biotek Powerwave XS plate reader (Bio-Tek Instruments, Vermont) or 544ex/590em, (M. 
intracellulare, A. fumigatus) using the Polarstar Galaxy Plate Reader (BMG LabTechnologies, 
Germany) prior to and after incubation. Percent growth was plotted versus test concentration to 
afford the IC50. 
3.3.3.8 Herbicidal activity of cladosporin 
The lettuce used was Iceberg A Crisphead from Burpee Seeds. Agrostis seeds were 
Penncross variety (Creeping Bentgrass species) obtained from Turf-Seed, Inc of Hubbard, 
Oregon. For seed preparation, all seeds were surface sterilized prior to use in any bioassay by 
mixing with a 5 to 10% Chlorox solution for approximately 10 minutes.  Seeds were thorough 
rinsed with deionized water (Millipore system) and air-dried in a sterile environment. All 
bioassays were done in duplicate in sterile non-pyrogenic polystyrene 24-well cell culture plates 
(CoStar 3524, Corning Incorporated). One filter paper disk (Whatman Grade 1, 1.5 cm) was 
placed in each well to be used. The control wells contained 200 mL of Millipore water. The 
control + solvent well contained 180 mL of water and 20 mL of the solvent. All sample wells 
contained 180 mL of water and 20 mL of the appropriate dilution of the sample.  Water was 
always pipetted into the well before the sample or solvent. All plate preparation was done in a 
sterile environment to lessen chances of any possible contamination. Figure 3.19 showed 
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cladosporin selectively inhibited the growth monot (agostis) and showed no activity against dicot 
(lettuce) (Figure 3.19). 
 
 
Figure 3.19 Herbicidal activity of cladosporin against monocot (Agrostis) 
 
When prepping lettuce plates, five seeds were placed in each well.  Lids were sealed with 
Parafilm. The plates were incubated in a Percival Scientific CU-36L5 incubator under 
continuous light conditions at 26°C and 120.1 umol s-1 m-2 average light intensity. Plates were 
incubated for at least seven days. Ranking of plant growth was subjective. Ranking was based on 
a scale of 0 to 5.  A ranking of 0 indicated no apparent inhibition (sample well plants looked 
identical to the Control + Solvent well plants).  A ranking of 5 indicated no growth or complete 
inhibition. A ranking of five was given only if no seeds germinated. 
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3.4 IDENTIFICATION AND BIOLOGICAL STUDY OF THE FUNGUS MILOGRANTE 
The fungus Milograntewas the second fungus chosen for further isolation study. In the 
bioautography bioassay, it showed very good antifungal activity against three Colletotrichum 
species (Figure 3.8) 
3.4.1 Identification of Fungus Milogrante 
3.4.1.1 Results 
The fungus Milogrante is inoculated in malt extract agar (MEA) after 10 days at 25 ± 2°C, 
under cool-white fluorescent lights (55 ± 5 µmol/m2/s) with a 12 h photoperiod, colonies with 23 
mm of diameter, expanding, velvety, olivaceous green and reverse olivaceous black (Figure 3.20 
a & b). The fungus shown conidiophores 50 µm long, 2-6 µm wide, without swellings, with 
terminal and lateral ramifications, bearing branched conidial chains, pale olivaceous brown, 
conidia ellipsoidal to limoni-form, smooth-walled, olivaceous brown, 1-celled, with dark scars 
(Figure 3.20 c). In addition, the sequence of fungus Milogrante displayed 99% of identity with 
different sequences of cultivable and non-cultivable fungi deposited in GenBank database. 
However, according to Gaziset al. (2011) 195and Koet al. (2011) 196, sequencing of the ITS region 
may fail to recognize some Ascomycota taxa and for this reason there are several erroneous 
fungal sequences deposited in GenBank. To increase the taxonomy accuracy and avoid mistakes 
on the phylogenetic inferences, the ITS1-5.8S-ITS2 nuclear ribosomal gene sequence of the 
fungus Milogrante was compared with sequence of type species of Cladosporium 
cladosporioides (Figure 3.20 d). In the phylogenetic analysis, the nucleotides difference among 
the fungus Milogrante and the sequence of the type species Cladosporium cladosporioides CBS 
144.35 (HM148012) was of the one nucleotide (0.17 %). Using physiological, morphological 
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characteristics and molecular techniques, the fungus Milogrante was identified as Cladosporium 
cladosporioides (Fres.) de Vries. 
 
 
Figure 3.20 Taxonomic data of the fungus Milogrante. (a & b: Morphological verse and reverse 
aspect of culture after 7 days on MEA at 7 days at 25 ± 2°; c: micromorphological structures 
(conidiophores and conidia)). 
 
Figure 3.20 d Phylogenetic analysis of the fungus and their nearest relatives. The tree was 
constructed based on the rRNA gene sequences (ITS1-5.8S-ITS2) by using the maximum 
composite likelihood model; the tree was rooted with Trametes versicolor [AF042324] as an 
outgroup. Tsequence of type species is shown in gray box. 
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3.4.1.2 Phylogenetic analysis 
Genomic DNA from the fungus Milogranteas extracted with DNeasy Plant Mini Kit 
(Qiagen Inc., Valencia, CA) and used as a template in PCR amplifications. The ITS1-5.8S-ITS2 
genomic region (ITS) was amplified from genomic DNA using the forward primer ITS1 (5´- 
TCCGTAGGTGAACCTGCGG-3´) and the reverse primer ITS4 (5´- 
TCCTCCGCTTATTGATATGC-3´) 197. PCR amplifications were carried out in 50 µL reaction 
mixture containing 1x PCR reaction buffer, 0.2 mM dNTP mixture, 0.2 µM of each forward and 
reverse primers, 1.5 mM MgSO4 and 2 U of Platinum Taq DNA Polymerase (Invitrogen, CA). 
The PCR program consisted of one initial denaturation step at 94°C for 3 min followed by 40 
cycles at 94°C for 30 sec, 50°C for 30 sec, 72°C for 1:30 min, with a final extension at 72°C for 
7 min. PCR was performed in an M&J Research Gradient Cycler PTC-225. After amplification, 
an aliquot was analyzed by electrophoresis on a 1% TAE agarose gel, visualized under UV light 
and PCR products were compared to the molecular size standard 1kb plus DNA ladder 
(Invitrogen, city CA). Successfully amplified PCR products were extracted using MinElute PCR 
Purification Kit (Invitrogen, city CA) and sequenced on an automated DNA Sequencer (model 
ABI 3730XL; Applied Biosystems, Foster City, CA). Consensus sequence data of the endophytic 
fungus was submitted to the GenBank database under the number NRRL 5507.The sequence 
obtained was submitted to phylogenetic inferences, which were estimated using MEGA Version 
5.0 198. The maximum composite likelihood model was used to estimate evolutionary distance 
with bootstrap values calculated from 1,000 replicate runs. The sequence of the type fungal 
species and some references sequences deposited in GenBank were added to phylogenetic 
analysis accuracy. Information about the fungal taxonomic hierarchical levels follows the 
databases MycoBank (www.mycobank.org) and Index Fungorum (www.indexfungorum.org). 
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3.4.1.3 Physiological and morphological analysis 
The physiological and morphological characteristics of the fungus Millogrante were 
observed on 2% malt extract agar ((malt extract 2%, peptone 0.1%, glucose 1.5% and agar 2% 
(MEA)). The colony diameter was measured on media, which was inoculated in three-point 
cultures and incubated for 7 days at 25 ± 2°C under cool-white fluorescent lights (55 ± 5 
µmol/m2/s) with a 12 h photoperiod to sporulation. A duplicate set of MEA plates was incubated 
in the dark at 25°C to microscopic parameters determination using slide cultures mounted in 
methyl blue in polyvinyl-lactophenol. 
3.4.2 Biological Study of Isolate 2 of C. cladosporioides (Milogrante) 
NMR-guided isolation showed that almost all the active constituents in isolate 2 are fatty 
acids, which is totally different from that in isolate 1. Fatty acid refers to a carboxylic acid 
bearing a long unbranched aliphatic chain. The long chain can be monounsaturated, 
polyunsaturated, or saturated with even number of carbons in the majority of naturally occurring 
fatty acids. Fatty acids play important roles in our daily life. As an important part of a healthy 
diet, they keep skin healthy, prevent early aging and promote weight loss 199. They also aid cell 
membrane development, strength, and function, which is essential for organs and tissue. Some 
polyunsaturated fatty acids are known to be major components of the human central nervous 
system (CNS). For example, Docosahexaenoic acid (DHA) and arachidonic acid (AA) are major 
components of the CNS, where they play a critical role in neural development. DHA has been 
shown to be essential in the prevention of numerous diseases. Low levels of DHA may lead to 
Alzheimer's disease. Arachidonic acid (AA) is another important fatty acid, which is a key 
inflammatory intermediate 200, 201, 202.  
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In recent years, more and more natural lipids have been identified as endogenous leads 
for the central cannabinoid receptors which belong to family of GPCRs and are associated with 
many processes including pain, craving, neurodegeneration, metabolic regulation, anxiety and 
immune function 203, 204. So discoveries in cannabinoid receptors have provided an exciting 
future for cannabinoid receptor-based therapies to treat a variety of disorders in CNS 205. 
Linoleic acid is an omega-6 essential polyunsaturated fatty acid and its deficiency can result in 
symptoms such as hair fall, dry hair, and poor wound healing 206. Palmitic acid is one of the most 
common saturated fatty acids found in animals and plants and mainly used to produce soaps, 
cosmetics, and release agents 207.  
3.4.2.1 Opioid and cannabinoid receptor binding affinity 
The EtOAc crude extract (36 g) of the isolate of C. cladosporioides (Milogrante) was 
chromatographed on silica gel 60, 70-230 mesh (400 g), with fractions stepwise eluted with 
hexanes, ethyl acetate and methanol, yielding seven fractions (fractions 1-7). The crude extracts 
and their fractions were submitted for opioid and cannabinoid receptor testing. The result showed 
that fractions 2 (Hex: EtOAc 1:1) showed promising activities against all three opioid receptors 
(δ, 92.80; µ, 95.07; and κ, 91.98) and fraction 3 (100% EtOAc) and fraction 6 (100% MeOH) 
showed modest activities against δ receptor. The crude extracts and fractions 1 (100% Hexanes), 
fraction 4 (MeOH: EtOAc 25:75), fraction 5 (MeOH: EtOAc 50:50) and fraction 7 (MeOH: H2O 
50:50) showed weak or no binding affinities for opioid receptors. All the fractions had no 
CB1/CB2 affinities. And then, fraction 3 (3.14 g) was chromatographed on liquid silica column 
to give 14 sub-fractions which were subsequently tested by opioid and cannabinoid receptor 
assays. The result showed 3 sub-fractions (DCM/EtOAc 60/40 (δ, 78.4); DCM/EtOAc50/50 (δ, 
70.84); DCM/EtOAc40/60 (κ, 59.82)) had affinity for δ or κ receptor (Table 3.4). 
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Table 3.4 Binding Affinity Assay of the Fungus Migrante for Human Opioid Receptors and 
Cannabinoid receptors. 
 
3.4.2.2 Antifungal study 
The crude extracts, fractions and sub-fractions from the isolate 2 of C. Cladosporioides 
were tested for their antifungal activity against three Colletotrichum species using bioautography. 
The crude extracts and fractions 6 (100% MeOH) and fraction 7 (MeOH: H2O 50:50) showed 
very good inhibition zones against C. fragariae (Figure 3.22).  
 
!  
Species  
 
Fractions (10 !g/ml) 
Opioid Receptors 
(%)  
Cannabinoid Receptors 
(%) 
" # µ CB1 CB2 
XW-
Migrante 
 
Crude extracts 20.38 49.06 44.23 43.2 8.7 
100% Hexanes -2.71 23.15 25.14 -24.20 -38.24 
Hex:EtOAc (1:1) 92.80 91.98 95.07 -70.63 -25.87 
EtOAc 53.96 20.27 38.47 -52.83 -42.32 
MeOH:EtOAc 
(25:75) 
47.90 6.58 22.14 -59.96 -17.36 
MeOH:EtOAc (1:1) 33.85 4.41 35.75 -55.80 -16.95 
 100% MeOH 57.16 7.30 47.45 -67.04 1.60 
 MeOH: H2O 39.67 
78.4 
70.84 
- 
13.78 
- 
- 
59.82 
33.30 
- 
- 
- 
-44.11 
- 
- 
- 
6.71 
- 
- 
- 
DCM:EtOAc (6:4) 
DCM: EtOAc (1:1) 
DCM:EtOAc (4:6) 
Naloxone (10 !m) 89.15 98.65 99.42 - - 
CP 55,940 (10 !m) - - - 105.75 100.19 
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Figure 3.22 Bioautographic result of fraction 6 and fraction 7 against C. fragariae. Four µL of 20 
mg/mL with 1 cm band size of fraction 6 and fraction 7 were applied at 1 cm measured from the 
bottom edge of the TLC (10 × 10 cm) and developed with CHCl3: MeOH (7:3). 
 
Fractions 6 were purified using gradient HPLC with acetonitrile and water. Two fractions 
were obtained at 20.93 min and 21.77 min (Figure 3.23). They were tested to exhibit promising 
antifungal activity against C. fragariae (Figure 3.24). NMR data showed that they all belonged 
to fatty acids. 
CHCl3: MeOH 7:3 
Fraction 6 Fraction 7 
	   85 
 
Figure 3.23 HPLC spectrum of two fatty acids (20.93 min, 21.77 min) from fraction 6. 
 
 
Figure 3.24 Bioautographyic result of two fractions from fraction 6. 
 
After GC/MS analysis, these two fractions were determined as linoleic acid and palmitic 
acid. The mixtures of these two acids with different ratios were tested for the binding affinity for 
human opioid receptors (µ, δ, κ) (done by Dr. Mohamed Radwan and Amer Tarawneh). The 
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result showed that the mixture of linoleic acid and palmitic acid with 1:1 ratio was the most 
potent with an IC50 value of 7.65 µM. This led us to believe that active components of these two 
acids are working synergistically to produce their effects. To our best knowledge, this is the first 
time to report opioid binding activity of these two acids. Besides the great potency of linoleic 
and palmitic acids, they offer greater safety in their application than the synthesized or semi-
synthesiezed drugs. So these lipids need to be further exploited. 
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CHAPTER 4 DEVELOPMENT OF A MINATURISED 24-WELL STRAWBERRY LEAF 
DISK BIOASSAY FOREVALUATION OF NATURAL FUNGICIDES 
4.1 INTRODUCTION 
Effective disease control strategies for crop plant pathogens rely on the use of fungicides. 
Wedge et al. reported on new fungicide management strategies for control of strawberry fruit rot 
diseases in the Gulf state region and the need for efficacious fungicides to provide growers with 
more options for controlling diseases 208.   Disadvantages of the use of these chemical controls 
include the development of resistant fungal strains as well as potential environmental and 
mammalian toxicities. Resistance of many plant pathogens to commonly used commercial 
fungicides is becoming a serious problem and has limited the number of effective disease control 
agents. For example, numerous isolates of Colletotrichum spp. developed benomyl insensitivity 
(only showed 40%-60% fungus growth inhibition) after several years of use to protect strawberry 
and other fruit crops 209. Colletotrichum species often cause typical symptoms of anthracnose, a 
disease characterized by sunken necrotic lesions usually bounded by a red margin 210. As we 
mentioned before, anthracnose diseases of strawberry (Fragaria × ananassa Duch) are serious 
problems for fruit and plant production in many areas of the world 211. The pathogens, 
Colletotrichum fragariae A. N. Brooks, C. gloeosporioides (Penz.) Penz., and C. fragariae CF -
75, can occur singly or in combination to infect flowers, fruit, leaves, petioles, stolons, and 
crowns 212. 
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In the continued fungicide discovery, we are focused on natural products derived from plants 
and fungal organisms with emphasis on compounds with fungicidal activity213. Natural 
antifungal agents are generally broad-spectrum compounds with low mammalian and 
environmental toxicity and 3-dimensional structures that synthetic compounds may lack. Along 
with discovery of new molecules with novel motion of action and our interest in antimicrobial 
agents from higher plants and fungi 17, a novel miniaturized bioassay for evaluating small 
amounts of available compounds is also needed 214.  
 
Development of new plant protectants with a lipophilic nature is limited by the lack of 
suitable bioassays to properly evaluate these compounds. While the lipophilic nature of 
phytochemicals allows them to embed themselves into the leaf waxes and persist through rainfall, 
hence making them potentially useful agrochemicals, this characteristic also makes them very 
difficult to evaluate in many aqueous bioassays.  Examples include essential oils and many 
marine extracts, which are hydrophobic and insoluble in most aqueous-based antimicrobial disc 
diffusion and micro-dilution broth bioassays. Direct bioautography on silica gel is our preferred 
primary screening bioassay and often the best assay for evaluating lipophilic compounds as 
fungicides for agricultural use, because this assay more closely mimics a leaf surface. Classical 
leaf bioassays, used to test fungicide efficacy at concentrations between 625 and 2500 ppm, may 
use 75-100 mg of an experimental compound that is often difficult to obtain. Therefore, the need 
for a novel miniaturized leaf disk bioassay that utilizes small sample sizes, has high throughput 
capability, and replicates the real leaf surface is of utmost importance to natural product 
fungicide discovery.  This study presents information about developing of a new 24-well 
detached leaf bioassay for evaluation of natural fungicides. 
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4.2 RESULTS AND DISCUSSION 
4.2.1 Salt Solutions For 24-well Leaf Disk Assay 
Leaf color index of 2.67 obtained after inspecting 7-day-old leaf disks indicated that half 
strength Hoaglands No. 2 basal salt media (PhytoTechnology Laboratories) provided excised leaf 
discs with the best physiological support (Table 4.1). Murashige and Skoog basal salts (Sigma-
Aldrich) demonstrated the lowest color index of 1.83.  While 2-N-morpholino ethane sulfonic 
acid (MES, Sigma-Aldrich) and water (control) had a color index of 2.42 and 2.83 respectively. 
However, MES and water did not gel sufficiently to provide adequate physical support to keep 
leaf disks afloat for subsequent inoculation with the conidial solutions. Typical working 
concentrations for Phytagel™ are 1.5-2.5 g/L in plant tissue culture media and up to 10 g/L in 
microbiological media. Phytagel™ requires the presence of cations (especially divalent) for 
gelling to occur. Concentrations of calcium and magnesium contained in most plant tissue 
culture media are typically sufficient for gelation. Low-salt media formulations, especially those 
used in microbiological applications may require supplementation with additional calcium or 
magnesium salts (e.g., CaCl2 or MgSO4) or higher concentrations of Phytagel. Therefore we 
chose ½ strength Hoaglands No. 2 basal salt media containing 1% Phytogel as the best medium 
to conduct all subsequent 24-well leaf disk studies. 
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Table 4.1 Half strength Hoagland’s No. 2, 2-N-morpholino Ethanesulfonic Acid (MES), 
Murashige and Skoog Basal Salt Mixture (M&S) and Water (control) Were Evaluated for Their 
Ability to Sustain Excised Leaf Discs for 7-10 days. 
Salt Solution Leaf Color Value (1-3) Standard Error 
H2O 2.83 a 0.11 
½ Hoagland’s 2.67 a 0.22 
M&S 1.83 ab 0.30 
MES 2.42 b 0.19 
Mean leaf color index on a scale from 1-3 (1 = light green, 2 = medium green, 3 = dark 
green) was used to describe leaf chlorophyll content. Means followed by the same letter are 
not significant at p<0.05. 
4.2.2 Pathogen Type, Surfactant, and Inoculum Volume 
Colletotrichum fragariae (CF75), C. fragariae (CF63), and C. gloeosporioides (CG162) 
were each evaluated for their ability to produce disease lesions under in vitro conditions at three 
levels of Tween 20 (0.3 %, 0.5 %, and 0.7%).  Mean necrosis indicated that Colletotrichum 
fragariae (CF75) and C. gloeosporioides (CG162) produced the highest number of lesions under 
in vitro conditions and C. fragariae (CF63) produced the lowest number of lesions (Table 4.2). 
The best treatment combination was C. fragariae (CF75) where inoculum amended with 0.5% 
and 0.7% Tween 20 produced 16.72 and 15.53 % necrosis of the leaf disks respectively. C. 
gloeosporioides (CG162) showed no significant differences in leaf lesions between the three 
Tween 20 concentrations. Lesion development (necrosis) indicated that there was no difference 
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between 10 or 20 µL inoculum volumes for any of the three Colletotrichum spore suspensions 
when applied to the leaf disk disks.   
 
Table 4.2 Percent mean necrosis was used to evaluate the ability of Colletotrichum fragariae 
(CF75), C. fragariae (CF63), and C. gloeosporioides (CG162) and three concentrations of 
Tween 20 (0.3 %, 0.5 %, and 0.7%) in the inoculum solution to produce disease lesions on 15 
mm leaf disks. 
Fungal isolate  &% Tween 20  % Mean Necrosis Standard Error 
CF63           0.3 7.34 cde 2.53 
CF63           0.5 4.84 efg 1.12 
CF63           0.7 5.78 def 2.05 
CF75           0.3 10.78 bcd 2.13 
CF75           0.5 16.72 a 0.93 
CF75           0.7 15.53 ab 8.52 
Cg162          0.3 12.47 abc 3.27 
Cg162          0.5 11.58 abc 2.02 
Cg162          0.7 12.00 abc 3.20 
H2O            0.3 0.56 fg 0.00 
H2O            0.5 0.14 g 0.00 
H2O            0.7 0.00 g 0.00 
Means followed by the same letter are not significant at p<0.05. 
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4.2.3 Phytotoxicity 
Phytotoxicity evaluations were made visually at 12 hrs after treatment of the fungicidal 
solution or solvent control and prior to inoculation (Figure 1).   Origanum onites essential oil 
above 1250 ppm demonstrated a 4+ phytotoxicity ranking and A. sinensis essential oil 
demonstrated 1+ phytoxicity ranking at 2500 ppm.  Percent healthy tissue, percent leaf necrosis 
and percent phytotoxicity of the leaf disk are presented in Table 4.3. The commercial fungicide 
azoxystrobin at 625 ppm had the greatest level of disease control efficacy at 99% healthy tissue. 
Even at 2500 ppm, azoxystrobin showed the lowest level of phytotoxicity (0.45%). Both O. 
onitesand and A. sinensis essential oils were phytotoxic at higher doses (Figure 4.1 and 4.2). 
Color analysis of Plate 1b (Figure 4.2) showed healthy area in green, diseased area in black and 
phytotoxicity in gray. Origanum onites essential oil was more phytotoxic to strawberry leaves 
than was A. sinensis essential oil. Angelica sinensis essential oil was a more effective antifungal 
agent against all three Colletotrichum species. 
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Table 4.3  Percent Healthy Tissue, % Leaf Necrosis, and % Phytotoxicity as Determined at Five 
Days After Inoculation by a Lemnatec Lemna HTS and SAW Scanalyzer Analyzing Software. 
 Azoxystrobin 
Essential oil of 
Origaniumonites 
Essential oil of 
Angelica sinensis  
 
625 
ppm 
1250 
ppm 
2500 
ppm 
625 
ppm 
1250 
ppm 
2500 
ppm 
625 
ppm 
1250 
ppm 
2500 
ppm Control 
% Healthy Tissue          
CF75 99.29 98.93 99.16 65.03 9.79 16.43 92.59 79.65 36.73 86.18 
CF63 99.55 99.51 99.64 96.17 7.32 20.94 96.02 72.20 16.18 92.22 
Cg162 99.65 99.21 99.80 98.66 33.72 17.42 98.53 97.33 27.64 94.27 
% Leaf Necrosis         
CF75 0.40 0.55 0.39 25.81 29.78 1.02 6.49 8.78 9.59 13.01 
CF63 0.13 0.23 0.03 3.39 17.17 0.33 2.89 7.58 0.09 6.85 
Cg162 0.04 0.40 0.09 1.13 15.97 7.19 1.05 1.42 0.91 4.85 
% Phytotoxicity          
CF75 0.31 0.52 0.45 9.16 60.44 82.55 0.92 11.57 53.67 0.80 
CF63 0.31 0.26 0.33 0.44 75.51 78.72 1.09 20.21 83.73 0.93 
Cg162 0.31 0.39 0.11 0.21 50.31 75.39 0.42 1.25 71.44 0.88 
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Plate 1 
 
 
 
 
Plate 2 
 
 
 
 
 
 
 
 
 
 
 
 
A
B
C
D
A
B
C
D
1250 1250
1250 1250
2500 2500
2500 2500
625 625
625 625
Azoxystrobin
Azoxystrobin
Origanum onites
Origanum onites
Angelica sinensis
Angelica sinensis
20% Ethanol control
20% Ethanol control
Figure 4.1 Phytotoxicity produced by Organium onites and Angelica sinensis. 15-mm excised leaf 
disks from anthracnose susceptible strawberry cultivar ‘Chandler’ demonstrate easy to visualize 4+ 
phytotoxicity of Organium onites essential oil above 1250 ppm. Angelica sinensis essential oil 
demonstrated 1+ phytoxicity at 2500 ppm. Plate 1 and plates 2 are duplicate treatments showing 
subtle variation in phytotoxicity bleaching between replicate plates. 
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Figure 4.2 Photographic image of the phytotoxicity produced by Organium onites and Angelica 
sinensis. Plate 1a is a photographic image of 15-mm excised leaf disks from anthracnose 
susceptible strawberry cultivar ‘Chandler’ following 3-5 second dip in fungicide test solutions 
in a dose-response format and inoculated 12 hrs later with CF75. Plate 1b is an image analysis 
of Plate 1a using the LemnaTec and SAW Scanalyzer analyzing software showing healthy 
tissue in green, diseased (necrotic) lesions in black, and bleached tissues (phytotoxicity) in 
gray.   
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4.3 EXPERIMENTAL 
4.3.1 Plant Preparations 
 Plants of the anthracnose-susceptible cultivar Chandler were obtained in October 2007 
from Shingleton Farms (Statonsburg, NC, USA), planted into 14 cm plastic azalea pots 
containing Metromix 350 (BWI- Memphis, TN), and placed in the greenhouse without shade. 
Plants were watered daily and Peter’s 20-20-20 nutritional solution (BWI- Memphis, TN) was 
applied weekly. Plants with any signs of disease were rouged and removed from the greenhouse 
daily. 
4.3.2 Leaf Disc Preparation 
 The first or second fully expanded leaves were removed from stock strawberry plants and 
transported directly to the laboratory so that the leaves were available for the bioassay in less 
than 4 hours. Immediately after collection, the leaves were placed in a tray lined with moist 
paper towels and the tray was closed to retain near 100% relative humidity (RH) and maintained 
at ~12°C. Only leaves with no visible signs of injury or symptoms of disease were collected. 
Whole leaves were disinfested by placement in a beaker with 2.5% Clorox for 3 min., then they 
were rinsed 2-3 minutes in sterile distilled de-ionized water three times. Leaves with any signs of 
bleaching were discarded. Strawberry leaf disks were then cut from the disinfested leaves using a 
15-mm stainless steal cork borer and placed in moisture plate until they were placed in the 24-
well plate.   
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4.3.3 24-well Leaf Disk Assay 
Three commercial in vitro salt solutions were evaluated for their ability to maintain leaf 
disks during the in vitro experiment: half strength Hoagland’s No. 2 (H, Phytotechnology 
Laboratories, Shawnee Mission, KS), 2-N-morpholino ethanesulfonic acid (MES, Sigma M8250, 
Sigma-Aldrich, St. Louis, MO), Murashige and Skoog basal salt mixture (MS, Sigma M5524). 
Water (control) was also evaluated for its ability to sustain excised leaf discs for 7-10 days. 
Stock solutions containing 1% Phytogel (Sigma P8169) were prepared as follows: Hoagland’s 
No. 2 solution (0.815 g/L), MES (195.2 mg/L) containing 5 mL Gamborg's Vitamins (Thiamine-
HCl 5mg/L, Pyridoxine-HCl 0.5 mg/L, Nicotinic acid  0.5 mg/L, Myo-inositol 50mg/L), and MS 
(2.2 g/L). All support solutions were adjusted to 6.5 pH using 0.1 N and 1.0 N NaOH. Excised 
leaf disks were placed onto the 1500 µL of either respective solidified salts/medium contained in 
each well of the 24-well plate.  Plates were maintained in the sterile biological hood over night 
prior to pathogen inoculation to allow time for the leaf disks to initiate wound healing and 
acclimate to the in vitro system. The plates were sealed with paper-based tape and placed in the 
incubator under (55±5 µmols·m-2·sec-1) (UFL-F17T8/741, Interlectric Corp., Warren, PA) with a 
12 h photoperiod in a growth chamber at 25º C for one week. All samples were duplicated and 
the experiments were repeated three times. 
4.3.4 Pathogen and Inoculum Preparation 
 Three Colletotrichum isolates were evaluated for their ability to produce disease lesions 
under the in vitro conditions of this study. Colletotrichum fragariae (CF75), C. fragariae (CF63), 
and C. gloeosporioides (CG162) isolated from strawberry were evaluated for their ability to 
produce anthracnose symptoms on excised strawberry leaf discs. Each Colletotrichum isolates 
was grown on 1/2 strength potato dextrose agar (PDA) in 9-cm Petri dishes and incubated under 
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Ushio Ultra 8 fluorescent lights (55±5 µmols·m-2·sec-1) at 25 °C as previously described (Abril 
et al., 2008). Conidia were harvested from 7- to 10-day-old cultures, and the aqueous conidial 
suspensions were filtered through sterile Miracloth (Calbiochem-Novabiochem Corp., La Jolla, 
CA, USA) to remove hyphae. Conidial concentrations were determined photometrically from a 
standard curve based on absorbance at 625 nm 215 and then stock suspensions were adjusted with 
sterile water to a concentration of 106 conidia / mL. Conidial suspensions for inoculation were 
then adjusted to a final concentration of 105 conidia/mL. Two inoculum volumes were evaluated 
where the inoculum volume applied to each leaf disk was either 10 or 20 µL of any of the three 
fungal spore suspensions. After leaf disk inoculation, the 24-well plate was sealed with paper-
based tape again and placed in the incubator for 6 days. Three concentrations of Tween 20 were 
also evaluated for their effects on promoting pathogen infection of the leaf disk. Tween 20 
concentrations of 0.3%, 0.5%, and 0.7% were prepared in 100 mL sterile distilled water. 
4.3.5 Disease Assessment and Phytotoxicity 
Experimental compounds were evaluated in a dose-response format.  Azoxystrobin that has 
protective and some curative activity were used as standards for comparison. A 20% ethanol: 
water solvent control is used in each study to solubilize lipophilic extracts. Angelica sinensis 
roots were purchased as a plant material from Jincheng Lingyi Drugstore, Weinan City, Shaanxi 
Province, China.  Origanim onites essential oil was purchased from ALTES Company, Turkey.  
Stock solutions containing 625, 1250, and 2500 ppm were prepared for azoxystrobin, Origanum 
onites essential oil, Angelica sinensis essential oil and 20% ethanol solvent control in 50 mL 
capped test tubes.   
Strawberry leaf disks prepared as previously described were dipped in antifungal test 
solutions for 3-5 seconds, excess solution was allowed to drain onto the edge of the test tube and 
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then placed into the appropriate row and column of the 24-well plates.  Plates were incubated 
over night at room temperature and inoculated the next morning with either 20 uL of conidial 
solution obtained from either C. fragariae (CF75), C. fragariae (CF63), or C. gloeosporioides 
(CG162). Percent healthy tissue, percent leaf necrosis, and percent phytotoxicity were 
determined at 5 days after inoculation by a LemnatecLemna HTS and SAW Scanalyzer 
analyzing software (LemnaTec GmbH, Wurselen, Germany). The instrument was set up to 
photograph (Sony DFW-SX900 camera) a 24-well plate containing the leaf disks using both top 
lighting and bottom lighting (8 W fluorescent tubes) and optimized for disk clarity and color.  
The software configurations were set to measure the area of each disk separately and classify the 
colors detected within each leaf. Color classification was set to differentiate healthy tissue, 
bleached tissue, and necrotic lesions on the leaf surface. 
 
SAS (Statistical Analysis System, Cary, N.C.) was used to conduct analysis of variance and 
mean separation tests on all three experiments. A completely randomized design was used for all 
experiments. All factors were considered to be fixed effects, except for surfactant concentration 
in the surfactant experiment.  Fisher's protected LSD was used to separate means 216. 
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Appendix: A 
Protocol 1. Preparation of ½ Strength Potato Dextrose Agar (PDA)  
Weigh/measure (using weighting boat on electronic balance 1/10000 gram) 
1. 19.6 g         PDA Powder (Difco-Becton, Dickinson and Company) 
2. 8 g              Bacto Agar (Difco-Becton, Dickinson and Company) 
3. 1000 mL    DDI H2O (Ultra Pore Millipore System) 
4. Add to Flask, Heat, and Stir 
5. Stirs suspension until completely dissolve--Divide into 2 Erlenmeyer flasks (500 mL)-- 
Cover the flask with aluminum foil & Autoclave tape – Autoclave at 121 oC for 45 min 
Protocol 2. Preparation of ½ Strength Potato Dextrose Agar/Oatmeal (PO) 
1. 24 g                PDA: OMA mixture 
2. 8 g                  Bacto Agar 
3. 1000 mL        DDI    H2O  
4. Erlenmeyer flask /magnetic stirring bar on Heat/stirrer 
5. Stirs suspension until completely dissolve--Move 1000 mL into 500 mL Erlenmeyer 
flasks cover the flask with aluminum foil. 
6. Autoclave at 121 oC for 45 min (don’t forget the autoclave tape).
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Protocol 3. Preparation of Potato Dextrose Broth (PDB) 
1. 12.5g            PDB Powder 
2. 0.5g              Bacto Agar  
3. 500mL          DDI H2O (Ultra Pore Millipore System) 
4. 0.5mL           Tween 80 (add it after upper materials are dissolved)  
5. Place on a stir plate and heat. While stirring and heating, pipette 0.5 mL of Tween 80 into 
flask with magnetic stirring bar. 
6. Stirs suspension until completely dissolve--Move 100mL into 250mL Erlenmeyer flasks 
cover the flask with aluminum foil – Autoclave at 121 oC for 45 min (don’t forget the 
autoclave tape). 
7. Place 100 mL aliquots in the refrigerator. 
8. Filter before use of spray (0.45 microns) 
Protocol 4. Streaking Plates 
1. Remove media plates from the refrigerator to be inoculated. 
2. Allow plates to warm to room temperature. 
3. Condensation on the plate lids, place the plates on the back of the hood with the lid 
slightly opened to allow the condensation to evaporate.  
4. Once there is no more condensation on the lid, close the plates. 
5. Label the bottom plate of the petri dish.   
i.e. ½ PDA  C. fragariae  fr. Stock 7-12-12 6-03-12 (today’s date) 
6. Add 50 µL of the inoculums to each plate.  
7. Streak the plate with a sterile inoculun loop. Change lops between each plate that is being 
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streaked to reduce contamination. 
8. Wrap the inoculated plate with 2 pieces of parafilm. 
9. Place the inoculated plate in the appropriate growth chamber with the lid side facing up. 
Protocol 5. Procedures of Fungus Harvest  
1. Remove fungal isolates inoculated 7-10 days from Percival Growth Chamber @ 24 °C 
(incubation period). 
2. Test the contaminated situation of the fungi, discard the green ones, reserve the black 
ones and discard the black parts. 
3. Label sterile test tubes and the cuvettes according to fungal isolates before harvesting 
(using the corresponding color codes). 
4. Use different color label bands label each different fungal isolate to avoid mistakes. 
5. Place sterile funnel into glass test tube using forceps. 
6. Remove miracloth square from sterile wrap, pouch and place into funnel. 
7. Place a fungal isolate (e.g. Ca Goff) plate onto turn table -----pipette 10 ml of sterile DDI 
H2O into the plate ----using L cell spreader softly remove conidia from media.  
8. Using Gilson 10ml Pipetman, pipette conidia suspension through Miracloth, seal test tube 
with Parafilm square, and then place tube with suspension in ice bucket. 
9. Prepare label microscope slide (size 25×75×1mm) and check for contamination using 
Olympus BX60 (pipette 15 µL of conidia suspension onto slide /cover by using cover 
glass). 
10. Examine: prepare conidia suspension. 
11. Collect spore suspension with pipette (10 mL) from media into sterile tube and remove 
test tubes from ice bucket and place in refrigerator until over night for harvesting spore 
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deposition. 
Protocol 6. Preparation of RPMI buffer for Stock Solution. 
To prepare 1 liter liquid medium: 
1. Measure out 800 mL distilled water and pour into a mixing container that is as close to 
the final volume as possible. 
2. Add 10.4 g powdered RPMI medium (GIBCO) to 15 to 30 oC (room temperature) water 
with gentle stirring (Do not heat water). 
3. Rinse out inside of package to remove all traces of powder 
4. Add 34.5 g MOPS sodium salt (3-(N-morpholino) propanesulfonic acid), Fluka) into the 
medium 
5. Dilute to a desired volume with water. Stir until dissolved.(Do not over-mix) 
6. Adjust PH of medium to 0.2-0.3 below desired final working PH (7.0): use of 1N NaOH 
is recommended. (Add slowly with stirring). After pH has been adjusted. Keep container 
closed until medium is filtered 
7. Sterilize immediately by 50 mm Diameter Filter Unit (150 mL or 250 mL, NALGENE) 
(Positive pressure recommended), and pH units usually rise 0.1-0.3 upon filtration and 
reach to 7.0 
8. Label 
9. Store @ 4 oC 
Protocol 7. Preparation for 10% Glycerol/RPMI Buffer Stock Solution (100 mL) 
1. Prepare 10% glycerol /RPMI buffer stock solution: 
    90 mL RPMI buffer (RPMI 10.4 g/L H2O, MOPS 34.5 g/L H2O) 
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    10 mL glycerol  
     Combine RPMI Buffer & Glycerol—VORTEX (for 2 min) 
2. Filter sterilizes (0.45 microns) 
3. Label 
4. Store at 4 oC 
Protocol 8. Inoculum Stock Solution (Long term) 
1. Add 50 µL of inoculums to 1 mL RPMI Buffer/Glycerol (10% stock solution) in 5 mL 
round bottom tube 
2. Vortex 
3. Label and parafilm tube 
4. Falcon Blue Max Jr., Falcon Max polypropylene Conical Tubes and Cryogenic vials can 
be used for storage at 4 oC 
5. Select Isolate for Storage 
6. From prepared conidial suspension pour off supernatant-add 5 mL of 10% 
Glycerol/RPMI Buffer stock spores (only) 
7. Votex-pipette 0.5 mL conidial suspension into each cryogenic vial 
8. Store at -80 oC 
Protocol 9. Silica Gel Storage of Fungal Isolates (Long-term) 
Using sterile technique, equipment and laminar flow food: 
1. Shake gently but thoroughly the tube of milk suspension; flame the mouth of the tube. 
2. Pour the milk suspension onto fungal growth in petri dish. Sometimes 2 tubes of milk 
suspension will be needed if the isolate exhibits a “fluffy” growth pattern. 
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3. Using a sterile glass rod, scrape the entire surface of the fungal culture to dislodge 
conidia – rotate dish gently to move milk over surface of the fungal growth. 
4. Label the tube of silica gel to be used for storage; include the name of the isolate and the 
date (Example: Goff  9/10/96  skim or dry milk ). 
5. Remove screw cap from silica gel tube. Remove cotton stopper with sterile forceps, 
flame the mouth of the tube. 
6. Using a sterile Pasteur pipette with a small pipette bulb attached, transfer 0.5ml – 2.0ml 
of the conidial-milk suspension into the silica gel tube. Flame the mouth of tube again; 
replace cotton stopper and screw cap securely. 
7. Immediately Vortex. Place tube on Vortex mixer and allow shaking vigorously, turning 
the tube so that the conidial-milk suspension is mixed well onto the silica gel crystals. 
The tube of silica gel will begin to heat when the milk suspension makes contact with the 
crystals. 
8. After the milk suspension has been combined well with the silica gel, plunge the tube 
into an ice bath to keep the contents from getting hot enough to kill the fungus. Be sure 
the tube has the cap screwed tightly to prevent moisture from entering the tube. 
9. After the tubes have cooled in the ice bath they may be stored in the refrigerator for an 
indefinite period of time. 
10. To start a fresh fungal culture from silica gel storage – shake out a few crystals onto 
prepared medium (PDA or Oatmeal-PDA) in petri dishes and allow fungus to grow. 
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Protocol 10. Target Range for %T (625 nm) for Conidia Concentrations 
 BECKMAN  SHIMADZU  
Fungus Target Range 
for %T (625 
nm) 
%T for 
1×10^6 
CFU/mL 
Target Range 
for %T (625 
nm) 
%T for 
1×10^6 
CFU/mL 
B. cinerea 8 --- 62 39 27 --- 79 60 
C. acutatum 2 --- 79 56 20 --- 83 64 
C. fragariae 15 --- 70 55 30 --- 77 67 
C. gloeosporioides  37 --- 72 61 50 --- 78 69 
C. gloeosporioides 162 34 --- 65 55 51 --- 77 68 
F. oxysporum 30 --- 65 55 49 --- 78 70 
P. obscurans 46 --- 80 77 50 --- 77 75 
P. viticola 37 --- 69 6 48 --- 76 67 
*Inoculum must be within the ranges showed on the table for bioautography and microtiter assay. 
The target range for %T is the ideal point for fungus growth; CFU=Colony Forming Units. 
Protocol 11. McFarland 0.5 Barium Sulfate Turbidity Standard 
1. McFarland Standard consists of 50uL 0.048mol/L BaSO4 stock solution and 9.95 mL 
0.18 mol/L H2SO4 stock solutions. 
2. H2SO4 stock solution: 0.18 mol/L H2SO4 (stock solution: 1mL conc. H2SO4 + 99 mL 
H2O. 
3. Barium chloride stock solution: 0.048mol/L BaCl stock solution (1.175g BaCl*2 H2O: 
99mL H2O). 
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4. 0.5 McFarland standard  % T (625 nm) = 70% 
5. Goes bad: make up every 3months. 
Protocol 12. Spotting and Spraying TLC plates for Bioautography 
Make 20 mg/mL of test samples: weigh the test samples and then adding the corresponding 
solvents. 
1. Label with date, fungal isolate, and name and/or sample designation on the top of the 
plate. 
2. For each essential oil treatment add 4 uL and 8uL onto different lineated sections on the 
plate. 
3. Spray fungal spore solution on the plate; remember to hold the plate as flat as possible, 
silica side up (spray once and allow to dry then completely cold the plate in the spore/ 
media solution and second time before placing directly into chamber). 
4. Place in moisture chamber and then into 250 oC incubator for 4 days. 
5. Measure the diameter of inhibitory zones and make any other observations you can about 
the plates. 
Protocol 13. Procedures for Grape Media 
Wash and rinse grape leaves (20 leaves) with DDI H2O. Allow the leaves to drain (paper towel) 
to remove excess water. Using a Waring Commercial Blender grind Grape leaves (with 500 mL 
DDI H2O). Pure the suspension into 500 mL erlenmeyer flask with a stir bar in it. Stir (Sti/Hot 
plate-No Heat!) until completely blended. Check pH of media (pH of Grape broth is around 3.0) 
and adjust it until 6.5 using 1 M NaOH. Wrap mouth of flask with folded aluminum foil and seal 
with autoclave tape. Sterilize at 121 °C for 45 minutes.  
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Protocol 14. Procedures for Agar Media 
20 g Bacto Agar 
1000 mL DDI H2O 
Using a 1000 mL erlemeyer flask combine agar and water. Stir (Stir/Hot plate) and heat until 
completely blended. Divide media into 500 mL aliquots in 1000 mL Erlenmeyer flask (to allow 
for volume during autoclaving). Wrap mouth of flask with folded aluminum foil and seal with 
autoclave tape. Sterilize at 121 for °C 45 minutes.  
Protocol 14. Procedures for Strawberry Agar Media 
500 mL Grape Media 
500 mL Agar media 
Using cooled sterilized Grape media pour into flask containing cooled agar media. Combine 
media and reseal flask with sterile aluminum foil removed from containing Agar media. Mix 
them well and pour plates in sterile hood while media is warm. Do not allow media to get cold. 
Protocol 15. Murashige and Skoog Supporting Solution 
1.  M&S Basal Salt Mixture (Sigma M5524)             2.2 g/L 
2. Sucrose (Sigma S8501)                                         10 g/L 
3. Gamborg's Vitamins                                              5 mL (of a 100x prepared solution) /L 
4. pH 5.7 
5. Phytagel (Sigma P8169)                                       1 g/L 
Protocol 16. MES with Sucrose 
1. (2-[N-Morpholino] ethane sulfonic acid) hydrate (Sigma M8250)        1 mM in water 
	   129 
2. Sucrose (Sigma S-8501)                                                                     2% W/V 
3. pH 6.5 
4. Phytagel (Sigma P8169)                                                                      1 g/L 
Protocol 17. Hoagland Solution 
1. Hoagland Basal salts  (Phytotechnology Laboratories, P.O. Box 13481, Shawnee Mission, KS 
66282                                    3.2 g/L 
2. Phytagel   (SigmaP8169)                       1 g/L 
Protocol 18. Preparation of Difco Mycological Broth 
Yeast                          40 g 
Mycological Broth    100 g 
Sucrose                      400 g 
DDI H2O                   2 L 
pH                              4.8 
Heat and stir 
Protocol 19. Preparation of Shredded Wheat Medium 
200 mL                       Difco mycological broth 
100 g                           shredded wheat 
put in 2.0 L                  Fernbach flask 
Autocalve for 45 min @ 121 °C 
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Protocol 20. Preparation of 2% Malt Extract Agar (MEA) Medium 
200 mL of 2% MEA medium: 
Malt extract 2% × 200 = 4 g 
Peptone 0.1% × 200 = 0.2 g 
Glucose 2% × 200 = 4 g 
Agar 2% × 200 = 4 g 
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   132 
 
 
 
 
 
1H NMR spectrum of 4-hydroxy-5, 6-dimethoxy-2-naphthaldehyde (9) 
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13C NMR spectrum of  9 
 
 
 
 
 
 
 
	   134 
 
 
 
 
 
COSY spectrum of 9 
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HMQC spectrum of 9 
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HMBC spectrum of 9 
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NOESY spectrum of 9 
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ROESY spectrum of 9 
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UV of 9 
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1H NMR spectrum of 12, 13-didehydro-20, 29-dihydrobetulin (10) 
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1C NMR spectrum of 10 
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DEPT spectrum of 10 
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 UV of 10 
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1H NMR spectrum of 7-methyljuglone (11) 
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13C NMR spectrum of 11 
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1H NMR spectrum of diospyrin (12) 
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13C NMR spectrum of 12 
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1H NMR spectrum of isodiospyrin (13) 
 
 
 
 
 
 
 
 
	   149 
 
 
 
13C NMR spectrum of 13 
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1H NMR spectrum of shinanolone (14) 
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13C NMR spectrum of 14 
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1H NMR spectrum of lupeol (15) 
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13C NMR spectrum of 15 
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1H NMR spectrum of betulinic acid (17) 
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13C NMR spectrum of 17 
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1H NMR spectrum of mitragynine 
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1H NMR spectrum of paynantheine 
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1H NMR spectrum of cladosporin (20) 
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13C NMR spectrum of 20 
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DEPT spectrum of 20 
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COSY spectrum of 20 
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HMBC spectrum of 20 
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HMQC spectrum of 20 
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TOCSY spectrum of 20 
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1H NMR of isocladosporin (21) 
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13C NMR of 21 
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DEPT spectrum of 21 
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1H NMR spectrum of asperentin-8-methyl ether (34) 
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13C NMR of 34 
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HMQC spectrum of 34 
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1H NMR of 6, 5’-diacetyl cladosporin (36) 
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A preparative overpressure layer chromatography (OPLC) method was successfully used 
for the separation of two new natural compounds, 4-hydroxy-5,6-dimethoxy-2-naphthaldehyde 
(1) and Δ12,13-20,29-dihydrobetulin (2) together with nine known compounds including 7-
methyl-juglone (3), diospyrin (4), isodiospyrin (5), shinanolone (6), lupeol (7), betulin (8), 
betulinic acid (9), betulinaldehyde (10), and ursolic acid (11) from the acetone extract of the 
roots of Diospyros virginiana. Their identification was performed with mono and bidimensional 
NMR spectroscopy and HR-ESI-MS methods. All the isolated compounds were evaluated for 
their antifungal activity against Colletotrichum fragariae, C. gloeosporioides, C. acutatum, 
Botrytis cinerea, Fusarium oxysporum, Phomopsis obscurans, and P. viticola using in vitro 
micro-dilution broth assay. The results indicated that compounds 3 and 5 showed high antifungal 
activity against P. obscurans at 30 µM with 97.0 % and 81.4 % growth inhibition and moderate 
activity against P. viticola (54.3 % and 36.6 %). It appears that an optimized OPLC system offers 
a rapid and efficient method of exploiting bioactive natural products. 
 
 
 
 
 
Introduction. −Discovery of new crop protections from natural products has received 
considerable interest as alternatives to synthetic agrochemicals for use as pest and disease control 
agents. This stems from these generally being safer for human health and the environment. 
Biologically active natural products can be used in modern crop protections or can serve as lead 
structures for the development of new semi-synthetic analogs. Our current research efforts are to 
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identify natural product-based fungicides. In this research program, we evaluated 37 plant 
extracts using a direct bioautography bioassay to detect antifungal activity against 
Colletotrichum.  Of these, Diospyros virginiana root extract showed the most promising activity. 
Based on preliminary screening results, a bioassay-guided fractionation of D. virginiana root 
extract was conducted in order to isolate and identify the pure metabolites possessing antifungal 
activity. Diospyros belongs to the family Ebenaceae that contains approximately 500 species of 
trees and shrubs [1], of which more than 350 species are distributed in tropical and subtropical 
regions worldwide [2-3]. The most well-known species is Diospyros kaki, which originated in 
East China and has been cultivated in Japan for centuries [4]. Some of the Diospyros species, 
such as D. peregrina and D. melanoxylon, have been used in folk medicine for the treatment of 
inflammation, urinary discharges and enrichment of blood [5]. Diospyros virginiana, the 
American persimmon, is native to North America and the fruits were reported to show 
cholesterol lowering activity, and usefulness to treat bloody stools, thrush and sore throats [6]. 
The literature shows reports of nine compounds being isolated and identified from either the 
leaves or the wood of D. virginiana [7-9]. However, there are no reports in the literature on 
chemical fractions from the roots of D. virginiana.  
OPLC was developed by Tyihák and Mincsovics in the late seventies [10]. In this process, a 
TLC plate is covered by a sheet of flexible material and subjected to a high external pressure. 
The high external pressure, which is generated by a programmable pump, pushes the mobile 
phase through the analytical or preparative adsorbent layer. This allows a faster separation and 
more compact spots than conventional TLC. Generally, the Rf of the migrated compounds is two 
to five times greater than in conventional TLC. OPLC also offers an advantage over traditional 
TLC as it is a sealed system, which results in less solvent loss through evaporation [11-12]. As 
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such, OPLC has been widely used in analytical and preparative applications [13-15]. Compared 
to conventional methods, OPLC offers a more rapid and reliable method for the isolation of 
naturally occurring compounds. In the present paper, we report the use of a preparative OPLC 
technique to isolate co-migrating bioactive metabolites from the roots of Diospyros virginiana. 
 
Results and Discussion. −The roots of D. virginiana were extracted using acetone in a 
Soxhlet extractor. The constituents of this extract were separated by flash chromatography, 
OPLC and preparative TLC. A new naphthyl derivative, 4-hydroxy-5,6-dimethoxy-2-
naphthaldehyde (1), and a triterpene, Δ12,13-20,29-dihydrobetulin (2) were isolated from a natural 
source for the first time, along with nine known compounds: 7-methyl-juglone (3) [16], 
diospyrin (4) [17], isodiospyrin (5) [16-18], shinanolone (6) [19], lupeol (7) [20], betulin (8) [21], 
betulinic acid (9) [22], betulinaldehyde (10) [23], and ursolic acid (11) [24].  Although they are 
common in most of the Ebenaceae family [5], compounds 10 and 11 were isolated for the first 
time from D. virginiana. The structures of the known compounds were confirmed by comparison 
of their spectroscopic data (MS, 1H and 13C NMR) with literature values. 
 
The HR-ESI-MS of compound 1 indicated a molecular formula C13H12O4 and its IR 
spectrum exhibited characteristic absorption bands for hydroxyl and conjugated carbonyl groups. 
The 1H NMR spectrum showed signals for an aldehyde group at δ 10.03 ppm, one aromatic AB 
system at δ 7.37 (d, J = 9.0 Hz) and 7.78 (d, J = 9.0 Hz). The above data suggested a 2-
naphthaldehyde structure with the presence of two methoxyl groups at δ 4.06, and 4.13 ppm, and 
a hydroxyl substituent at δ 9.75 ppm. The 13C-NMR spectrum showed thirteen signals with ten 
typical aromatic carbons. Assignment of structure was accomplished by HMBC experiment. The 
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NOESY experiment showed a correlation between the methoxyl group at δ 4.06 and H-7 (δH 
7.37, d) and methoxyl group at δ 4.13 and the hydroxyl signal at δ 9.75 ppm, corroborating the 
location of the methoxyl groups at C(5) and C(6). Thus, 1 was characterized as 4-hydroxy-5,6-
dimethoxy-2-naphthaldehyde. 
 
Compound 2 was obtained as a white solid. The molecular formula was determined as 
C30H51O2 by HR-ESI-MS ([M + H]+ at m/z = 443.3874). The 13C NMR data of 2 indicated the 
presence of 30 carbons comprising seven methyl groups, ten methylenes, seven methines and six 
quaternary carbons. The seven methyl groups resonated at δH 0.79 (s, 6H), 0.93 (d, 6H, J = 6.8), 
0.98 (s, 3H), 0.99 (s, 3H), and 1.10 (s, 3H) in the 1H NMR spectrum indicating the lupane 
triterpene skeleton for 2 [25]. The 13C NMR spectrum also revealed the presence of one olifenic 
methine (δ(C) 125.0) correlated in the HMQC spectrum with the proton at δ(H) 5.20 (H-C(12)). 
The last proton showed HMBC correlation with C(9), C(14), and C(18), this correlation led to 
the placement of the double bond between C(12) and C(13). This was confirmed by the COSY 
correlation between H-C(12) (δ(H) 5.20) and H2-C(11) (δ(H) 1.90) and further supported by the 
HMBC correlation of H3-C(27) (δ(H) 1.10) and C(13) (δ(C) 136.7) (Fig. 1). From these data, the 
compound 2 was deduced to be Δ12,13-20,29-dihydrobetulin. This is the first report for the full 
spectral data and isolation of 2 from a natural source, although it has been prepared synthetically 
and only the 1H NMR data was reported [26]. 
 
The antifungal activity of compounds 1-11 was examined using a 96-well micro-dilution 
broth assay against the plant pathogens: Botrytis cinerea, Fusarium oxysporum, Phomopsis 
obscurans, P. viticola and three Colletotrichum species. Phomopsis species were the most 
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sensitive fungi to these compounds. 7-methyl-juglone (3) and isodiospyrin (5) showed the most 
antifungal activity against P. obscurans. Compound 3 showed 97.0 % growth inhibition of P. 
obscurans at 120 h at 30 µM, whereas compound 5 showed 81.4 % growth inhibition. The 
antifungal activity of 3 and 5 at 30 µM against P. viticola was 53.4% and 57.7%, respectively. 
 
The newly reported compounds, 4-Hydroxy-5, 6-dimethoxy-2-naphthaldehyde (1) and 
Δ12,13-20,29-dihydrobetulin (2) at 30 µM showed weak antifungal activity with 26.9 % and 22.1 
%, respectively (Fig. 2). Compound 3 and compound 5 at 30 µM caused 54.3 % and 36.6 % 
growth inhibition of P. viticola at 120 h.  Any test compound possessing <50% growth inhibition 
at 30 µM is considered to have weak antifungal activity in this bioassay. Compound 1 was more 
active against P. vitricola at 120 h than at 144 h.  This response is often seen when an inducible 
enzyme system is turned on and a compound is detoxified by the fungus.  However, the upward 
slope of the graph for compound 1 in Fig 3 from the low to high concentration is indicative of 
precipitation in the aqueous microdilution broth assay.  Because the microtiter plate reader 
measures changes in optical density it does not discriminate between fungal growth and 
precipitation.  Compound 1 appears to have come out of solution at the higher concentration (30 
µM) in the P. viticola testing (Fig 3).  Lipophilic compounds are problematic in in vitro aqueous 
bioassays and follow-up antifungal testing will take place using a detached leaf bioassay [27].  
Interpretation of the graphical results indicate that compounds 2, 3, and 5 appear to remain 
soluble at 120 h and 144 h. 
Commercial fungicides standards captan and benomyl are significantly more active than 
any of the compounds tested.  Azoxystrobin, which is commercially used to control 
Colletotrichum and Botrytis diseases, shows poor activity against P. viticola.  Both captan and 
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azoxystrobin show 100% growth inhibition at 3 µM against P. obscurans.   Although once an 
excellent agent for controlling anthracnose and other diseases of strawberries and ornamentals, 
resistance developed by pathogens has resulted in benomyl being less useful [28].  While the test 
compounds appear inherently antifungal, we hypothesize that these compounds are probably 
present in the plant as constitutive defense compounds that act to deter infection or fungal 
growth.  Since these compounds were found without elicitation they are probably constitutive in 
nature [29-30] and may have a potential role in preventing fungal infection in D. virginiana. 
 
Conclusions. − Using a bioassay-guided fractionation of the acetone extract D. 
virginiana were able to isolate the antifungal constituents of the roots of this plant. This research 
demonstrates that OPLC is a powerful technique that can be used to separate and isolate co-
migrating natural products produced by plants. These constituents were tested for the first time 
against Colletotrichum spp, B. cinerea, F. oxysporum, P. obscurans, and P. viticola. The most 
promising agricultural lead compounds against the pathogen P. obscurans are 3 and 5.  
Phomopsis leaf blight and fruit rot is a serious disease with strawberries and causes serious 
economic loss of this fruit each year. Our results suggest that compounds 3 and 5 warrant further 
in vivo testing as plant protectants to control Phomopsis species [27]. 
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Experimental Part 
Chemistry 
General. UV spectra were obtained in MeOH using a Varian Cary 50 spectrophotometer 
and IR spectra were recorded using Bruker Tensor 27 spectrophotometer. 1H- and 13C-NMR 
spectra were obtained on Bruker model AMX-500 and 400 NMR spectrometers with standard 
pulse sequences, operating at 500 and 400 MHz for 1H and 125 and 100 MHz for 13C. High 
resolution electrospray ionization mass spectroscopy (HR-ESI-MS) was recorded on a 
Micromass Q-Tof Micro mass spectrometer with a lock spray source. OPLC separations were 
performed with the Personal OPLC 50 instrument (OPLC-NIT, Budapest, Hungary) at 50 bars 
external pressure. OPLC silica gel layer, F254 20 × 20 cm on glass plate (LG 011, OPLC-NIT Ltd, 
Budapest Hungary) with 200 µm sorbent thickness, 11 µm particle size, 6 nm pore size, and 20 × 
20 cm on aluminum sheet (BSLA 001, OPLC-NIT Ltd, Budapest Hungary) with 200 µm sorbent 
thickness, 5 µm particle size, 6 nm pore size. An AS-30 sample applicator (DESAGA, Wiesloch, 
Germany) was used for the sample application. Classical TLC analysis was performed on silica 
gel 60 F254 20 × 20 cm on aluminum sheet (Gibbstown, New Jersey, USA). Detection was 
carried out under UV light (254 nm, 366 nm) and visualization made with vanillin-H2SO4 (1 g 
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vanillin in 100 ml of 20 % H2SO4 in EtOH) reagent followed by heating at 105 ºC for 5 min. 
ACS-grade solvents, acetonitrile, acetone, chloroform, dichloromethane (DCM), diethyl ether, 
ethyl acetate (EtOAc), EtOH, n-hexane, isopropanol (IPA), methanol and toluene from Fisher 
Scientific (New Jersey, USA) were used for silica gel column chromatography and TLC 
separations. HPLC-grade solvents (acetonitrile, chloroform and DCM) from Sigma-Aldrich (St. 
Louis, USA) were used for OPLC chromatograms. 
 
Plant material. The roots of D. virginiana were collected from the Missouri Botanical 
Garden, U.S.A., in June 2009. The plant material was identified by Dr. Vaishali C. Joshi, and a 
voucher specimen CON310700-2-A was deposited at the National Center for Natural Products 
Research, School of Pharmacy, University of Mississippi.  
 
Extraction and Isolation. Dried powdered roots (66 g) were extracted in a Soxhlet extractor 
with acetone (600 ml) for 8 h and the extract was subsequently evaporated under vacuum to yield 
the dry residue (2 g). The crude extract was fractionated on a silica gel column (100 g, 50 × 5 cm, 
ChemGlass) using n-hexane (500 ml), 5 % EtOAc in n-hexane (600 ml), chloroform (600 ml), 5 
% IPA in chloroform (600 ml) and methanol (600 ml), respectively. Four fractions were obtained 
in total F-1 to F-4. Direct-bioautography guided assay showed that the activity was found to 
reside in F-1 (120 mg) and F-2 (240 mg), with some activity in F-3 (710 mg), while F-4 (800 mg) 
did not show activity against three notorious plant pathogenic fungi of the Colletotrichum 
species. A portion of F-1 (10 mg) showed one major product and was purified using preparative 
TLC (SiO2, n-hexane-chloroform 1:1) to furnish 7-methyl juglone (3, 1.5 mg). A portion of F-2 
(20 mg) was purified using OPLC with DCM as the eluent. Elution conditions were as follows: 
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flash volume, 300 µl; eluent volume, 30,000 µl; flow-rate, 500 µl min-1; development time, 3606 
s; external pressure, 50 bars. Eighty-eight sub-fractions (1 ml / fraction) were obtained in total, of 
which sub-fractions 49-54 gave betulinaldehyde (10, 0.8 mg). Sub-fractions 72-88 afforded 
ursolic acid (11, 1.3 mg). Sub-fractions 28-37 were combined (7.9 mg) and further purification 
was performed by OPLC with n-hexane-ether (6/4, v/v, 20,000 µl; flash volume, 300 µl; flow-
rate, 500 µl min-1; development time, 2406 s) as eluent and 66 sub-fractions (1 ml / fraction) 
were obtained, among which sub-fractions 10'-18' furnished lupeol (7, 2 mg). Sub-fractions 19'-
66' (marked as fraction A) were combined to give a mixture of 3.6 mg containing four 
compounds with close Rf values in several TLC systems (SiO2, n-hexane-EtOAc 6:4, DCM-IPA 
9:1, CHCl3-MeOH 19:1). In order to obtain enough material for further purification, OPLC 
procedures were repeated six times for F-2 using the same conditions, then fraction A (19.6 mg) 
was obtained and purified by OPLC with DCM (100 %, 20,000 µl; flash volume, 300 µl; flow-
rate, 400 µl min-1; development time, 3007 s) as mobile phase. Sub-fraction 12″ yielded a new 
product 4-hydroxy-5, 6-dimethoxy-2-naphthaldehyde (1, 1 mg). Sub-fractions 9″-11″ gave 
diospyrin (4, 2 mg). Sub-fractions 14″-21″ afforded isodiospyrin (5, 2 mg). Fraction 3 (24 mg) 
was chromatographed using OPLC with CHCl3-EtOAc (95/5, v/v, 40,000 µl) with flash volume 
300 µl, flow rate 500 µl min-1 and an elution time of 4806 s. One hundred and twenty-three sub-
fractions (1 ml / fraction) were collected. Sub-fractions 54-66 yielded betulin (8, 3.4 mg). Sub-
fractions 67-90 (7.4 mg), containing at least four compounds, were purified by OPLC with 
CHCl3-acetonitrile (98/2, v/v) and flash volume 300 µl, flow rate 300 µl min-1 and a total elution 
time of 4806 s. Sub-fractions 79'-87' gave shinanolone (6, 1.5 mg). The other minor compounds 
were in such small quantity that they were impossible to isolate. In order to obtain enough 
material for further purification, flash chromatography of F-3 (400 mg) using a BIOTAGE 
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(Isolera One) with CHCl3-EtOAc (0-5 %, 200 ml) and CHCl3 (100 %, 201 ml-640 ml), and flow 
rate, 5 ml min-1 (Si, SNAP 25 g column) was conducted. A total of 81 sub-fractions (1 
ml/fraction) were collected. Subfractions 38-51 were combined to yielded a 30 mg mixture. This 
mixture was subjected to the OPLC system with CHCl3-acetonitrile (98/2, v/v, 40,000 µl) with 
flash volume 300 µl, flow rate 250 µl/min and total elution time 9624 s. One hundred and eighty-
three subfractions (1 ml / fraction) were obtained. Subfractions 100-112 were combined and 
identified as betulin (8, 2 mg). Subfractions 136-144 yielded betulinic acid (9, 1 mg). Subfraction 
114-126 gave a new triterpene, Δ12,13-20,29-dihydrobetulin (2, 1 mg) as a natural product. 
4-hydroxy-5,6-dimethoxy-2-naphthaldehyde (1): Yellow amorphous solid; UV (MeOH): 
λmax nm (log ε): 375 (4.1), 320 (4.2), 270 (3.8); IR (neat): νmax 3332, 2923, 2851, 2360, 2341, 
1687, 1372, 1274, 1055 cm-1; 1H- NMR (500 MHz, CDCl3): δ 4.06 (3H, s, OMe), 4.13 (3H, s, 
OMe), 7.29 (1H, s br, H-C(3)), 7.37 (1H, d, J= 9.0 Hz, H-C(7)), 7.78 (1H, d, J=9.0 Hz, H-C(8)), 
7.81 (1H, s br, H-C(1)), 9.75 (1H, OH-C(4)), 10.03 (1H, s, H-C(11)); 13C-NMR (125 MHz, 
CDCl3): δ 56.67 (OMe), 62.20 (OMe), 106.14 (C(3)), 115.46 (C(7)), 121.49 (C(10)), 126.02 
(C(1)), 127.19 (C(8)), 130.120 (C(9)), 134.09 (C(2)), 143.46 (C(5)), 149.95 (C(6)), 154.28 
(C(4)), 191.79 (C(11)); HR-ESI-MS: m/z = 233.0812 ([M + H]+,  C13H13O4; calc.  233.0814). 
Δ12,13-20,29-dihydrobetulin (2): White amorphous solid; [α]20D = +79.2 (c 0.05, MeOH ); IR 
(KBr): νmax 3340, 2940, 2867, 1446, 1372, 1027 cm-1; 1H-NMR (400 MHz, CDCl3): δ 0.73 (1H, 
d, J=7.2 H-C(5)), 0.79 (6H, s, Me-24, Me-26), 0.89 (1H, m, , H-C(20)), 0.93 (6H, d, J= 6.8 Hz, 
Me-29, Me-30), 0.98 (3H, s, J=9.0 Hz, Me-25), 0.99 (3H, s, Me-23), 1.10 (3H, s, Me-27), 1.20-
1.81 (8CH2), 1.90 (2H, m, H2-C(11)), 3.19 (1H, d, J=10.4, H-C(28ª)), 3.22 (1H, m, H-C(3)), 3.53 
(1H, d, J=10.4, H-C(28b)), 5.13 (1H, bs, H-C(12)); 13C NMR (100 MHz, CDCl3): δ 15.6 (C(29)), 
15.7 (C(24)), 16.7 (C(25)), 17.3 (C(26)), 18.3 (C(6)), 21.3 (C(30)), 23.2 (C(21)), 23.3 (C(27)), 
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23.4 (C(11)), 25.9 (C(2)), 27.2 (C(15)), 28.1 (C(23)), 30.6 (C(16)), 32.8 (C(7)), 35.2 (C(1)), 36.9 
(C(14)), 38.7 (C(22)), 38.0 (C(4)), 39.3 (C(20)), 39.4 (C(19)), 40.0 (C(10)), 42.0 (C(8)), 42.3 
(C(17)), 47.6 (C(18)), 54.0 (C(9)), 55.1 (C(5)), 69.9 (C(28)), 79.0 (C(3)), 125.0 (C(12)), 136.7 
(C(13)). HR-ESI-MS m/z = 443.3874 ([M + H]+,  C30H51O2; calc. 443.3889). 
 
Biological Assay 
Direct-bioautography assay. Bioautography procedures were described in our previous 
studies [31-32]. The acetone extract of D. virginiana roots was applied at 80 and 160 µg/spot in 
chloroform onto a silica plate. Technical fungicide grade standards benomyl, cyprodinil, 
azoxystrobin, and captan (Chem Service Inc., West Chester, PA) were used as positive controls at 
2 mM in 2 µl of 95% ethanol.  TLC profiles of F-1 to F-4 in chloroform were tested against 
Colletotrichum spp and mild polar compounds appear to be responsible for antifungal activity. 
Micro-dilution broth assay. A standardized 96-well micro-dilution broth assay developed 
by Wedge and Kuhajek [33] was used to evaluate the antifungal activity of pure compounds from 
D. virginiana that were identified as active by bioautography. 
 Isolates of Colletotrichum acutatum Simmonds, Colletotrichum fragariae Brooks, 
Colletotrichum gloeosporioides (Penz.) Penz & Sacc. In Penz, Botrytis cinerea Pers.:Fr, 
Fusarium oxysporum Schlechtend:Fr, Phomopsis obscurans (Ellis and Everh.) B. sutton, and P. 
viticola Sacc., were used to evaluate the antifungal activity of the test compounds using in vitro 
micro-dilution broth assay.  Each fungus was challenged in a dose-response format using test 
compounds where the final treatment concentrations were 0.3, 3.0 and 30.0 µM. Technical grade 
commercial fungicides captan, azoxystrobin, and benomyl, which represent three different modes 
of actions, were used as positive fungicide standards.  Each compound was evaluated in 
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duplicate and the experiment was performed three times in time.  Mean absorbance and standard 
errors were used to evaluate fungal growth after 48 and 72 h, except for P. obscurans and P. 
viticola (120 and 144 h). 
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Figures Legends 
Fig. 1. Relevant 1H-13C HMBC (→) and 1H-1H COSY (↔) correlations of 2 
Fig. 2. Mean fungal growth inhibition (%) of Phomopsis obscurans after exposure to 1, 2, 3 and 
5 using a dose-response format at 120 and 144 h.  Abreviations: Cap: Captan; Azo: Azoxystrobin; 
Ben: Benomyl 
Fig. 3. Mean fungal growth inhibition (%) of Phomopsis viticola after exposure to 1, 2, 3 and 5 
using a dose-response format at 120 and 144 h.  Abreviations: Cap: Captan; Azo: Azoxystrobin; 
Ben: Benomyl 
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Fig. 2. Mean fungal growth inhibition (%) of Phomopsis obscurans after exposure to 1, 2, 3 and 
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Fig. 3. Mean fungal growth inhibition (%) of Phomopsis viticola after exposure to 1, 2, 3 and 5 
using a dose-response format at 120 and 144 h.  Abreviations: Cap: Captan; Azo: Azoxystrobin; 
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Abstract 
 
Introduction 
Fruit rot diseases of strawberry (Fragaria x ananassa Duch.) are serious problems for 
strawberry producers in many areas of the world [1](Maas, 1998) and are particularly severe in 
the southeastern United States where diseases are often enhanced by warm temperatures and 
frequent rains during the harvest season.  Losses by Florida strawberry growers due to disease 
were estimated to be 10 to 15% of the crop whose farm gate revenue averages over $100 million 
each season [2] (Legard, et al., 1997).  Anthracnose diseases caused by Colletotrichum spp. 
[3,4,5] (Smith, 1998a, 1998b, 1998c) can be especially devastating since other plant parts may be 
infected in addition to the fruit.  
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Effective disease control strategies for crop plant pathogens often rely on the use of 
fungicides. Wedge et al. [6], reported on new fungicide management strategies for control of 
strawberry fruit rot diseases in the Gulf state region and the need for efficacious fungicides to 
provide growers with more options for controlling disease.   Disadvantages of the use of these 
chemical controls include the development of resistant fungal strains as well as potential 
environmental and mammalian toxicities.  Resistance of many plant pathogens to commonly 
used commercial fungicides is becoming a serious problem and has limited the number of 
effective disease control agents.  Numerous isolates of Colletotrichum spp. developed benomyl 
insensitivity after several years of use to protect strawberry and other fruit crops [7,8] (Peres et 
al., 2002, 2004; [9,10]Smith and Black, 1993 a-b). Colletotrichum species often cause typical 
symptoms of anthracnose, a disease characterized by sunken necrotic lesions usually bounded by 
a red margin [11,12] (Freeman et al., 1998; Wedge et al., 1999). Anthracnose diseases of 
strawberry (Fragaria × ananassa Duch) are serious problems for fruit and plant production in 
many areas of the world [14] (Maas, 1998).  The pathogens, Colletotrichum fragariae A. N. 
Brooks, C. gloeosporioides (Penz.) Penz., and C. fragariae CF -75, can occur singly or in 
combination, and can infect flowers, fruit, leaves, petioles, stolons, and crowns (Howard et al., 
1992; [15,3,4,5] Smith 1998 a, b, c). 
  Fungicide discovery efforts at the USDA–ARS, Natural Products Utilization Research 
Unit, National Center for Natural Products Research, University, MS, are focused on natural 
products derived from plants and marine organisms with emphasis on compounds with 
fungicidal activity [16] (Wedge and Kuhajek, 1998).  Along with discovery of new chemistry 
and our interest in antimicrobial agents from higher plants [17] (Zhou and Wedge, 2007), we 
have also had to developed novel miniaturized bioassays for evaluating small amounts of 
	   195 
available compound [18,19] (Wedge and Smith, 2006; Abril et al., 2008).  Natural antimicrobial 
agents from plants are generally broad-spectrum compounds with low mammalian and 
environmental toxicity [17] (Zhou and Wedge, 2007).  
Development new plant protectants with a lipophilic nature are limited by the lack of 
suitable bioassays to properly evaluate these compounds. While the lipophilic nature of 
phytochemicals and marine compounds allows them to embed themselves into the leaf waxes 
and persist through rainfall, hence making them potentially useful agrochemicals, this 
characteristic also makes them very difficult to evaluate in many bioassays.  Essential oils and 
many marine extracts are hydrophobic and insoluble in most aqueous-based antimicrobial disc 
diffusion and micro-dilution broth bioassays. Direct bioautography on silica gel is our preferred 
primary screening bioassay and often the best assay for evaluating lipophilic compounds as 
fungicides for agricultural use because this assay more closely mimics a leaf surface.  Classical 
leaf bioassays used to test fungicide efficacy at concentrations between 625 and 2500 ppm may 
use 75-100 mg of an experimental compound that is often difficult to obtain. Therefore the need 
for a novel miniaturized leaf disk bioassay that utilizes small sample sizes, has high throughput 
capability, and replicates the real leaf surface is of utmost importance to natural product 
fungicide discovery.  This paper presents information about our progress in developing of a new 
24-well detached leaf bioassay and we discuss problems associated with evaluating natural 
product fungicides. 
 
Experimental 
  
Plant preparations  
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 Anthracnose-susceptible ‘Chandler’ plants were obtained in October 2007 from 
Shingleton Farms (Statonsburg, NC, USA), planted into 14 cm plastic azalea pots containing 
Metromix 350 (BWI- Memphis, TN), and placed in the greenhouse without shade. Plants were 
watered daily and weekly with Peter’s 20-20-20 nutritional solution (BWI- Memphis, TN).  
Plants with any signs of anthracnose or wilt disease were rouged and removed from the 
greenhouse daily.  
 
24-well Leaf Disk Assay 
Three commercial in vitro salt solutions were evaluated for their ability to maintain leaf 
disks during the in vitro experiment. Half strength Hoagland’s No. 2 (H, Phytotechnology 
Laboratories, Shawnee Mission, KS), 2-N-morpholino ethanesulfonic acid (MES, Sigma M8250, 
Sigma-Aldrich, St. Louis, MO), Murashige and Skoog basal salt mixture (MS, Sigma M5524), 
and water (control) were evaluated for their ability to sustain excised leaf discs for 7-10 days.  
Stock solutions containing 1% Phytogel (Sigma P8169) were prepared as follows: Hoagland’s 
No. 2 solution (0.815 g/L), MES (195.2 mg/L) containing 5 mL Gamborg's Vitamins (Thiamine-
HCl  5 mg/L, Pyridoxine-HCl 0.5 mg/L, Nicotinic acid  0.5 mg/L, Myo-inositol 50mg/L), and 
MS (2.2 g/L).  All support solutions were adjusted to 6.5 pH using 1 N NaOH and 0.1 N NaOH.  
Excised leaf discs were placed onto the 1500 µL of either respective solidified salts/medium 
contained in each well of the 24-well plate.  Plates were maintained in the sterile biological hood 
overnight prior to pathogen inoculation to allow time for the leaf disks to initiate wound healing 
and acclimate to the in vitro system.  24-well were plates were sealed with paper-based tape and 
placed in the incubator under (55±5 µmols·m-2·sec-1) Ushio Ultra 8 fluorescent lights (UFL-
F17T8/741, Interlectric Corp., Warren, PA) with a 12 h photoperiod in a growth chamber at 25º 
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C for one week. All samples were done in duplicate and the experiments were repeated three 
times in time. 
 
Leaf disc preparation 
 The first or second fully expanded leaves were removed from stock strawberry plants and 
transported directly to the laboratory so that the leaves were available for the bioassay in less 
than 4 hours. Immediately after collection, the leaves were placed in a tray lined with moist 
paper towels and the tray was closed to retain near 100% relative humidity (RH) and maintained 
at ~12°C. Only leaves with no visible signs of injury or symptoms of disease were collected. 
Whole leaves were disinfested by placement in a beaker with 2.5% Clorox for 3 min., leaves 
were rinsed 2-3 minutes in sterile DDI water three times, and leaves with any signs of bleaching 
were discarded.  Strawberry leaf discs were then cut using a 15-mm stainless steal cork borer and 
placed in moisture plate until they were placed in the 24-well plate.   
 
Pathogen and Inoculum Preparation 
 Three Colletotrichum isolates were evaluated for their ability to produce disease lesions 
under in vitro conditions.  Colletotrichum fragariae (CF75), C. fragariae (CF63), and C. 
gloeosporioides (CG162) isolated from strawberry were evaluated for their ability to produce 
anthracnose symptoms on excised strawberry leaf discs.  Each Colletotrichum isolates was 
grown on 1/2 strength potato dextrose agar (PDA) in 9-cm Petri dishes and incubated under  
(55±5 µmols·m-2·sec-1) Ushio Ultra 8 fluorescent lights (UFL-F17T8/741, Interlectric Corp., 
Warren, PA, USA) at 25º C as previously described (Abril et al., 2008). Conidia were harvest 
from 7- to 10-day-old cultures, and the aqueous conidial suspensions were filtered through sterile 
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Miracloth (Calbiochem-Novabiochem Corp., La Jolla, CA, USA) to remove hyphae. Conidial 
concentrations were determined photometrically from a standard curve based on absorbance at 
625 nm (Espinel- Ingrof and Kerkering, 1991; Wedge and Kuhajek, 1998), and then stock 
suspensions were adjusted with sterile water to a concentration of 106 conidia / ml.  
 
Surfactant and Inoculum Volume  
 Three concentrations of Tween 20 were evaluated for their effects on promoting pathogen 
infection of the leaf disk.  Tween 20 concentrations of 0.3 %, 0.5 %, and 0.7% were prepared in 
100 ml sterile distilled water.  Conidial suspensions for inoculation were adjusted to a final 
concentration of 1.0 ×105 conidia / ml.  Two inoculum volumes were also evaluated where the 
inoculum volume applied to each leaf disk was either 10 or 20 µl of either of the three fungal 
spore suspensions. After inoculation the 24-well were plates were sealed with paper-based tape 
and placed in the incubator under (55±5 µmols·m-2·sec-1) Ushio Ultra 8 fluorescent lights (UFL-
F17T8/741, Interlectric Corp., Warren, PA) with a 12 h photoperiod in a growth chamber at 25º 
C for 6 days. 
 
Fungicidal and phytotoxicity 
Experimental compounds were evaluated in a dose-response format.  Azoxystrobin that 
have protective and some curative activity were used as standards for comparison.  A 20% 
ethanol:water solvent control is used in each study to solubilize lipophilic extracts. Angelica 
sinensis roots were purchased as a plant material from Jincheng Lingyi Drugstore, Weinan City, 
Shaanxi Province, China.  Origanim onites essential oil was purchased from ALTES company, 
Turkey.  Stock solutions containing 625, 1250, and 2500 ppm were prepared for azoxystrobin, 
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Origanum onites essential oil, Angelica sinensis essential oil and 20% ethanol solvent control in 
50 ml capped test tubes.   
Strawberry leaf disks prepared as previously described were dipped in antifungal test 
solutions for 3-5 seconds, excess solution was allowed to drain onto the edge of the test tube and 
then placed into the appropriate row and column of the 24-well plates.  Plates were incubated 
over night at room temperature and inoculated the next morning with either 20 ul of conidial 
solution obtained from either C. fragariae (CF75), C. fragariae (CF63), or C. gloeosporioides 
(CG162). Percent healthy tissue, percent leaf necrosis, and percent phytotoxicity were 
determined at 5 days after inoculation by a Lemnatec Lemna HTS and SAW Scanalyzer 
analyzing software (LemnaTec GmbH, Wurselen, Germany). The instrument was set up to 
photograph (Sony DFW-SX900 camera) a 24-well plate containing the leaf disks using both top 
lighting and bottom lighting (8 W fluorescent tubes) and optimized for disk clarity and color.  
The software configurations were set to measure the area of each disk separately and classify the 
colors detected within each leaf and color classification was set to differentiate healthy tissue, 
bleached tissue, and necrotic lesions on the leaf surface. 
 
Experimental Design 
 SAS (Statistical Analysis System, Cary, N.C.) was used to conduct analysis of variance 
and mean separation tests on all three experiments.  A completely randomized design was used 
for all experiments.  All factors were considered to be fixed effects, except for surfactant 
concentration in the surfactant experiment.  Fisher's protected LSD was used to separate means 
(Steel and Torrie, 1980). 
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Results and discussion 
 
24-well Leaf Disk Assay/ Salt solutions 
Leaf color index obtained from visual evaluation of the leaf disks at 7 days indicated that ½ 
strength Hoaglands No. 2 basal salt media provided excised leaf discs with the best physiological 
support with a color index of 2.67.  Murashige and Skoog basal salts demonstrated the lowest 
color index of 1.83.  While MES salts and water had a color index of 2.42 and 2.83 respectively. 
However, MES and water did not gel sufficiently to provide adequate physical support to keep 
leaf disks (Figure 1) afloat for subsequent inoculation with the conidial solutions (Table 1).  
Typical working concentrations for Phytagel™ are 1.5-2.5 g/L in plant tissue culture media 
and up to 10 g/L in microbiological media. Phytagel™ requires the presence of cations 
(especially divalent) for gelling to occur. Concentrations of calcium and magnesium contained in 
most plant tissue culture media are typically sufficient for gelation. Low-salt media formulations, 
especially those used in microbiological applications may require supplementation with 
additional calcium or magnesium salts (e.g., CaCl2 or MgSO4) or higher concentrations of 
Phytagel. Therefore we chose ½ strength Hoaglands No. 2 basal salt media containing 1% 
Phytogel as the best medium to conduct all subsequent 24-well leaf disk studies. 
 
Pathogen type, surfactant, and inoculum volume 
Colletotrichum fragariae (CF75), C. fragariae (CF63), and C. gloeosporioides (CG162) 
were each evaluated for their ability to produce disease lesions under in vitro conditions at three 
levels of Tween 20 (0.3 %, 0.5 %, and 0.7%).  Mean necrosis indicated that Colletotrichum 
fragariae (CF75) and C. gloeosporioides (CG162) produced the highest number of lesions under 
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in vitro conditions and C. fragariae (CF63) produced the lowest number of lesions (Table 2).  
The best treatment combination was C. fragariae (CF75) where inoculum amended with 0.5% 
and 0.7% Tween 20 produced 16.72 and 15.53 % necrosis of the leaf disks respectively.  C. 
gloeosporioides (CG162) showed no significant differences in leaf lesions between the three 
Tween 20 concentrations.  Lesion development (necrosis) indicated that there was no difference 
between 10 or 20 µl inoculum volumes for either of the three Colletotrichum spore suspensions 
when applied to the leaf disk surface.   
 
Fungicidal and phytotoxicity     
Phytotoxicity evaluations were made visually at 12 hrs after treatment of the fungicidal 
solution or solvent control and prior to inoculation (Figure 1).   Origanum onites essential oil 
above 1250 ppm demonstrated a 4+ phytotoxicity ranking and A. sinensis essential oil 
demonstrated 1+ phytoxicity ranking at 2500 ppm.  Percent healthy tissue, % bleached tissue, 
and % necrosis of the leaf disk are presented in Table 3.  The commercial fungicide azoxystrobin 
had the greatest level of disease control efficacy at 99% healthy tissue at 625 ppm and the lowest 
level of phytotoxicity (0.45%) at 2500ppm.  Both O. onites and A. sinensis essential oils 
demonstrated phytotoxicity in a dose-dependent manner that was shown visually in Figure 1 and 
Figure 2, Plate 1a.  Color analysis presented in Figure 2, Plate 1b show healthy area in green, 
diseased area in black and phytotoxicity in gray.  Origanum onites essential oil was more 
phytotoxic to strawberry leaves than was A. sinensis essential oil. Angelica sinensis essential oil 
appeared to be a more effective antifungal solution and was effective against all three 
Colletotrichum species and had a lower % necrosis that did O. onites essential oil. 
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Conclusions 
Discovery and evaluation of natural product fungicides is largely dependent upon the 
availability of miniaturized antifungal bioassays.  Essentials for natural product bioassays 
include sensitivity to microgram quantities, selectivity to determine optimum target pathogens, 
and adaptability to complex mixtures. These assays should be relevant to potential pathogen 
target sites in the natural infection process of the host and applicable to the agrochemical 
industry.  Bioassays need to take advantage of high-throughput technology to evaluate dose-
response relationships, commercial fungicides standards, modes of action, and structure activity 
studies [18, 22].   
The 24-well leaf disk bioassay has numerous advantages over conventional pot or field 
studies.  The most important aspect of an in vitro assay is that testing is conducted under 
controlled conditions and miniaturized so that micro amounts of experimental compounds can be 
studied.  The addition of digital photography and color imaging and analysis software make this 
assay a very powerful technique to evaluate lipophilic and other lead compounds directly on the 
leaf surface.  Images can be stored electronically and analyzed at one’s convenience rather that 
trying to conduct visual assessments in the field in the blazing sun or on a cold-wet windy day.  
Moreover, the opportunity to go back and adjust the color images and the analysis parameters to 
fine tune the data analysis that was frozen in time can not be replicated in the greenhouse or in 
the field.  Identification of new potential lead compounds can be repeated quickly in time and 
real on-the-leaf-surface activity can be evaluated in high throughput formats and published in a 
reasonable time.  There will still be a place for the studies evaluating multiple geographical 
locations and 3-year repeated studies but cost and efficiency of discovery research will continue 
to drive the need for the development of new techniques such as the 24-well leaf disk assay. 
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Table 1.  Half strength Hoagland’s No. 2, 2-N-morpholino ethanesulfonic acid (MES), 
Murashige and Skoog basal salt mixture (MS, and water (control) were evaluated for their ability 
to sustain excised leaf discs for 7-10 days.  Mean leaf color index on a scale from 1-3 (1 = light 
green, 2 = medium green, 3 = dark green) was used to describe leaf chlorophyll content. 
 
Salt Solution Leaf Color Value (1-3) Standard Error 
H2O 2.83 a 0.11 
½ Hoagland’s 2.67 a 0.22 
M&S   1.83 ab 0.30 
MES 2.42 b 0.19 
Means followed by the same letter are not significant at p<0.05. 
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Table 2.  Percent mean necrosis was used evaluate the ability of Colletotrichum fragariae 
(CF75), C. fragariae (CF63), and C. gloeosporioides (CG162) and three concentrations of 
Tween 20 (0.3 %, 0.5 %, and 0.7%) in the inoculum solution to produce disease lesions on 15 
mm leaf disks.  
 
       
Fungal isolate  &  % Tween 20  % Mean Necrosis Standard Error 
Cf63           0.3 7.34 cde 2.53 
Cf63           0.5 4.84 efg 1.12 
Cf63           0.7 5.78 def 2.05 
Cf75           0.3 10.78 bcd 2.13 
Cf75           0.5 16.72 a 0.93 
Cf75           0.7 15.53 ab 8.52 
Cg162          0.3 12.47 abc 3.27 
Cg162          0.5 11.58 abc 2.02 
Cg162          0.7 12.00 abc 3.20 
H2O            0.3 0.56 fg 0.00 
H2O            0.5 0.14 g 0.00 
H2O            0.7 0.00 g 0.00 
Means followed by the same letter are not significant at p<0.05. 
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Plate 1 
 
 
 
 
 
 
 
 
Plate 2 
 
 
Figure 1.  15-mm excised leaf disks from anthracnose susceptible strawberry cultivar ‘Chandler’ 
demonstrate easy to visualize 4+ phytotoxicity  of Organium onites essential oil above 1250 ppm. 
Angelica sinensis essential oil demonstrated 1+ phytoxicity at 2500 ppm. Row A contained 
azoxystrobin, row B contained Organium onites essential oil, row C contained Angelica sinensis 
essential oil at three concentrations. Row D contained 20% ethanol/water solvent control. 
Column 1 and 2 contain 625 ppm, column 3 and 4 contain 1250 ppm, and row 5 and 6 contain 
2500 ppm of the respective test compounds or extracts.     
 
 
  
A
B
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D
A
B
C
D
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1250 1250
2500 2500
2500 2500
625 625
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Azoxystrobin
Azoxystrobin
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Origanum onites
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Angelica sinensis
20% Ethanol control
20% Ethanol control
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Plate 1a 
 
 
 
 
 
 
 
 
Plate 1b  
 
 
 
Figure 2. Plate 1a is a photographic image of 15-mm excised leaf disks from anthracnose 
susceptible strawberry cultivar ‘Chandler’ following 3-5 second dip in fungicide test solutions in 
a dose-response format and inoculated 12 hrs later with Colletotrichum fragariae isolate #75.  
Plate 1b is an image analysis of Plate 1a using the LemnaTec and SAW Scanalyzer analyzing 
software showing healthy tissue in green, diseased (necrotic) lesions in black, and bleached 
tissues (phytotoxicity) in gray.  
Azoxystrobin
Azoxystrobin
Origanum onites
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Angelica sinensis
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Table 3.  Percent healthy tissue, % leaf necrosis, and % phytotoxicity as determined at 5 days 
after inoculation by a Lemnatec Lemna HTS and SAW Scanalyzer analyzing software.  
Colletotrichum fragariae (CF75), C. fragariae (CF63), and C. gloeosporioides (CG162) were 
the test isolates used in these experiments.    
 
 Azoxystrobin Origanium onites Angelica sinensis  
 
625 
ppm 
1250 
ppm 
2500 
ppm 
625 
ppm 
1250 
ppm 
2500 
ppm 
625 
ppm 
1250 
ppm 
2500 
ppm Control 
% Healthy Tissue          
Cf75 99.29 98.93 99.16 65.03 9.79 16.43 92.59 79.65 36.73 86.18 
Cf63 99.55 99.51 99.64 96.17 7.32 20.94 96.02 72.20 16.18 92.22 
Cg162 99.65 99.21 99.80 98.66 33.72 17.42 98.53 97.33 27.64 94.27 
% Leaf Necrosis         
Cf75 0.40 0.55 0.39 25.81 29.78 1.02 6.49 8.78 9.59 13.01 
Cf63 0.13 0.23 0.03 3.39 17.17 0.33 2.89 7.58 0.09 6.85 
Cg162 0.04 0.40 0.09 1.13 15.97 7.19 1.05 1.42 0.91 4.85 
% Phytotoxicity          
Cf75 0.31 0.52 0.45 9.16 60.44 82.55 0.92 11.57 53.67 0.80 
Cf63 0.31 0.26 0.33 0.44 75.51 78.72 1.09 20.21 83.73 0.93 
Cg162 0.31 0.39 0.11 0.21 50.31 75.39 0.42 1.25 71.44 0.88 
 	  
	   212 
 
VITA 
 
Xiaoning Wang 
Department of Medicinal Chemistry 
School of Pharmacy 
The University of Mississippi 
 
417 Faser Hall  
University, MS, 38677 
Mobile: (662) 202-4383 
E-mail: xwang1222@gmail.com 
 
 
EDUCATION 
8/2012 
 
The University of Mississippi, MS, USA 
Ph.D. in Pharmaceutical Sciences emphasis on Natural Products Chemistry 
Dissertation Advisor: Dr. Stephen Cutler 
Dissertation Title: Isolation, Structure Elucidation and Biological 
Evaluation of Natural Products from Plants and Fungi. 
9/2006 Shandong Normal University, Jinan, China 
B.S. in Biotechnology 
 
EMPLOYMENT 
	   213 
7/08-present Graduate Research Assistant, School of Pharmacy, University of 
Mississippi, USA 
7/08-present Biological Science Lab Assistant, National Center for Natural Products 
Research, USDA-ARS, USA 
7/07-2/08 Visiting Scholar, School of Pharmacy, University of Mississippi, USA 
9/06-7/08 Graduate Research Assistant, College of Agronomy and Biotechnology, 
China Agricultural University, China 
 
WORKING/SUBMITTED PAPERS 
1. Xiaoning Wang, Mohamed M. Radwan, Amer H. Tarawneh, David E. Wedge, Stephen J. 
Cutler. Isolation and structure elucidation of secondary metabolites with antifungal activity 
from Milogrante. 2011. In preparation. 
2. Amer H. Tarawneh, Mohamed M. Radwan, Xiaoning Wang, David E. Wedge, Stephen J. 
Cutler. Two fatty acids with in vitro binding affinity for cannabinoid receptors from fungus 
UK-149. Medicinal Chemistry Research, 2011. In preparation. 
3. Xiaoning Wang, Mohamed M. Radwan, Jiangtao Gao, Amer H. Tarawneh, David E. Wedge, 
Horace G. Cutler, Stephen J. Cutler. Bioactive metabolites from Cladosporium 
cladosporioides against plant pathogens. Journal of Agricultural and Food Chemistry, 2011. 
In preparation. 
4. Jiangtao Gao, Mohamed Radwan, Francisco León, Xiaoning Wang, Olivia Dale, Susan P. 
Manly, Gui Ma, Afif Husni, Corey Gamelli, Frank Dugan, Robert Hill, Horace G. Cutler, and 
Stephen J. Cutler. Neocosmosins A-C: resorcyclic acid lactone derivatives from Fusarium 
	   214 
soloni with binding affinity for cannabinoid and opioid receptors. Journal of Natural 
Products, 2011. Submitted. 
PEER-REVIEWED JOURNAL ARTICLES 
1. Jiangtao Gao, Mohamed M. Radwan, Francisco León, Xiaoning Wang, Melissa R. Jacob, 
Babu L. Tekwani, Shabana I. Khan, Shari Lupien, Robert A. Hill, Frank M. Dugan, Horace 
G. Cutler, Stephen J. Cutler. Antimicrobial and antiprotozoal activities of secondary 
metabolites from the fungus Eurotium repens. Medicinal Chemistry Research, 2011. 
Accepted on September 12th. 
2. Xiaoning Wang, Eman Habib, Francisco Leon, Mohamed Radwan, Nurhayat Tabanca, 
Jiangtao Gao, David E. Wedge, Stephen J. Cutler. Antifungal metabolites from the roots of 
Diospyros virginiana by overpressure layer chromatography. Chemistry and Biodiversity, 
2011, 8 (12): 2331-2340. 
3. Jiangtao Gao, Francisco León, Mohamed M. Radwan, Olivia R. Dale, Corey A. Gemelli, 
Susan P. Manley, Shari Lupien, Xiaoning Wang, Robert A. Hill, Frank M. Dugan, Horace G. 
Cutler, Stephen J. Cutler. Benzyl derivatives with in vitro binding affinity for human opioid 
receptors and cannabinoid receptors from the fungus Eurotium repens. Journal of Natural 
Products, 2011, 74 (7): 1636-1639. 
4. Xiaoning Wang, David E. Wedge, Nurhayat Tabanca, Robert D. Johnson, Stephen J. Cutler, 
Patrick F. Pace, Barbara J. Smith, Ligang Zhou. Development of a miniaturized 24-well 
strawberry leaf disk bioassay for evaluating natural fungicides. Natural Product 
Communication, 2008, 3(0): 1-6. 
5. Nurhayat Tabanca, David E. Wedge, Xiaoning Wang, Betul Demirci, Kemal Husnu Can 
	   215 
Baser, Ligang Zhou, Stephen J. Cutler. Chemical composition and antifungal activity of 
Angelica sinensis essential oil against three Colletotrichum species. Natural Product 
Communications, 2008, 3 (0): 1-6. 
6. Youwen Gong, Xiujuan Zhang, Xiaoning Wang, Ligang Zhou. Effect of Essential Oil from 
Zanthoxylum bungeanum and Phellodendron chinense on Hyphal Morphology and Cell Wall 
Degrading Enzymes of Rhizoctonia solan. Natural Product Research and Development (in 
Chinese), 2008, 20: 193-197. 
 
CONFERENCE PRESENTATIONS AND POSTERS 
1. Xiaoning Wang, Stephen J. Cutler. 2012. New leads to potential agrochemical agents from 
Cladosporium cladosporioids. Poster, 11th Annual Oxford International Conference on the 
Science of Botanicals (ICSB), Oxford, MS. 
2. Xiaoning Wang, Stephen J. Cutler. 2011. Bioactive metabolites from Cladosporium 
cladosporioides against plant pathogens. Platform, MALTO Meeting, Houston, TX. 
3. Xiaoning Wang, Stephen J. Cutler. 2010. Bioactivity directed isolation and characterization 
of antifungal compounds from Diospyros virginiana. Poster, American Society of 
Pharmacognosy & the Phytochemical Society of North America Meeting, Saint Petersburg, 
FL. 
4. Xiaoning Wang, Stephen J. Cutler. 2010. Isolation and purification of antifungal metabolites 
from the roots of Diospyros virginiana by overpressure layer chromatography. Poster, 
MALTO Meeting, Oxford, MS. 
	   216 
5. Xiaoning Wang, David E. Wedge, Stephen J. Cutler. 2010. Isolation and purification of 
antifungal metabolites from the roots of Diospyros virginiana by overpressure layer 
chromatography. Poster, NCNPR Internal Poster Session, Oxford, MS. 
6. Xiaoning Wang, David E. Wedge, Stephen J. Cutler. 2009. Development of a miniaturized 
24-well strawberry leaf disk bioassay for evaluating natural fungicides. Poster, American 
Society for Horticultural Science Annual Conference, Saint Luis, MI. 
7. Xiaoning Wang, David E. Wedge, Stephen J. Cutler. 2009. Development of a miniaturized 
24-well strawberry leaf disk bioassay for evaluating natural fungicides. Poster, 7th Annual 
Oxford International Conference on the Science of Botanicals (ICSB), Oxford, MS. 
8. Xiaoning Wang, David E. Wedge, Stephen J. Cutler. 2007. Development of a miniaturized 
24-well strawberry leaf disk bioassay for evaluating natural fungicides. Poster, NCNPR 
Internal Poster Session, Oxford, MS. 
 
